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ABSTRACT
Status epilepticus (SE) is a medical neurological emergency and may cause brain injury 
associated with epilepsy and cognitive decline. Evidence suggests that the hippocampus is 
particularly vulnerable to injury from SE and that the resulting hippocampal injury has been 
hypothesised to continue to evolve on to mesial temporal sclerosis associated temporal 
lobe epilepsy (MTS-TLE). This form o f epilepsy is particularly difficult to treat with current 
medical therapies, and thus it is the most common epilepsy that requires surgical 
intervention. Therefore understanding the relationships between SE, hippocampal injury 
and MTS-TLE may provide the basis for development o f novel therapies for treating post- 
SE injury.
Clinical magnetic resonance imaging (MRI) studies have indicated that the hippocampus is 
injured following SE, but whether this injury will progress on to MTS-TLE remains 
unclear. To facilitate research, experimental models have been developed for investigating 
SE and its sequelae. Therefore, this study used the pilocarpine rat model for investigating 
SE and its related injury with multi-parametric MRI.
The first part o f this work investigated post-SE pathology with MRI and results indicate a 
characteristic injury profile for various brain regions injured by SE. Analysis o f the 
hippocampus indicated a peak response 2 days following the insult showed a striking 
relationship to the degree o f later injury, suggesting that imaging during the early period 
may predict later outcome. To investigate this response further, a combination of MRI and 
proteomic analysis was used and protein changes were identified. The second part of this 
study consisted o f developing a method for imaging the onset and evolution o f SE, and 
results suggest that limited perfusion may contribute to the hippocampal vulnerability to 
prolonged seizures.
This work has identified an early MRI biomarker o f later injury, and possible protein 
substrates for interventional therapy. Furthermore, evidence for the selective vulnerability 
to SE was found.
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ABBREVIATIONS
2-D E ..................................................... ................................ two-dimensional gel electrophoresis
A D C ...................................................................................................apparent diffusion coefficient
AMPA ................................   OC-amino-3-hydroxy-5-methyllisoxazole-4-propionate
ANO VA ..............................................................................................................analysis of variance
ASL  arterial spin labelling
A TP  adenosine triphosphate
B B B .......................................................................................................................blood brain barrier
BO LD ................................................................................... blood oxygenation level dependent
Ca...............................................................................................................................................calcium
CA ................................................................................   cornu amonis
CASL.......................................................   continuous arterial spin labelling
CBF ...................................................................................................................... cerebral blood flow
CLP........................................................................................control imaging lithium-pilocarpine
CLS control imaging lithium-saline
C N S ...............................................................................................................central nervous system
COX .............................................................................................................................cyclooxygenase
CSF...................................................................................................................... cerebral spinal fluid
DW I....................................................................................................... diffusion-weighted imaging
D N A .................................................................................................................deoxyribonucleic acid
D RP-2 ................................................................................. dihydropyrimidinase related protein-2
ECG ........................................................................................................................ electrocardiogram
E D H F  endothelium-derived hyperpolarizing factor
E E G .................................................................................................................electroencephalogram
E P I  echo-planar imaging
FLP ................................................................................................................full lithium-pilocarpine
FLS  full lithium-saline
GABA y-aminobutyric acid
HSP27  heat shock protein 27
11-1.....................................................................................................................................interleukin-1
KA........................................................................................................................................ kainic acid
LC M S/M S  liquid chromatography coupled to tandem electrospray mass spectrometry
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MASAGE-IEPI... . .multiple acquisition o f spin and gradient echoes using interleaved EPI
MRI magnetic resonance imaging
MTS............................................................................................................mesial temporal sclerosis
NM D A ............................................................................................................N-methyl-D-aspartate
NM R  nuclear magnetic resonance
N O    nitric oxide
N O S .............................................................................................   nitric oxide synthase
PFA.........................................................................................................................paraformaldehyde
PGI2...................................................................................................................................prostacyclin
P N  post natal
PWI....................................................................................................... perfusion-weighted imaging
RF  radio frequency
ROI...........................................................................................................................region o f interest
ROS....................................................................  ......................................... reactive oxygen species
SE ......................................................................................................   status epilepticus
s .e .m ....................................................................................................... standard error of the mean
SRS...................................................................................................spontaneous recurrent seizures
SDS-PAGE.................................... sodium dodecyl sulfate polyacrylamide gel electrophoresis
T D .........................................................................................................................................delay time
T E ..........................................................................................................................................echo time
T I ................................................................................   inversion time
TLE .................................................................................................................temporal lobe epilepsy
T N F ....................................................................  ......................................... tumour necrosis factor
TR ................................................................................................................................. repetition time
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THE VALUE OF HAVING FOR A TIME RIGOROUSLY PURSUED A RIGOROUS SCIENCE DOES NOT 
REST ESPECIALLY IN ITS RESULTS: FOR IN RELATION TO THE SEA OF WORTHY KNOWLEDGE, 
THESE WILL BE BUT A NEGLIGIBLE LITTLE DROP. BUT IT BRINGS FORTH AN INCREASE OF 
ENERGY, OF DEDUCTIVE ABILITY, OF PERSISTENCE; ONE HAS LEARNED TO GAIN ONE’S 
PURPOSE PURPOSEFULLY. T O  THIS EXTENT, IN RESPECT TO ALL ONE DOES LATER, IT IS 
VERY VALUABLE TO HAVE ONCE BEEN A SCIENTIFIC MAN
FRIEDRICH NIETZSCHE
18
THESIS OUTLINE
This project focuses on the use of MRI to investigate the hypothesis that status epilepticus 
can cause hippocampal injury that evolves into mesial temporal sclerosis associated 
temporal lobe epilepsy in the pilocarpine rat model.
Chapters 1 to 4 provide the background information for the MRI investigations into this 
hypothesis. In chapter 1, a brief history o f the evolution o f ideas that underlie SE is 
described, also SE is contextualised from the perspective of a clinical problem, and a 
discussion as to how the hypothesis developed from clinical observations. Chapter 2 
describes the basic theories and physiological mechanisms that are thought to underlie SE, 
brain injury and epileptogenesis, and discusses some of their proposed roles in brain injury 
and the epileptogenic process. Chapter 3 details the use o f animal models in epilepsy and 
describes their relevance to epilepsy research, with a particular focus on the status 
epilepticus models. In addition, the rationale for using the pilocarpine model for this 
project is presented. Chapter 4 provides an introduction to the basic concepts that underlie 
MR imaging, including diffusion and perfusion, as well as a review o f experimental MRI 
studies on SE, brain injury and epileptogenesis.
The fifth chapter details the methodological developments that were necessary for 
conducting the subsequent MRI studies and begins with establishing the pilocarpine model 
at the department. Chapter 6 presents MRI investigations on post-SE pathology. The work 
in chapter 7 is derived from chapter 6 and examines the molecular alterations that parallel 
the multi-parametric MRI changes reported in chapter 6. Chapter 8 describes the findings 
from the MRI investigations during SE.
Finally, chapter 9 contains a general discussion of the implications o f the work and outlines 
future avenues o f research that have emerged from this project.
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CHAPTER 1: A HISTORICAL A N D  CLINICAL PERSPECTIVE OF  
STA TUS EPILEPTICUS
True science is the imitation o f nature in concepts
Friedrich Nietzsche
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1.1. A HISTORY OF STATUS EPILEPTICUS
Status epilepticus (SE) and epilepsy are both terms derived from the Greek word 
“epilamvanein”, which means “to take hold o f ’ or “to attack” (Gross, 1992), and reflects 
the very nature o f these conditions. Thus, it is o f no great surprise that the study of SE has 
been invariably intertwined with the study o f epilepsy. It is now clear that SE has its own 
pathology distinct from seizures and may even lead on to epilepsy. Seizures have always 
generated much curiosity and the journey to our current state o f knowledge can be traced 
back to the earliest beginnings o f recorded human history.
An epileptic seizure can be a visually striking phenomenon. As such, it is not surprising that 
widespread accounts o f epilepsy can be found throughout human history, and that epilepsy 
has often been attributed to the work of the supernatural. This was certainly recognised by 
Hippocrates in his ironically entitled work on epilepsy “O n the sacred disease”. In this 
work, he dismissed the supernatural origins of epilepsy, but the term “sacred disease” 
reflects much o f what many cultures ascribe to its causes. This association with the 
supernatural has meant that sufferers have been often stigmatised because they were 
considered to be unclean or evil (Gross, 1992). An example o f attributing mystical causes 
to epileptic seizures can be found in one o f the earliest known medical references to 
epilepsy, the Sakkiku cuneiform.
The Sakkiku cuneiform is a Babylonian medical text which dates from around 718-612 BC 
and within this ancient tome is an entire section devoted to epilepsy (Wilson and Reynolds, 
1990). This text details many different forms o f epileptic seizures and attributes their causes 
to the actions o f ghosts and demons. Intriguingly the Sakkiku cuneiform also contains the 
first known description o f status epilepticus:
“If  the possessing demon possesses him many times during the middle o f the night, 
and at the time o f his possession his hands and feet are cold, he is much darkened, 
keeps opening and shutting his mouth, is brown and yellow as to the eyes and... It 
may go on for some time, but he will die”
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Even though epilepsy has inspired a lot o f interest through the ages, none more so than the 
classical works by Hippocrates in 500 BC and Galen in the second century, descriptions of 
conditions resembling SE have been surprisingly few (Shorvon, 1994).
The first step that marked the separation of the study o f SE from that o f epileptic seizures 
was taken in the 19th Century, when the term “Etat de mal epileptiqui’ first appeared in Louis 
Calmeil’s university dissertation (1824), a term coined by the patients he was working with 
at the Salpetriere hospital. However, it was only in 1868 that the more familiar latinised 
English expression, status epilepticus, was first introduced in Bazires’ translation of 
Trousseau’s lectures on clinical medicine.
Early research into SE proceeded primarily by clinical observation and histological 
evaluation, and seminal studies include work by Trousseau and Bourneville. In 1903 Clark 
and Prout provided the first systematic analysis o f the clinical and pathological features of 
SE. In this paper, they described SE as the “the maximum expression of epilepsy”, 
although it is worth noting that their definition of SE incorporated only the generalised 
convulsive form.
The year 1924 marked the discovery o f the electroencephalogram by Berger and this 
signalled a revolution in epilepsy and SE research. This discovery meant that it was now 
possible to probe the electrophysiological basis o f seizures.
In 1962, at the tenth European conference on epileptology and clinical neurophysiology in 
Marseilles, the first systematic classification o f SE was formulated. This was the first 
meeting to be entirely devoted to the study o f SE and, based on clinical and 
electrophysiological data, the definition of SE was extended from the generalised 
convulsive variety to incorporate all types o f seizures. From this meeting the term SE was 
used to define “a seizure [that] persists for a sufficient length o f time or is repeated 
frequently enough to produce a fixed or enduring epileptic condition” and this definition 
remains widely used today (Shorvon, 1994).
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1.2. D E FIN IT IO N S OF STATUS EPILEPTICUS
The 1962 definition of status epilepticus by Gastaut and colleagues remains widely 
accepted and has been updated by the global authority on epilepsy research: the 
International League Against Epilepsy (ILAE). The current ILAE definition of status 
epilepticus is:
‘A seizure which shows no clinical signs o f arresting after a duration encompassing 
the great majority of seizures o f that type in most patients or recurrent seizures 
without resumption of baseline central nervous system function interictally’
Although this definition captures the prolonged and /or iterative nature of SE and also 
implies that it can occur in different types o f seizures, the question o f duration is not 
addressed. This is because the definition o f SE will depend on the specific context that it is 
used in.
There are at least two definitions for the threshold between seizure and SE. If the purpose 
o f the definition was to investigate the effect o f SE, such as for epidemiological studies 
investigating the morbidity or mortality following SE, then the 30 minutes threshold first 
proposed by Gastaut is the appropriate definition for SE. This was in light o f evidence that 
demonstrated neuropathological changes after a 30 min seizure but not in shorter seizures 
(see chapter 2) (Meldrum and Brierley, 1973; Klitgaard et al., 2002).
The second definition is in the emergency treatment o f patients. If  a patient has a seizure 
that is likely to continue then it would be unethical to wait for SE to be established before 
beginning therapy, as injury is associated with prolonged seizure activity. In a paper on a 
new classification of SE, Rona and colleagues have proposed a threshold o f 10 minutes 
(Rona et al., 2005). This threshold was proposed in the light o f a number o f studies which 
indicate that self-limiting seizures rarely last longer than a few minutes, and the seizures 
that do last longer tend to continue for more than 30 minutes (Theodore et a l, 1994; Rona 
et al., 2005). This is further underlined in studies that have demonstrated an associated
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time-dependent development of pharmacoresistance to first line anti-convulsant drugs such 
as diazepam (Lowenstein, 1999).
For the purposes o f this thesis, SE is defined as 90 minutes o f continuous seizure activity, 
as earlier studies have demonstrateed that this duration was associated with all animals 
progressing on to epilepsy (Cavalheiro et al., 2006), and in the tradition of Clark and Prout, 
will be restricted to the generalised convulsive variety.
1.3. T H E  EPIDEM IOLOGY OF STATUS EPILEPTICUS
The epidemiology o f status epilepticus has been reviewed systematically by Chin and 
colleagues (Chin et al., 2004). Their review has incorporated data from various population- 
based studies that included key studies based from Richmond, Virginia and Rochester, 
Minnesota (Delorenzo et a l, 1996; Hesdorffer et al., 1998; Chin et al, 2004) and this section 
is based primarily on their review.
1.3.1. Incidence of status epilepticus
The incidence o f SE has been measured at 6.8 — 41 per 100,000 individuals per year, 
varying across different age-groups. The cases o f SE followed a bimodal distribution with 
peak frequencies occurring in children under the age o f 1 and in patients over the age of 
60. Overall, patients with a history o f epilepsy accounted for less than 50%, with 16-38% of 
children and 42-59% of adults having a history o f epilepsy. This is a key point as SE has 
been hypothesised to be one o f the causes of epilepsy, which is the focus o f this thesis.
1.3.2. Aetiologies of status epilepticus
The aetiologies o f SE include cerebrovascular accidents, fever, hypoxia, alcohol-related, 
metabolic disorders and withdrawal or low levels o f anti-epileptic drugs (Delorenzo et al.,
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1996). However, there is an age effect in that the main causes o f SE in adults were 
cerebrovascular accidents, and withdrawal or low levels o f anti-epileptic drugs which 
accounts for 34% of the cases (Chin et a l, 2004). In children, on the other hand, fever was 
the predominant factor (33-35%) and also low levels of anti-epileptic drug (21%) (Chin et 
a l, 2004).
1.3.3. Mortality associated with status epilepticus
A number of studies have concluded that age and aetiology are the main determining 
factors of mortality associated with SE (Delorenzo et a l, 1996; Hesdorffer et a l, 1998; Chin 
et al, 2004). Deaths across all age groups were between 7.6-22% within 30 days of an 
episode o f SE and 43% within ten years. In children, the group with the highest incidence 
o f SE, mortality was 2-9% in the first 30 days and 7% within the first ten years compared 
to 22-38% in the acute period and 82% in the longer term for the elderly. However, the 
highest mortality in the first 30 days was observed in children under the age of 1 (17-18%) 
and this finding may be due more to the mortality associated with the underlying cause of 
SE rather than SE itself. This is perhaps emphasised in that no deaths in the short-term 
occurred in children who had had an episode o f fever-induced SE.
1.3.4. Morbidity associated rvith status epilepticus
SE has been associated with neurological, cognitive, and behavioural impairments. For 
example, case studies of severe impairment in anterograde memory have been reported 
following SE (Cendes et al, 1995). Also, other impairments include speech deficits in 
children following SE, and a low intelligence quotient associated with patients that have a 
history o f SE (Raspall-Chaure et a l, 2006). However, clinical evidence for these 
impairments as a direct result of SE remains unclear because o f the difficulties that arise in 
dissociating the effect of SE from its underlying cause. As such, aetiology, along with 
seizure duration, has been shown to be the major determining factors for outcome 
(Raspall-Chaure et al, 2006). Nevertheless, clinical observations have led to a hypothesis 
that proposes that one particular outcome o f SE is the subsequent development o f mesial
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temporal sclerosis associated with temporal lobe epilepsy, evidence for which is discussed 
in the next section (Cavanagh and Meyer, 1956; Scott et al, 2003).
1.4. T H E  RELATIONSHIPS BETW EEN STATUS EPILEPTICUS. 
HIPPOCAMPAL INJURY A N D  MESIAL TEMPORAL SCLEROSIS 
ASSOCIATED W ITH TEMPORAL LOBE EPILEPSY
The relationship between SE and the subsequent development of TLE was first proposed 
by Cavanagh and Meyer in their seminal paper on MTS associated with TLE (Cavanagh 
and Meyer, 1956). They described a histological study on the resected tissue o f patients 
who had undergone surgical treatment for TLE, and intriguingly, they noted a striking 
association with an earlier episode of SE in their medical history:
“Closer examination [of the temporal lobe specimens] shows that [Ammon’s horn 
sclerosis] is due to the remarkably high incidence o f status epilepticus at or preceding the 
onset o f the epileptic history”
As a result o f this observation, the hypothesis was born that SE can cause hippocampal 
injury that in turn leads on to the development o f MTS associated with TLE. In order to 
test this hypothesis, a series o f questions needs to be addressed. Does MTS play a role in 
TLE? Can SE cause hippocampal injury? And if SE can cause hippocampal injury then can 
this injury evolve into MTS and TLE?
1.4.1. The role of mesial temporal sclerosis in temporal lobe epilepsy
MTS is the most common pathology associated with TLE, and it is characterised by 
selective cell loss in the CA1 and CA3 subfields o f the hippocampus (fig. 1.1) (Engel, Jr., 
1996; Sloviter, 2005). This form of the disease is one o f the most resistant to current 
medical therapies and therefore it is the most common type o f epilepsy that requires 
surgery (Sloviter, 2005). The effectiveness o f this surgery suggests that the MTS plays a key
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role in TLE, and observations of abnormal electrical activity in these patients further 
support this hypothesis that MTS plays a central role in seizure generation (Sloviter, 2005).
Figure 1.1. Human mesial temporal sclerosis compared to normal hippocampus. (A) Autopsy control 
specimen showing normal human hippocampus. (B) Mesial temporal sclerosis in a surgical specimen. Note 
extensive neuron loss in the dentate hilus (h) and in areas CA.3 and CA.1, and survival of CA2 and 
subicular (sub) neurons. Sg denotes straight gyrus. Stained with 1% cresyl violet and magnifications at 8x. 
(adaptedfrom Sloviter 2005).
1.4.2. Status epilepticus and hippocampal injury
The causal link between SE and hippocampal injury has a long pedigree and dates back to 
the studies by Boumeville (1876) and Pfleger (1880) (Shorvon, 1994). Since then, post 
mortem studies of patients who die due either to SE or to an underlying cause have 
repeatedly shown that the hippocampus is damaged (DeGiorgio et al., 1992). However, the 
question still remained as to whether a non-fatal episode of SE can cause hippocampal 
injury. The advent of imaging modalities such as magnetic resonance imaging (MRI) can 
provide an answer to this question by providing the means to investigate the hippocampus 
following SE in vivo.
\
The first MRI study that provided evidence for this process was conducted by 
vanLandingham and colleagues. T2-weighted scans were performed on children shortly 
after prolonged febrile convulsions (PFCs), the most common form of SE seen in children, 
and revealed hyperintensities in the hippocampus, which is indicative of acute oedema 
(VanLandingham et al., 1998).
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In another study, Scott and colleagues also imaged patients after PFCs and identified 
enlarged hippocampal volumes and elevated T2 relaxation times in patients imaged within 2 
days but these changes were not detected in the patients imaged between 2 and 5 days. 
Taken together, these results suggest that oedema formation occurs in the hippocampus 
shortly after PFC (Scott et a l, 2002).
1.4.3. The relationship between SE-induced hippocampal injuiy and mesial temporal sclerosis
It is clear that SE can induce acute hippocampal injury but whether this injury will evolve 
into MTS still needs to be clarified. Scott and colleagues attempted to explore this further 
with a follow up study (Scott et a l, 2003). The patients imaged shortly after PFC were 
scanned again around 4-8 months after PFC. They reported that hippocampal volumes and 
T2 relaxation times were no different from those o f controls at the later time point and 
suggest that the oedema has resolved by the later time point. Although these patients did 
not meet the criteria for MTS on MRI, it was suggested that the injury may still be evolving 
at this still relatively early time and, in fact, may eventually progress onto MTS. An 
additional finding was that there were increasing hippocampal asymmetries in the follow- 
up scan, but the underlying basis for these asymmetries is not clear because PFC induce 
hippocampal changes that are bilateral in nature (Scott et a l, 2003).
One possible reason for the hippocampal asymmetries is that PFC causes injury to both 
hippocampi but one is selectively more vulnerable to damage or one is more resistant. 
Alternatively, these children may have had pre-existing abnormalities prior to the 
occurrence o f PFC. A combination o f both explanations is also plausible, that is the 
patients have a pre-existing unilateral hippocampal abnormality that is either more 
susceptible or less vulnerable to PFC damage (Scott et a l, 2003). Whatever the reason, most 
patients present with unilateral MTS and it is clear that longer term studies will help to 
clarify whether children following PFCs will eventually develop MTS.
So far, there have been a few case reports that have suggested that this SE-induced injury 
will eventually develop into MTS. These include a case study by Nohria and colleagues on a
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young child who presented with SE. They imaged this patient with MRI and observed 
hippocampal abnormalities shortly after SE. The child later developed mesial temporal 
sclerosis with temporal lobe epilepsy, and subsequently required epilepsy surgery (Nohria et 
a ly 1994). Also, there was an interesting case reported by Cendes and colleagues in which a 
patient was poisoned by the excitotoxic glutamate analogue, domoic acid, and later 
developed bilateral hippocampal sclerosis with temporal lobe epilepsy (Cendes et al, 1995) 
(for more detail please refer to section 3.3.).
A systematic characterisation of this process, from SE through to the development o f TLE 
is still required. For such a characterisation, the serial imaging as well as obtaining samples 
for histological analysis precludes such a study in humans, but this can be done in animal 
models. Another advantage of using animal models is that a relatively homogenous 
population can be investigated, and, considering these advantages together, it may be 
possible to identify molecular substrates that could be important for the development of 
therapies for treating brain injury and also preventing the development of medically 
intractable temporal lobe epilepsy.
1.5. SUMMARY
The visual impact o f epileptic seizures has ensured that epilepsy has generated scholarly 
interest since the earliest days of recorded human history. However, it was not until 
comparatively recently that status epilepticus, the most extreme form of seizures, was 
considered to warrant a distinct entity for study. Since then, SE has been suggested to 
cause brain injury that may be associated with cognitive decline. Moreover evidence is also 
mounting which suggests that this injury may evolve into medically intractable epilepsy.
Although the clinical data remain inconclusive with respect to SE due to the dependency 
on aetiology, animal models have so far provided the most compelling evidence for the 
progression from SE-induced brain injury on to MTS-TLE. Thus understanding the nature 
o f this progression may provide the basis for developing diagnostic and therapeutic 
strategies for injury and epilepsy.
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CHAPTER 2: TH E PH YSIO LO G Y OF STA TUS EPILEPTICUS . 
B R A IN  INTURY A N D  EPILEPTO GENESIS
It is a m istake to try to look too fa r  ahead. The chain o f destiny can only 
be grasped one link at a time
Winston Churchill
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2.1. INTR O D U CTIO N
Seizures can be described as cell-signalling dysfunction within the CNS leading to mass 
synchronous firing, and status epilepticus is an unremitting form of this condition. 
Although controversy remains as to whether short seizures cause brain injury, there is 
overwhelming evidence that supports the damaging effect of prolonged seizures. This 
injury caused by SE is associated with cognitive decline and has been hypothesised to lead 
on to the development of medically intractable MTS-TLE. The relationships between SE, 
brain injury and TLE in humans remain contentious but work on animal models support 
this hypothesis. From this work, many physiological mechanisms have been identified and 
have been suggested to underlie the transition from the normal state to seizure and SE, as 
well as injury through to the development of TLE. This chapter will review some o f these 
physiological mechanisms in this particular context.
2.1. STATUS EPILEPTICUS A N D  SEIZURES
2.1.1. Seizure initiation, propagation and termination
Initiation, propagation and termination are three distinct stages o f seizures. The initiation 
stage is characterised by the transition from neuronal activity that is sparse, asynchronous, 
and local to activity that is dense, synchronous and outwardly spreading. Propagation can 
be described roughly as a pulse of synchronous activity transmitted from one neuronal 
population to the next. And finally the termination phase that can be understood, in space, 
in terms o f propagation failure and, in time, in terms o f secondary activity patterns 
following in the wake of an initial wave of seizure activity and ultimately a return to rest 
(Pinto et al., 2005). Electrophysiological evidence suggests that although short and 
prolonged seizures share similar characteristics for the initiation and propagation stages, it 
is, by definition, the failure o f the termination stage that distinguishes seizures from SE 
(Shorvon, 1994).
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2.1.1.1. Initiation
For a seizure to begin, three factors are required: the presence of cells with intrinsic burst- 
generating properties, loss o f postsynaptic inhibitory control around these cells and also the 
synchronisation o f the epileptic discharges (Shorvon, 1994). Burst-generating cells are 
thought to be the key initiators o f a seizure and examples o f cells with burst-generating 
properties include the hippocampal pyramidal cells in the CA1 and CA3 layers, and in 
neocortical cells, especially in layers IV and V (Shorvon, 1994). These cells can be made to 
burst by a variety o f changes in their microenvironment and these have been demonstrated 
both in vitro and in vivo. Examples of these changes include increases in the extracellular 
concentration o f either K + or pH, and also decreases in extracellular Ca2+ (Yaari and Beck, 
2002).
A number o f mechanisms have been suggested to underlie the synchronisation of epileptic 
discharges. One hypothesis is that gap junctions could be central to this process. This 
followed the observation that very high frequency EE G  activity (>80Hz) often precedes 
epileptiform activity and these high frequency oscillations are too fast to be accounted for 
by synaptic transmission, and thus gap junctions may underlie this fast activity by 
facilitating diffusion of ions between cells (Traub et al., 2005). Intriguingly, there is an 
abundance o f gap junctions on glutamatergic neurons, the activation of which is critical for 
seizure generation (Avoli et al., 2002; Traub et al., 2005), but the contribution of gap 
junctions to this process requires further study.
2.1.1.2. Propagation
Propagation occurs primarily along existing neuronal pathways (Shorvon, 1994) but 
changes in the extracellular environment can also facilitate the recruitment of other brain 
regions (Traub et al., 2005). One study that demonstrates the importance of existing 
neuronal pathways in seizure propagation was conducted using a rat model of cortical 
dysplasia (Setkowicz et al., 2006). In this study, cortical dysplasia was induced in rats at 
different gestational periods with gamma radiation, and when the animals had reached 
adulthood, SE was induced with pilocarpine. SE caused clear differences in patterns of
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injury and the pattern depended on when cortical dysplasia was induced, thereby suggesting 
that altering neuronal pathways will alter the propagation o f seizure activity and thus injury.
Changes in the extracellular environment can also influence propagation. These alterations 
include changes in ion concentration o f the extracellular fluid, and volume transmission. 
Volume transmission is the accumulation of neurotransmitters in the synaptic cleft, which 
may result from the repeated firing o f action potentials, and these molecules can diffuse 
out o f the cleft resulting in activation o f neighbouring cells.
The speed of seizure propagation can vary quite substantially, ranging from <200 pm /s to 
>10 m m /s (Trevelyan et a l, 2007). Trevelyan and colleagues have demonstrated, using 
hippocampal slices, that the speed of seizure propagation is modulated by a feedforward 
inhibition mechanism (Trevelyan et al., 2006). However, this feedforward mechanism 
becomes less effective after repeated stimulation (Trevelyan et a l, 2007). The researchers 
therefore suggested that this mechanism may account for the range o f propagation 
velocities seen in seizures.
Some seizures only remain focal whereas some seizures generalise, but the mechanisms that 
facilitate seizure generalisation are not known. This is possibly due to sufficient inhibitory 
activity outside o f the epileptic focus that prevents seizure activity from propagating to 
other brain regions. One hypothesis is that rapid generalisation occurs through recruitment 
of the thalamus, but studies have been, as yet, unable to substantiate this theory (Timofeev 
and Steriade, 2004).
2.1.1.3. Termination
It has been postulated that the termination mechanisms fail in SE and that this failure is the 
primary distinction between short and prolonged seizures (Shorvon, 1994). However, the 
nature o f these mechanisms is still incompletely understood. One o f the mechanisms 
proposed to play a primary role involves the Na+/K + ATPase pump, which is critical for 
repolarisation of the membrane potential by actively resetting the ionic concentration 
gradient following neuronal firing (Heinemann and Jones 1990). This pump requires energy 
and has been estimated to consume around 60% of total cerebral ATP. However, it is the
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by-products of ATP metabolism that could be important for seizure termination. Repeated 
seizure activity leads to more metabolism o f ATP which in turn leads to an increase in the 
levels of adenosine (fig. 2.1) and adenosine, acting through A1 receptors, has been shown to 
have an anti-convulsant effect (Ribeiro et a l, 2002). Furthermore, in vitro experiments have 
shown that K x receptors are critical for the transition from short seizures to SE (Avsar and 
Empson, 2004) (see section 2.1.2.3 for more details). Taken together, it can be 
hypothesised that seizures are inherently self-limiting. A seizure starts and propagates, then 
as the seizure continues, more ATP is used leading to increases in adenosine; following a 
sustained period of seizure activity adenosine accumulates, and this therefore exerts an anti­
convulsant effect thereby stopping the seizure.
Figure 2.1. Major pathways of adenosine production, metabolism and transport through the cell 
membranes (Adaptedfrom Yusjenko, 2006) (Yutjenko and Kiec-Kononowic% 2006)
Evidence for a role of adenosine in seizures include findings that elevated adenosine levels 
during seizure activity have been identified in the epileptic foci of MTS-TLE patients using 
microdialysis probes (During and Spencer, 1992; Boison, 2005). Furthermore, an increase 
in adenosine of between a 6-31 fold was measured in these patients and this rise was 
suggested to be sufficient to terminate seizures (During and Spencer, 1992).
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Other mechanisms may also contribute to seizure termination, for example a reduction in 
pH, which can occur due to increased respiration (i.e. increased CO^ or during anaerobic 
respiration (i.e. increased lactic acid) (Dulla et al, 2005). Interestingly, the inhibitory 
neurotransmitter GABA can be metabolised for ATP production (Heinemann et al, 2002), 
but whether this has any implications for persistent seizure activity is unclear.
Termination mechanisms fail in SE, but the mechanisms that underlie this remain unclear. 
Presumably in certain situations a combination o f various factors come together to 
override termination mechanisms such as those involving adenosine. For example, consider 
prolonged febrile convulsions.
Prolonged febrile convulsions are the most common form o f status epilepticus in children 
and are seen almost exclusively within a specific age-range, between 6 months and 1 year, 
and this suggests a seizure-susceptibility period in development. Also, fever, as the name 
implies, is a defining characteristic o f PFCs and the fact that increases in temperature cause 
a lowering o f seizure threshold in neurons suggests an additional seizure-susceptibility 
factor. Therefore this would suggest that these two factors - age and fever - would favour 
seizure initiation, and seizure prolongation may possibly reflect the reduction in seizure 
threshold to an extent that the inherent termination mechanisms become ineffective.
The failure o f termination mechanisms is likely to be dependent on aetiology and the mode 
o f initiation. Whatever the mechanism for termination, the failure to do so can lead to 
disruption o f autoregulatory processes within the brain as well as activation of potentially 
harmful mechanisms such as excitotoxicity, which can have important implications for the 
sequelae to SE.
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2.1.2. Neurochemical changes associated with status epilepticus
The modulation o f brain neurochemistry forms the basis of many of the anti-convulsant 
drugs used for the treatment or prevention of seizures and SE. Brain chemistry changes 
considerably from the moment a seizure begins, and these changes have led to the 
hypothesis that a seizure starts when there is a disruption in the balance between excitatory 
and inhibitory neurotransmission, with a net increase in excitation (Shorvon, 1994; 
Urbanska et a l 1998; Morimoto et a l, 2004; Boison, 2005). This is further emphasised in 
chemoconvulsant models of seizures and SE in which chemicals are used to induce a net 
increase in excitation. These chemicals, when applied, can induce seizure-like or seizure 
activity in in vitro and in vivo models respectively. The in vitro experiments are typically 
electrophysiological, using brain slice preparations and modulation of physiological 
mechanisms. Examples include low magnesium solutions that removes the magnesium 
block and voltage dependence of NMDA receptors; K-channel blockers such as 4- 
aminopyridine (4AP), which prolongs and enhances synaptic potentials; and low calcium 
solutions, which increase membrane excitability while blocking chemical synaptic 
transmission. Similarly, in vivo administration of chemicals such as pilocarpine, which acts 
on cholinergic muscarinic receptors; kainic acid, a glutamate analogue; bicuculline, a 
GABAa antagonist, and 4AP have been used to induce seizures in animal models. This 
section will review the neurochemistry of glutamate and y-amino butyric acid (GABA), the 
two most abundant and extensively studied CNS neurotransmitters, and also adenosine, 
which has been implicated in intrinsic anti-seizure mechanisms (see section 2.1.1.3).
2.1.2.1. Glutamate
Glutamate is the most prevalent excitatory neuro transmitter in the central nervous system 
(Nicholls et a l, 2001) and exerts its effect through the activation of various receptors, 
which are ionotropic or metabotropic receptors.
Enhancement o f excitatory neurotransmitter mechanisms has been proposed to have a 
central role in epilepsy. Indeed, in the CNS, facilitation of transmitters acting on the 
cholinergic system (pilocarpine, soman) or glutamatergic system (kainic acid) can result in 
seizures. The glutamatergic system has attracted the most attention in epilepsy research
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because o f its abundance in the brain and association with excitotoxicity. Evidence that 
supports a role for glutamate in seizures include elevated levels of glutamate that have been 
found in vivo both in animal models and in patients (Urbanska et al., 1998; Ueda et al., 2002).
There are three types of ionotropic glutamate receptors: N-methyl-D-aspartate (NMDA), 
0C-amino-3-hydroxy-5-methyllisoxazole-4-propionate (AMP A), and 2-carboxy-3-
carboxymethyl-4-isopropenylpyrrolidine (kainate) receptors.
AMPA and kainate receptor activation leads to the influx o f N a+ and the efflux o f K +. The 
NMDA receptor has a different pharmacology to that o f the AMPA and kainate receptors. 
Mg2+ acts to block the receptor in the resting state and partial depolarisation is required to 
remove Mg2+ before glutamate and glycine can bind to activate this channel. This receptor, 
when activated, allows the influx o f Na+ and Ca2+ and the efflux of K +. The NMDA 
receptor has received a lot o f attention due to its central role in a number of processes in 
neurons. It has crucial roles in synaptic transmission, regulation of gene expression, 
dendritic sprouting, synaptic remodelling, long-term potentiation and long-term depression 
(Waxman and Lynch, 2005) which may all have roles to play in injury and epileptogenesis. 
N ot surprisingly, drugs acting on NMDA receptors have received widespread interest, and 
studies have indicated that NMDA antagonists, such as ketamine, can produce substantial 
neuroprotection when given after the onset o f SE (Fujikawa, 1995). However when the 
NMDA antagonists (e.g. MK-801, remacemide) were tested in clinical trials, these drugs 
were effective for reducing seizure frequency, but this effect did not last, and the 
accompanying adverse effects, such as psychoses, have thus limited their clinical 
application (Urbanska et al., 1998).
The metabotropic glutamate receptors are G-protein linked and thus have an indirect 
influence on neurotransmission via modulation o f secondary messenger mechanisms such 
as IP3 and cAMP (Ure et al., 2006). Presently, 8 different receptor subtypes are known 
(mGhij-mGlug) and these are subdivided into three groups depending on their 
pharmacological profile and sequence homology: Group I, II and III. Their pharmacology 
is beyond the scope of this thesis but Group I and III agonists and Group II antagonists 
are thought to have anti-convulsant properties (Moldrich et a l, 2003). As such there is 
increasing interest in these receptors as potential targets for anti-epileptic drugs.
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Group I mGluRs are especially prominent in the CA3 region o f the hippocampus. 
Activation of these receptors enhances neuronal excitability and this has been shown to 
facilitate long-term potentiation induction and provoke long-term depression, as well as 
internalisation o f AMPA receptors. These receptors may also have a role in prolonging 
seizure activity. Using guinea pig hippocampal slices, Merlin and Wong demonstrated that 
selective agonists of Group I mGluRs converted picrotoxin-induced brief discharges into 
prolonged discharges lasting several seconds, and these prolonged discharges induced by 
the agonists continued for hours even after the agonist was removed (Merlin and Wong, 
1997)., which supports the hypothesis that these receptors have a role in seizures.
2.1.2.2. y-amino butyric acid
y-aminobutyric acid (GAB A) is the major inhibitory neuro transmitter in the brain (Nicholls 
et al., 2001), and alterations in GABAergic transmission have been implicated in epilepsy. 
There are three types of GABA receptors that have been classified: GABAa, GABAb and 
GABAC. Both GABAa and GABAC are ionotropic receptors that modulate the passage of 
Cl , whereas GABAb is a metabotropic G-protein-linked receptor. Although epilepsy 
research has focussed mainly on the GABAa receptor, increasing evidence suggests 
GABAb also plays a role (Sperk et al., 2004; Enna and Bowery, 2004; Bettler et al., 2004). 
GABAC has only recently been identified in the developing rat hippocampus and it remains 
to be seen whether this receptor type is important in the epileptic brain (Alakuijala et al., 
2005).
One of the reasons for the interest in GABAa receptor is the anti-convulsant properties of 
barbiturates and benzodiazepines that act to enhance its function (Nicholls et al., 2001). 
The benzodiazepines are commonly used clinically and they are the first line drugs for the 
treatment of SE. However, studies suggest that both barbiturates and benzodiazepines 
gradually lose their efficacy as SE continues and this partly underpins the need to treat SE 
quickly and effectively. This loss o f efficacy is known as pharmacoresistance and functional 
modulation o f GABAa receptors has been hypothesised to underlie this decrease in 
effectiveness (Jones et al., 2002).
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Both short and long-term changes in GABA receptors have been demonstrated in animal 
models and patients (Morimoto et al., 2004), and these changes may be relevant to 
epileptogenesis. Studies have suggested that the ionotropic GABA receptors can shift from 
an inhibitory to an excitatory action in pathological conditions (Cossart et al., 2005) and this 
has been identified in the resected hippocampi of patients with TLE (Cohen et al., 2002). 
This implies that the major inhibitory neurotransmitter could actually facilitate seizure 
activity in these patients and could be important for understanding their medically 
intractable condition. Also GABAergic transmission has a major role in the 
synchronisation of neuronal networks such as in non-REM sleep and thus could be an 
important mechanism for seizure synchronisation (Cossart et al., 2005).
2.1.2.3. Adenosine
Adenosine has been suggested to be an endogenous cerebral anticonvulsant and may play a 
primary role in seizure termination mechanisms (Shorvon, 1994; Boison, 2005) (see section 
2.1.1.3). A 6-31 fold increase in adenosine has been detected in the epileptogenic focus of 
intractable MTS-TLE patients during seizures and this increase has been suggested to be 
sufficient to suppress seizure activity (During and Spencer, 1992). Adenosine is not a 
classical neurotransmitter, like glutamate and GABA, in the sense that it is not stored in 
synaptic vesicles but is released from the cytoplasm to the extracellular space via a 
nucleoside transporter (Ribeiro et al., 2002).
There are four types of adenosine receptor- Als A2A, A2B and A3- which are all G-protein 
linked (Ribeiro et al, 2002), and it is the A x receptor that has generated the most interest in 
epilepsy research. The hippocampus possesses high levels o f A x receptors, which are found 
both pre- and post-synaptically. The activation of A x reduces excitatory neurotransmitter 
release pre-synaptically and stabilises membrane potential post-synaptically. This action is 
through the inhibition o f adenylate cyclase and activation of phospholipase C (Boison, 
2005).
Evidence for the role o f A x receptors in seizures has been shown, in vitro, to be critical for 
the transition from seizure to SE (Avsar and Empson, 2004). Furthermore, At knockout 
mice develop lethal SE shortly after traumatic brain injury when compared to wild-type 
mice, which suggests that A t receptors are critical for modulation o f seizure-induced injury
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(Kochanek et al., 2006). Although the precise function o f A x receptors in epilepsy is not 
known, it is notable that a reduction in A1 receptors and altered A x function have also been 
reported in epilepsy patients and in animal models of chronic epilepsy (Boison, 2005).
Adenosine agonists have been shown to be effective for seizure suppression, while 
antagonists facilitate seizures (Boison, 2005). However, adenosine agonists in therapy have 
had limited success due to the associated peripheral and central side effects, such as 
sedation (Ribeiro et al., 2002). Nevertheless adenosine-based medications remain an 
attractive avenue for development of novel therapies for intractable epilepsy.
2.1.2.4. Other neurochemical changes
Although glutamate, GABA and adenosine are altered in seizures, a considerable range of 
neurotransmitters and neuromodulators and their respective receptors are also modulated. 
A detailed discussion o f all of these molecules is beyond the scope of this thesis; however, 
changes in acetylcholine, dopamine, noradrenaline, serotonin, taurine, glycine, aspartate, 
opioid as well as neuropeptides such as substance P, neuropeptide Y and galanin have all 
been identified (Shorvon, 1994; Wasterlain et al., 2002). This list is not completely 
exhaustive and other neurochemicals, perhaps as yet unidentified, may also play major roles 
in seizures and SE.
2.1.3. The pathophysiology of status epilepticus
The pathophysiology of SE is summarised in figure 2.2. These physiological changes can be 
divided into two phases: compensation and decompensation (Lothman, 1990). The first to 
occur is compensation and this is the period when various physiological mechanisms are 
recruited to match the increases in energy demand from seizing neurons. Short seizures are 
confined to this period. The second stage, decompensation, begins after around 30mins of 
continuous seizure activity and this is the point when the compensatory mechanisms begin 
to fail (Lothman, 1990).
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During the compensation phase of SE, tachycardia and blood pressure increase, and raised 
plasma levels of lactate and glucose can be detected. The pH begins to fall, due to increases 
in C 0 2 and lactate, and changes in brain metabolism occur with measurable increases in 
CBF and also in glucose and oxygen utilisation.
Figure 2.2. Summary of systemic alterations and brain metabolism in SE. Various events are aligned 
with respect to a time line. Note discontinuities in the time line and the designation of a critical transition 
period after 30 minutes of SE. (1) loss of reactivity of brain oxygen tension later in SE, (2) postulated 
mismatch between the sustained increase in oxygen and glucose utilisation and a fall in CBF, (3) depletion 
of brain glucose and glycogen, (4) decline in the brain energy state. PEDs = paroxysmal epileptiform 
discharges. (Adaptedfrom Eothman, 1990).
After a period of approximately 30 minutes of continuous seizure activity, the mechanisms 
recruited to meet demand begin to fail. At this point cerebral autoregulation begins to fail,
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and CBF becomes wholly reliant on systemic blood flow, which falls gradually. As the 
seizure continues, respiratory and metabolic acidosis, electrolyte imbalance and 
hyperthermia develop, and all can contribute to SE-associated injury (Shorvon, 1994). 
Although neuronal death can be detected after around 30mins, it is still not understood at 
which stage epileptogenesis begins or whether it is independent o f these phenomena.
2.2. MECHANISMS OF BRAIN INJURY
2.2.1. Ischaemia
Ischaemia, defined as restriction o f blood supply, had been hypothesised to be the 
underlying mechanism for SE-induced injury, but has since been discredited as the primary 
mechanism for SE-induced injury following the work by Meldrum and colleagues. The 
ischaemia hypothesis was suggested following observations that the hippocampus was a 
particularly vulnerable structure to both global ischaemia and SE, and that there were 
striking histological similarities between hippocampal cells following these injuries (Siesjo 
and Wieloch, 1986). However, Meldrum and colleagues demonstrated that the primary 
mechanism o f injury was through seizure activity. In their seminal study, they avoided SE 
associated systemic complications by paralysing and ventilating their experimental animals, 
adolescent baboons, and thereby maintained a constant blood supply (Meldrum and 
Brierley, 1973), they therefore demonstrated that, independent o f systemic complications, 
prolonged seizure activity alone can cause neuronal death. Subsequent studies have 
suggested that the likely mechanism responsible for this neuronal injury is excitotoxicity, 
and that this mechanism of cell injury underlies injury in SE, ischaemia and hypoglycaemia, 
therefore explaining the histological similarities following each o f these insults (Siesjo and 
Wieloch, 1986). Nonetheless, it should be acknowledged that ischaemia may contribute to 
SE-induced injury through systemic complications commonly associated with SE (see 
section 2.1.3).
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2.2.2. Hxcitotoxicity and Ca+
Excitotoxicity is the main mechanism that underlies seizure-induced neuronal injury, 
mediated primarily through the influx of extracellular Ca2+ via glutamatergic NMDA 
receptors (Chen and Wasterlain, 2006). The damaging effect o f glutamate was first 
described by Lucas and Newhouse who demonstrated that administering monosodium 
glutamate systemically caused retinal damage in rat pups, which they attributed to a direct 
effect o f glutamate (Lucas and Newhouse, 1957). Subsequently, the role of NMDA 
receptors in cell injury was revealed by Olney and colleagues when they used selective 
glutamate analogues to demonstrate that neuronal cell death was due to the activation of 
these receptors (Olney et al., 1974; Olney and de Gubareff, 1978).
Clinical and experimental studies have demonstrated that SE is associated with increased 
levels of extracellular glutamate during seizure initiation and maintenance (During and 
Spencer, 1993; Ueda et al., 2002). The persistent activation of NMDA receptors in SE 
causes a toxic accumulation o f intracellular levels o f Ca2+ by activating intracellular 
pathways that can lead to cell death. These include the activation o f proteases, 
phospholipases, endonucleases, kinases and nitric oxide synthases. Activation of these 
systems can lead to degeneration of cell membranes, DNA destruction, and mitochondrial 
dysfunction, which in turn can lead to the production o f toxic levels of highly reactive free 
radicals that causes membrane and DNA destruction and can ultimately lead to cell death.
2.2.2.1. A  hypothesised role of Ca+ and the development of epilepsy
Ca2+ is a ubiquitous intracellular second messenger and has a central role in many 
physiological processes including neurotransmitter release, cell growth and differentiation 
and gene expression (Delorenzo et al, 2005). However, there is increasing evidence which 
suggests that Ca2+ may be a potential marker for SE, epileptogenesis and epilepsy 
(Delorenzo et al., 2005). Raza and colleagues reported that, in a time-course study using the 
pilocarpine model of SE, elevated levels o f intracellular Ca2+ were seen in hippocampal 
neurons from immediately after SE until 1 year later (Raza et al, 2004). Furthermore, they
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demonstrated that inhibition o f the NMDA receptor, using MK-801, prevented both the 
increases in Ca2+ and the development of spontaneous recurrent seizures (Raza et al, 2004).
Although some cells do die after SE, it is the surviving population o f cells which is of 
interest as dead cells cannot elicit any seizure activity. Delorenzo has suggested that, 
following SE, the neurons that survive have a compromised Ca2+ homeostasis due to the 
seizure activity, and as Ca2+ is involved in processes such as neurotransmitter release, 
consistently elevated levels of intracellular Ca2+ can lead to a perennial hyper-excitable state, 
and therefore contribute to the development of epilepsy (Delorenzo et al., 2005). This Ca2+ 
hypothesis is intriguing as it is the first to suggest and have evidence for a link between SE, 
brain injury, epileptogenesis and epilepsy.
2.3. PATHOPHYSIOLOGY FOLLOWING STATUS EPILEPTICUS
2.3.1. Cell death
There remains little doubt that prolonged seizures can cause cell death, the main 
mechanism underlying this being excitotoxicity. Specific brain regions are particularly 
susceptible to convulsive SE, the most studied o f which is the hippocampus; however 
neuronal injury also occurs in extra-hippocampal regions. Convulsive SE causes a selective 
destruction o f the hippocampal CA1, CA3 and CA4 sub fields, whereas CA2 is relatively 
spared. This is thought to be due to the connections between these regions. Also, it has 
been hypothesised that this pattern o f cell loss, which is a defining characteristic of MTS, 
may reflect the progression o f SE-induced injury that can lead on to the development of 
MTS-TLE.
2.3.1.1. Selective vulnerability of the hippocampus
The selective vulnerability o f the CA1, CA3 and CA4 subfields of the hippocampus is 
thought to reflect the physical circuitry of the hippocampus that provides the pathway for
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seizure propagation, and the relative sparing o f CA2 reflects the lack o f major connections 
within the hippocampal network (Paxinos, 1995)(fig. 2.3). This has been supported in 
animal models in which electrical stimulation of areas such as the entorhinal cortex, the 
perforant pathway or the hippocampus can generate seizures with injury to the vulnerable 
subregions (White, 2002). Furthermore, electrophysiological experiments on brain slices 
have demonstrated that cutting the Schaffer collaterals prevents seizure activity in CA1 and 
cutting the perforant pathway prevents abnormal activity propagating to the hippocampus 
(Avoli et a l, 2002). In addition, the vulnerable sub fields may also reflect the low levels of 
calcium-binding proteins and the relative abundance o f NMDA receptors and KA 
receptors found in these regions (Shorvon, 1994; Cendes, 2004).
Figure 2.3. Major intrinsic connections of the rat hippocampal formation. Arrows indicate the 
directionality of the connections. EC, entorhinal cortex; DG, dentate gyrus; S, suhiculum; PrS, 
presuhiculum; PaS, parasuhiculum. (Adaptedfrom Paxinos et al, 1995)
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2.3.1.2. Other regions of brain injury
Although the hippocampus is the region that has received the most attention in epilepsy 
research, as it is the most commonly and severely affected region of the brain, other areas 
are also injured by SE. These include the thalamus, cortex, amygdala and the cerebellum in 
which cell loss and gliosis have also been observed (Shorvon, 1994)
2.3.1.3. Cell loss continues long after status epilepticus
The duration and severity of SE determine the degree o f subsequent injury, and a period of 
between forty to sixty minutes of continuous seizure activity is required before neuronal 
death is observed (Fujikawa, 1995). However, even though cell death can be seen 
immediately after SE, cell loss continues after this period. The temporal evolution of cell 
death following SE has been described by Fujikawa using the pilocarpine model, with cell 
death being more severe at 24h than immediately after SE (Fujikawa, 1996). In addition, 
MRI studies have also shown that there is a progressive and ongoing cell death after SE. 
Roch and colleagues imaged rats following pilocarpine-induced SE and reported 
progressive brain atrophy (Roch et al., 2002a), and Pitkanen and Sutula have reported 
neuronal damage to continue for up to 2 months after SE (Pitkanen et al., 2002). Clinical 
studies have also indicated a progressive cell loss following SE. In a longitudinal MRI study 
by Scott and colleagues, an increasingly asymmetry in hippocampal volumes as observed in 
patients following SE and it was suggested that this injury may progress onto MTS (Scott et 
al., 2003). Taken together, these studies indicate that cell loss continues for a substantial 
period after SE. However, whether subsequent epileptic seizures contribute to this cell loss 
remains unclear.
2.3.1.4. Cell death mechanisms
The terms apoptosis and necrosis have been suggested to cause confusion due to the 
ambiguities in their definition (Sloviter, 2002) and therefore cell death will be used as a 
term that encompasses both descriptions. Cell death mechanisms can occur via two distinct
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pathways: extrinsic or intrinsic. The extrinsic pathway is activated by extracellular stimuli 
via the cell-surface ligand-gated death receptor family (Delhalle et al., 2003). Members of 
this family include TNFR1, Fas/CD95, DR3, DR4, DR5, and DR6 and can be activated by 
members of the tumour necrosis factor family of cytokines. The intrinsic pathway is 
induced by intracellular signals and the mitochondria play a central role in this cell death 
pathway. The initiating step is DNA damage and this leads to the release of cytochrome c 
from the intermembrane space. Both pathways lead to the activation of caspases and, 
ultimately, cell death.
Up-regulation o f caspases has been identified following SE in experimental studies and in 
the epileptic human temporal cortex (Becker et al., 1999; Henshall et al., 2000; Narkilahti 
and Pitkanen, 2005). Furthermore, there is evidence which suggests that cell death 
pathways are active beyond the period after the initial injury and into the epileptogenic 
period (Henshall and Simon, 2005). This is further supported by the fact that cell loss has 
been observed to continue up to two months following SE (Pitkanen et al., 2002). 
However, the role o f caspases in epileptogenesis has yet to be fully elucidated. In a study by 
Narkilahti and colleagues (Narkilahti et al., 2003), the administration of a caspase-3 inhibitor 
during and after SE did not influence the severity o f the acquired epilepsy in the amygdala- 
kindled rat. Moreover, the animals had a reduction in neuronal damage when compared to 
controls, and also a reduction in mossy fibre sprouting and thus Narkilahti and colleagues 
suggested that prevention o f cell death may not be the best focus for development o f anti- 
epileptogenic compounds.
Although injury, by definition, is required for epileptogenesis in acquired epilepsy, the 
notion that cell death may not be has also been demonstrated by drugs that are effective at 
preventing cell death but had litde effect on subsequent epilepsy. Examples include the use 
o f NMDA antagonists, and also the anti-convulsant, valproate (Brandt et al., 2003; Brandt et 
al., 2006). However, although these drugs do not influence the acquired epilepsy, the 
effectiveness o f these agents may become an important part o f post-SE therapy as cell loss 
is associated with cognitive decline.
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2.3.2. Inflammation
The role of inflammation in the pathogenesis o f SE has received increasing interest 
following studies which indicate that the immune response is the most prominent process 
that is modulated post-SE, and this has been found in patients and also in experimental 
models of SE (Gorter et al., 2006). Although inflammation has been implicated in a wide 
range o f CNS pathologies including traumatic brain injury, multiple sclerosis and cerebral 
ischaemia, its role in post-SE pathology remains unclear. Recently, it has been suggested 
that inflammation may have a key role in epileptogenesis, as up-regulation of inflammatory 
genes have been found that seemed to be independent of aetiology (Lukasiuk and Pitkanen, 
2007).
Inflammation is the body’s first line of defence against tissue injury and invasion by foreign 
pathogens, and it is characterised by the presence of a host of molecules that are not or 
barely detectable in physiological conditions (Vezzani and Granata, 2005). These molecules 
include cytokines and various established mediators o f inflammation, and they are 
associated with the recruitment of phagocytic cells, including monocytes/macrophages and 
microglia. It is notable that the regional and cellular patterns of induction of these 
inflammatory molecules, and their time course o f activation, appear to depend on the 
nature and severity o f the injury (Vezzani and Granata, 2005).
It is still not clear whether it is cell death or continuous seizure activity that initiates the 
inflammatory response, but various inflammatory mediators have been associated with SE 
(Vezzani, 2005). These include tumour necrosis factor-a (TNF- a), interleukin-1(5 (11-1(5), 
and cyclooxygenase-2 (COX-2) (Jankowsky and Patterson, 2001; Voutsinos-Porche et al!, 
2004; Turrin and Rivest, 2004; Iosif et a l, 2006). TNF- a and 11-1(5 can exacerbate seizure 
activity (Vezzani and Granata, 2005) and their expression is rapidly increased (<30mins) 
after the induction of seizures (De Simoni et a l, 2000). Although the mechanisms that 
underlie this enhancement of seizure activity are not completely clear, cytokines have been 
shown to modulate neurotransmitter systems. For example, 11-1(5 enhances NMDA 
receptor-mediated increases in intracellular calcium (Viviani et a l, 2003), which may have 
implications for seizure-induced injury. Taken together, these studies indicate that 
cytokines may have a role in the pathogenesis of SE.
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SE is associated with selective damage to the limbic system, and if inflammation is 
determined by the nature and severity of the injury, then the time course and distribution 
of inflammatory mediators may provide a clue as to the degree of injury and the processes 
that are modulated. Il-iP and TNF-a levels are increased across the entire brain following 
SE and this suggests that there is a CNS-wide inflammatory response. However, the 
increased expression of COX-2 has been shown to be localised almost exclusively in the 
hippocampus and the piriform cortex following pilocarpine-induced seizures, areas known 
to exhibit progressive injury. This suggests that the vascular recruitment of inflammatory 
cells occurs in these regions (Turrin and Rivest, 2004). A recent study using the lithium- 
pilocarpine model demonstrated that a selective COX-2 inhibitor administered following 
SE can reduce the severity of subsequent epilepsy (Jung et al, 2006), and may indicate an 
important role for COX-2 in epileptogenesis.
These studies indicate that the inflammatory process may have a key role to play in brain 
injury and the development of epilepsy. It is likely that certain inflammatory pathways are 
beneficial for brain injury following SE while, perhaps, certain ones are exacerbating the 
situation. Its effect on epileptogenesis requires further study and may be an interesting 
avenue for the development of novel post-SE therapies.
2.3.3. Neurogenesis
Although it is now widely accepted that SE can result in an increase in neurogenesis - the 
birth of newborn neurons - the functional consequences o f this phenomenon in injury and 
epileptogenesis remain unclear, and constitute an active area of research. However, whether 
this process is beneficial or deleterious is still a matter o f debate.
The dentate gyrus of the hippocampus is one o f only two regions in the mammalian brain 
in which neurogenesis is known to occur throughout adulthood, and SE has been shown to 
induce an increase in neurogenesis in this area. This has been repeatedly demonstrated in 
various animal models of SE including chemoconvulsant and electrical stimulation models 
(Parent et al., 1997; Bengzon et al., 1997; Gray and Sundstrom, 1998; Parent et al., 1998).
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However, it is not just persistent seizure activity that can increase neurogenesis; a single 
after-discharge, induced by stimulation o f the hippocampus, can lead to an increase which 
can still be detected 2 weeks later (Bengzon et al, 19'97). This suggests that neurogenesis 
could be modulated not just in SE but also by short seizures. Further evidence for this 
includes a study by Cha and colleagues, in which they induced spontaneous recurrent 
seizures using the lithium-pilocarpine method, and they found that these spontaneous 
seizures could also lead to elevated levels of neurogene sis (Cha et a l, 2004).
The molecular signals that orchestrate physiological neurogenesis and seizure-induced 
neurogenesis have only begun to be elucidated. These include hormones, growth factors, 
neurotrophins and extracellular matrix molecules, which have all been found to be 
modulated following seizures, and also alterations in neurotransmitter and 
neuromodulatory systems including glutamate, serotonin, nitric oxide and glucocorticoids 
(see Abrous for a comprehensive review) (Parent, 2002; Abrous et a t, 2005). 
Glucocorticoids have historically been one of the first factors studied for their influence on 
adult neurogenesis (Abrous et al, 2005). These steroids increase during physiological stress 
and have been shown to inhibit neurogenesis, and also cause neuronal atrophy in the rat 
hippocampus (Woolley et a t, 1990; Kim et a l, 2004). Elevated glucocorticoid levels have 
been detected in patients following SE (Calabrese et al., 1993) and have also been shown to 
potentiate seizures (Lee et al., 1989), but whether they have a role to play in pathology 
remains to be seen. Moreover, glucocorticoids can also suppress inflammation, which is a 
mechanism that has also been implicated in post-SE pathology (see section 2.3.2). These 
data suggest that glucocorticoids have an effect on both neurogenesis and inflammation, 
and may therefore have a role in SE-induced pathology-
Until recently, it was unclear as to whether electrical ac tivity, cell death, or both lead to the 
increases in neurogenesis (Parent, 2002). However, it seems that either one of these 
mechanisms can lead to increases in neurogenesis. Evidence for this has been provided by 
Smith and colleagues who demonstrated that, in the rapid amygdala kindling model, 
neurogenesis can be induced without a concomitant increase in cell death (Smith et al, 
2005). Also cell death mechanisms have been shown co facilitate neurogenesis (Abrous et 
a l, 2005).
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Although evidence shows that an increase in newborn cells can be found after SE, whether 
these new born cells integrate fully into the existing brain circuitry and function properly is 
still not completely clear. One important factor in integration o f the new cells is the 
severity o f the initial SE. Mohapel and colleagues found that, four weeks after SE, a 
majority o f these new neurons die in fully convulsed animals but not in partially convulsed 
rats (Mohapel et a l 2004). Also, newly born cells have been shown to migrate to abnormal 
locations within the hippocampus, such as the CA3 layer, dentate hilus and the inner 
molecular layer, and have altered physiological characteristics, which suggests a role for 
neurogenesis in the reorganisation o f brain circuitry post-SE (Abrous et al., 2005). 
Furthermore, it is not just the new born cells that can form aberrant synaptic connections, 
pre-existing granule cells have also been shown to do so too (Parent et al., 1999).
The hypothesis that alterations in brain circuitry facilitate seizure generation (see section on
2.3.4.) is supported by studies that found SE-induced granule cells have abnormal 
electrophysiological dynamics, and exhibit hyperexcitability that occurs synchronously with 
CA3 pyramidal neurons (Scharfman et a l, 2000; Jakubs et al., 2006). However, it is notable 
that neurons are not the only cell type formed following seizures, as gliogenesis - the 
formation o f new astrocytes and oligodendrocytes - has also been identified following SE 
(Parent et a l, 2006b). For example, Hinterkeuser and colleagues have identified immature 
astrocytes in the CA1 region in patients with TLE and these astrocytes have altered 
potassium channel function that is thought to favour seizure generation (Hinterkeuser et al., 
2000). But the role and function of these new glia cells in brain injury and epileptogenesis 
require further study.
2.3.3.1. Granule cell dispersion
The precise role o f the alteration in neurogenesis in MTS and epileptogenesis is still far 
from clear. One proposed abnormality in which neurogenesis has been implicated is 
granule cell dispersion (GCD), which is seen in approximately 40% of MTS patients 
(Blumcke et al., 2002). GCD is characterised by a widening o f the granule cell layer of the 
dentate gyrus (Fahrner et al, 2007). Studies have identified associations between GCD 
density and the severity of hippocampal cell loss, and also between GCD and early seizure
51
onset (Blumcke et a l 2002). However, there are also data that suggest that GCD may be a 
pre-existing developmental abnormality rather than an abnormality associated specifically 
with seizures and SE. For example, GCD has been observed without hippocampal cell loss; 
however these specimens analysed were accompanied by widespread cortical 
malformations (Blumcke et al., 2002).
2.3.4. Mossy fibre sprouting
Mossy fibre sprouting is the formation o f new synaptic contacts on abnormal locations in 
the supragranular region, the inner molecular layer of the dentate gyrus, and the CA3 
region of the hippocampus (Longo et al., 2003), and has been described in human TLE as 
well as in experimental animal models. Mossy fibre sprouting is one of the hallmarks of 
MTS (Longo and Mello, 1997; Pitkanen et al., 2000b) and it has been hypothesised that this 
sprouting occurs following SE and forms a reverberating circuit that facilitates seizure 
generation, and therefore could be critical in epileptogenesis and the maintenance of 
epilepsy. Nevertheless, the significance o f mossy fibre sprouting in epilepsy remains a 
controversial issue.
Mossy fibre synapses are an important component o f inhibitory circuits in the normal 
hippocampus, and abnormal and excessive sprouting have been identified in humans with 
TLE (Frotscher et al., 2006). These mossy fibres in TLE have also been shown to have 
abnormal electrophysiological dynamics, therefore suggesting a role in the generation of 
seizures in epilepsy (Wilson et al., 1998; Frotscher et al., 2006; Sloviter et al., 2006).
The role of mossy fibre sprouting in epileptogenesis has been questioned following a series 
of observations. Experimental studies have demonstrated that recurrent seizures can 
develop before the appearance of mossy fibre sprouting (Bouilleret et al., 1999). Also, in a 
study by Longo and Mello mossy fibre sprouting was blocked with cycloheximide, a 
protein synthesis inhibitor. This drug was investigated in both the pilocarpine model and 
kainate model, and in both models the animals still progressed on to spontaneous recurrent 
seizures despite having a reduction in sprouting (Longo and Mello, 1997). Therefore these 
data suggest that sprouting is not critical to epileptogenesis. However, it should be noted
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that subsequent studies have questioned whether cycloheximide does indeed block 
sprouting (Williams et al, 2002).
There are conflicting reports as to whether mossy fibre sprouting maintains epilepsy via the 
development of recurrent excitatory circuits. Gorter and colleagues observed that there was 
an increase in mossy fibre sprouting in rats with progressive epilepsy — animals that had a 
progressive increase in numbers of seizures — when compared to rats with non-progressive 
epilepsy (Gorter et al., 2006). However, Pitkanen and colleagues found no association 
between the densities of mossy fibre sprouting with the total number of lifetime seizures or 
seizure frequency in experimental models or human TLE (Pitkanen et al, 2000a). Whether 
this sprouting plays a significant role or is just an epiphenomenon in epilepsy still requires 
clarification.
2.4. SUMMARY
This chapter has aimed to review the physiological mechanisms that underlie SE, brain 
injury and epileptogenesis. In short, disruption o f neurochemical processes may act as an 
initiator to seizures. When a seizure begins, a series o f physiological changes occur, and, in 
most cases, inherent mechanisms act to terminate this event. However, when these 
termination mechanisms prove to be insufficient then injury can occur, and areas such as 
the hippocampus are particularly vulnerable to such an event. It has been hypothesised that 
injury to the hippocampus can eventually evolve into an area that acts as a seizure 
generator.
Following SE, a host o f complex physiological mechanisms is activated, and these may 
have important roles in the evolution o f SE-induced injury. In areas such as the 
hippocampus, cells die due to repeated depolarisation and this continues long after the end 
o f the seizure. Neurogenesis is also increased following continuous seizure activity, and this 
may be beneficial or detrimental. In the early period following SE, the body’s defences are 
recruited but it is still not known what role inflammation may play. It is possible that it is 
the interactions between these mechanisms that may play a critical in injury.
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Nevertheless, as the injury evolves a number of marked and characteristic anatomical 
changes can be found. These include granule cell dispersion and mossy fibre sprouting, 
which have been hypothesised to play a role in seizure generation. It is likely that other, 
perhaps unknown, mechanisms also play important roles in SE and the development of 
epilepsy.
In the context o f an evolving injury, the advantages of monitoring the injury over time are 
apparent and MRI offers the opportunity to do so. Previous MRI studies have already 
provided novel insights into seizures and epilepsy. However, recent advances in MR 
technologies have yet to be used to investigate these processes. It is now possible to use 
MRI to report on changes in energy status, function and morphology, as well as perfusion 
alterations that may provide clues to underlying pathology. It can be envisaged that the 
advent of molecular targeting MRI techniques that are currently being developed, may 
reveal exciting insights into SE, brain injury and epileptogenesis.
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CHAPTER 3: ANIM AL M ODELS OF STA TUS EPILEPTICUS . 
B R AIN  INJURY A N D  EPILEPTOGENESIS
The best model of a cat is a cat -  preferably the sam e cat
Nobert Weiner
3.1. INTRO DUCTIO N
There are a considerable number of epilepsy syndromes that have been defined by the 
ILAE, and therefore it is not surprising that a large number of animal models have been 
developed for investigating these syndromes in epilepsy research. An exhaustive review of 
which is beyond the scope of this thesis, and the interested reader is referred to “Models of 
Seizures and Epilepsy” for an in-depth review of epilepsy models (Pitkanen et al., 2006).
There is litde doubt that animal models have been a primary research tool for epilepsy 
research, and the use of these models has led to breakthroughs that provide much of the 
theory that underlies the current state of knowledge on epilepsy today. Furthermore, in the 
last century, animal models have also led to therapeutic advances in seizure management. 
For example, the effectiveness of phenytoin as an anti-convulsant was discovered through 
animal experiments, and since its introduction in 1939 it remains an important medication 
for the acute treatment of seizures and SE.
Despite these advances, the search for a therapy that treats the underlying causes of 
epilepsy remains an elusive goal. However, development of animal models that mimic 
human epileptogenesis, in parallel with clinical studies, have begun to reveal some of the 
processes that occur during epileptogenesis, some of which have been outlined in chapter 
2. It is hoped that by understanding the role o f these processes in epileptogenesis will point 
to productive avenues for developing preventative therapies.
An initial brain insult leading to brain injury that evolves into acquired epilepsy is the 
context that epileptogenesis has been most widely studied in. As such, the SE models, in 
which all o f these events occur, have been the subject of intense investigation. This 
sequence of events is thought to share many similarities with the human condition, and 
because o f the occurrence o f spontaneous recurrent seizures, or acquired epilepsy, these 
models fall into a class of animal models that are thought to be true models of epilepsy.
This chapter will review the most commonly used SE models: kainic acid, pilocarpine (with 
or without lithium pre-treatment) and the electrical induction models. In addition, an
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overview of the hyperthermia model of prolonged seizures in the immature rat will be 
presented. Furthermore, the choice o f an appropriate animal model is critical for answering 
specific investigative questions, and as such, the rationale for choosing the pilocarpine 
model for our current studies will also be discussed.
3.2. T H E  USE OF ANIMAL MODELS IN  EPILEPSY RESEARCH
Ideally, research on human epilepsy should be carried out on humans with epilepsy, but 
human research is not always possible or practical (Engel and Schwartzkroin, 2006). There 
are obvious ethical problems associated with human epilepsy research, especially when 
invasive techniques are required. Moreover, it is often difficult to control for clinical 
variables, such as genetic background, and the economic cost of conducting studies can be 
prohibitive because typically large populations o f patients need to be included. Although 
new non-invasive technologies offer many exciting opportunities for investigating the 
human condition, the need for new approaches for diagnosis, treatment and prevention of 
epilepsy can be facilitated by the use o f animal models in parallel with human epilepsy 
research.
Despite the development of animal models for research into epilepsy, the range o f animal 
models developed does not completely mimic all of the complex aetiologies and varieties of 
syndromes identified in humans (Ben-Ari and Cossart, 2000). However, the nature of 
animal models is that they share basic similarities with aspects of human epilepsy, and by 
investigating these similarities they provide the tools to divulge basic molecular and cellular 
mechanisms associated with epilepsy and seizures. Furthermore, the relevance of the 
animal models can be articulated by the key role that they have played since the early half 
o f the 20th century in which animal models have led to the discovery o f treatments for 
epilepsy disorders, some of which are still commonly used today (Sarkisian, 2001). 
Nevertheless, most o f the treatments used in epilepsy are predominantly used for the 
management of seizures, and therapies that treat the underlying causes o f epilepsy are still 
required.
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Since the relationship between SE, brain injury and MTS-TLE was first hypothesised by 
Cavanagh and Meyer (Cavanagh and Meyer, 1956), animal models have been developed 
that display a similar sequence o f events in which the animals progress on to spontaneous 
recurrent seizures following an initial brain insult. Moreover, these models share a number 
of other similarities to the human condition. The most important of these are a latent 
period that separates the initial insult and the occurrence of the first spontaneous recurrent 
seizure, the non-convulsive and convulsive seizures lasting 1 to 3 mins are observed in the 
animals and appear similar to complex partial seizures with secondary generalisation in 
humans, and once epilepsy had been established there is an increase in seizure frequency. 
In addition, features such as neuronal loss, reactive gliosis, and axonal sprouting in the 
hippocampus and several surrounding structures in the animals parallel many of the 
changes observed in tissue from patients with TLE (Dudek et al, 2006).
So far, evidence from these models suggest that there are differences between the 
mechanisms underlying epileptogenesis and the mechanisms involved in maintaining the 
expression o f seizures, and therefore suggest that the drugs which prevent epileptogenesis 
may be different from the drugs that manage seizures (Leite et al, 2002).
Even though epileptogenesis models share many similarities to the human condition, the 
direct relevance o f these models have been questioned, in that whether these events 
actually occur in humans. However, an incident in Canada, outlined below, offers a human 
equivalent o f the widely used epilepsy models and supports the view that these models are 
important for investigating epileptogenesis in humans.
3.3. DOMOIC ACID POISONING: A H UM AN M ODEL OF ACQUIRED  
EPILEPSY
In 1987, over 150 people became acutely ill after eating contaminated blue mussels (Jeffery 
et al, 2004). O f these people, 19 individuals were hospitalised and 4 people died as a result 
of the poisoning. It was subsequently established that these mussels were contaminated 
with domoic acid, which is an analogue o f kainic acid and has similar actions on the
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glutamatergic system. These mussels feed on phytoplankton and the contamination 
occurred as a result of a bloom of a specific species of phytoplankton, Vseudonit^schia f . 
mulitseries, in the region where the mussels originated from.
One specific case of domoic acid poisoning was in an elderly patient with no previous 
history of epilepsy, which was reported by Cendes and colleagues (Cendes et al, 1995). This 
patient developed complex partial SE, which required large doses of phenobarbital to 
control. After the episode, the patient acquired severe anterograde memory impairment 
that was consistent with hippocampal injury, but no EEG  abnormalities were observed in 
him over the first 8 months following intoxication. However, one year after the poisoning 
incident the patient developed complex partial seizures. When he was taken back to the 
hospital, he had a complex partial seizure with secondary generalisation after which MRI 
revealed a hyperintense T2 signal and marked atrophy in both hippocampi. The patient 
subsequently died from pneumonia, and histology revealed substantial cell loss throughout 
the hippocampi that was consistent with MTS.
This case report supports the view that associates SE, brain injury and TLE in humans, and 
therefore supports the use of SE-induced epilepsy models for investigating epileptogenesis.
3.4. MODELS OF STATUS EPILEPTICUS W ITH EPILEPTOGENESIS
The most common animal models used to study SE, brain injury and epileptogenesis 
involve either electrical stimulation or chemical convulsants to initiate SE (Loscher, 2002). 
The electrical stimulation models require surgical insertion of an electrode in areas such as 
the hippocampus or the amygdala, followed by the application of an electric current to 
induce SE. The chemical convulsants can be administered either systemically or focally for 
generating SE. Alternative methods for generating SE include a hyperthermia model in 
immature rats that also display SE, brain injury and epileptogenesis. Whatever the 
induction method, one of the key features o f these models is that after the onset of the 
seizure, the seizure becomes independent o f the mode o f induction and therefore are self- 
sustaining (Mazarati et al., 2006).
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The decision as to which animal model to use depends on the investigative question that is 
being asked. As such, it is important to understand the advantages and disadvantages of 
specific models. The electrical models have a distinct advantage over the chemical models 
in that the investigator can be sure that the injury that results from stimulation is solely due 
to electrical activity, and not from the side effects that a persistent chemical agent 
introduces. However, a disadvantage of the electrical models is that both neuronal and 
non-neuronal tissue will be stimulated during the induction of SE. A major advantage of 
the chemical models is that SE induction is a lot less labour intensive than the electrical 
models, and thus they are comparatively straightforward to set-up.
Regardless of whether electrical or chemical method is used for initiating SE, over 80% of 
the animals will subsequently develop epilepsy, and therefore the SE models are considered 
to be the most reliable and robust way to induce chronic epilepsy (Dudek et a l, 2006; 
Mazarati et al., 2006). In contrast, the hyperthermia model induces epilepsy in around 35% 
of the animals, although these data are from animals that had seizures lasting for less than 
30 minutes (Dube et a l, 2006). It has been suggested that it is the identification o f common 
mechanisms between the different models that will provide valuable insights into the 
fundamental mechanisms of brain injury and epileptogenesis (Dudek et al, 2006).
3.4.1. Electrically-induced status epilepticus models
Electrical stimulation can be used to induce self sustaining SE in a variety o f locations in 
the limbic system, such as the perforant pathway or the amygdala. These methods require 
surgical implantation of the electrodes into the relevant stimulation site, and also a 
stimulator and EEG  recording equipment for assessing the success of seizure generation 
and activity.
The localised activation of the limbic regions offers a number of advantages over the 
chemoconvulsant models. As previously mentioned, the investigator can be sure that it is 
the propagation of electrical activity that is inducing injury and not the systemic effects of 
an initiating drug. It is perhaps because of this that there are lower mortality rates
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associated with these methods with a reported survival rate o f nearly 100% (Mazarati et a l, 
2006).
The neuropathology following electrically-induced SE is very much dependent on the 
protocol in which the duration of SE and the area of induction are key factors in 
determining outcome. The injury observed following SE is typically less than that found in 
the chemoconvulsant models, with varying degrees of cell loss in the hippocampus, 
amygdala, entorhinal and piriform cortices, as well as the thalamus (Mazarati et al., 2006).
An additional advantage of these models is that EEG  is recorded during SE. Treiman and 
colleagues have characterised five different stages o f EEG  activity during SE, and noted an 
association between periodic epileptiform discharges and subsequent development of 
epilepsy (Treiman, 1995). Therefore, if periodic epileptiform discharges are observed 
during the seizure then this could be used as a good predictor of which animals will 
progress on to spontaneous recurrent seizures (Bertram and Cornett, 1993).
3.4.2. Chemically-induced status epilepticus
Status epilepticus and seizures can be induced with a variety of chemicals with many 
different mechanisms o f action (Velisek, 2006). These include bicuculline, a GABAa 
antagonist; flurothyl, a convulsant; and the selective glutamatergic agonist NMDA. 
However, not all o f these chemicals will elicit subsequent development of epilepsy 
following SE, an example of which is flurothyl. Therefore the selection of an appropriate 
model is required if SE and epileptogenesis are to be investigated.
The most widely used models for investigating SE, brain injury and epileptogenesis are the 
pilocarpine model and the kainic acid model (Sarkisian, 2001), which act on the cholinergic 
and the glutamatergic neurotransmitter systems respectively. Other drugs that act on these 
systems can also be used to study brain injury and epileptogenesis; for example, soman, a 
cholinesterase inhibitor, and domoic acid, a selective kainate agonist, have also been used 
(Bhagat et a l, 2001; Velisek, 2006).
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Whether using pilocarpine or kainic acid, either drug is most commonly administered by 
via the intraperitoneal route. Alternatively, these drugs can be given subcutaneous, 
intravenous, intracerebroventricular, and intrahippocampal. In either model, a single 
systemic injection is associated with higher mortality than with multiple low doses, and not 
all animals will experience SE with the single dose (Velisek, 2006).
For the pilocarpine model, pre-treatment with lithium can substantially reduce the 
pilocarpine dose needed for inducing SE, although the precise mechanism of lithium is not 
known, hypotheses include the ability o f lithium to prevent the desensitisation of the 
muscarinic receptor (Clifford et a l, 1987; Pontzer and Crews, 1990). In a study that 
compared the single dose pilocarpine with the lithium-pilocarpine models, Clifford and 
colleagues did not observe any behavioural, electrographic, metabolic or histopathological 
differences between the two (Clifford et al!, 1987). However, a possible disadvantage of 
lithium pre-treatment is that its mechanism of action has not been fully defined, but this 
may be out-weighed by its advantages in that this model is associated with higher 
reproducibility of SE and lower mortality, which may be a reflection of reduced systemic 
cholinergic effects when compared to high doses o f pilocarpine.
With action on different neurotransmitter systems, it is not surprising that there are several 
differences between the kainic acid and the pilocarpine models. In the kainic acid model, 
EEG  changes are first detected in the hippocampus, whereas in the pilocarpine model 
these are found first in the ventral forebrain (Clifford et al., 1987). Furthermore, although 
metabolic activation was detected in the forebrain of the pilocarpine animals, this was not 
found in the kainic acid rats. In terms o f the injury observed following SE, kainic acid was 
reported to cause slightly more damage in the hippocampus than in the pilocarpine model, 
but pilocarpine induced greater neocortical changes following SE.
Similarly to the electrical models, both the kainic acid and pilocarpine models (with or 
without lithium pre-treatment) induce neuronal injury in a variety of regions in the brain. 
These include the hippocampus, piriform cortex, entorhinal cortex and the amygdala 
(Dudek et al!, 2006; Cavalheiro et al., 2006; Mazarati et al!, 2006). It should also be noted 
that although a vast majority o f animals in either model will progress on to spontaneous 
recurrent seizures, these animals display different pharmacological responses to dmg
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therapy. For example, valproate is effective at preventing epilepsy and reducing 
neurodegeneration in the kainic acid model, which is in contrast to the pilocarpine model 
(Loscher, 2002). The differences between the effectiveness of drugs in various models are 
perhaps not surprising given that the SE induction chemicals have distinct mechanisms of 
actions, and that systemic effects may play a role.
3.4.3. Experimentalprolongedfebrile seizures
Prolonged febrile convulsions are the most common type o f SE in humans and are 
characterised by fever and seizures in a specific age range (Chin et al'., 2004). These 
characteristics have been incorporated and developed into an animal model of 
experimental prolonged febrile seizures (Dube et al., 2006). These seizures are induced by 
hyperthermia in rats aged between postnatal day (PN) 7 — 14 and which, in terms of 
hippocampal development, are thought to be equivalent to the first year of human life 
(Avishai-Eliner et al., 2002).
In this rat model, seizures are generated by raising and maintaining the core temperature to 
40-42C for 30 minutes, and these rats will have a seizure that lasts for around 24mins 
(Dube et al., 2006). EEG  data indicate that these seizures are limbic in origin and involve 
the hippocampal formation. Furthermore, this model, in which seizures last for less than 30 
minutes, does not lead to acute or long term neuronal death, but a transient neuronal injury 
in limbic structures including the hippocampus, amygdala and perirhinal cortex. Acute T2 
changes have also been reported in the hippocampus, amygdala, piriform cortex and medial 
thalamus, which are consistent with other models o f SE (Dube et al., 2004). Around 88% of 
these experimental animals that have undergone early prolonged febrile seizures have been 
reported to show interictal discharges, and approximately 35% of these animals developed 
spontaneous recurrent seizures (Dube et al., 2006).
It is unclear how this model compares with the other prevailing models o f SE. The 
duration o f and the severity o f SE have been shown to be critical in SE sequelae (Fujikawa, 
1996), and therefore most studies have used a seizure duration significantly greater than 30 
minutes compared to the 24 minutes in this model. It may be argued that the prolonged
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febrile seizure model is focussing on injury and epileptogenesis in the absence o f neuronal
death, and therefore this model indicates that neuronal death is not critical for
epileptogenesis. However, it remains to be seen whether longer seizures that will result in 
cell death facilitate the development of epilepsy.
3.5. O TH ER MODELS OF EPILEPTOGENESIS
The main characteristic of the chronic epilepsy models is the expression 
recurrent seizures (SRS) some time after a precipitating brain insult 
Although the SE models are the most widely used for investigations into 
there are other models that also display this phenomenon. These include 
infection or traumatic brain injury as an initiating brain insult.
3.6. RATIONALE FOR USE OF T H E  LITHIUM -PILOCARPINE/
PILOCARPINE M ODEL IN  THIS STUDY
The pilocarpine model was chosen for this thesis for a variety of reasons. The most 
important reason is that SE, brain injury and epileptogenesis can both be investigated using 
this one model. Additional benefits o f the pilocarpine model are that this model is highly 
reproducible, with a majority of the animals entering SE, and depending on the duration of 
SE, most o f these will also progress on to spontaneous recurrent seizures.
Furthermore, we decided to use an animal model that was well-established in the epilepsy 
research field because this was the first experimental epilepsy project to be conducted in 
our laboratory. An example of the widespread use of pilocarpine can be shown with a 
search on PubMed with the parameters: status epilepticus, animal, journal article in the last 
5 years with either one of electrical, kainic acid or pilocarpine. This search returned 41, 143 
and 237 articles respectively. This may reflect that the pilocarpine model is, compared to 
the electrical stimulation models, relatively simple to set up, and the cost o f the drugs used
of spontaneous 
(White, 2002). 
epileptogenesis, 
stroke, cerebral
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in this model is not prohibitive with 1 gram costing £12.76 (Sigma-Aldrich, UK), unlike 
kainic acid in which an equivalent amount costs £9,880.00 (Sigma-Aldrich, UK). For these 
reasons the lithium-pilocarpine/pilocarpine model was chosen for our investigations.
3.7. SUMMARY
There have been many advances in identifying the underlying mechanisms o f epilepsy and 
epileptogenesis in recent times that have been underpinned by the use of animal models. 
These have helped in the development of anti-convulsant therapies that have been effective 
for the management o f seizures, and we have moved away from primitive and ineffective 
treatments such as those used in the 19th century that included mistletoe, turpentine and 
even castration (Gross, 1992). However, the goal of providing a therapy that will prevent 
epilepsy remains elusive.
The development of animal models of acquired epilepsy, such as the SE models outlined in 
this chapter, can provide the necessary tools for elucidating the underlying mechanisms of 
brain injury and epileptogenesis, which may provide the basis for therapy. However, there 
is a multitude o f ways for inducing brain injury and epileptogenesis, and differences even 
exist between the SE models. But, as Dudek had suggested (Dudek et a l, 2006), the most 
valuable aspects o f these models are likely to be in identifying mechanisms that are 
common across the models, and these are likely to be associated with the fundamental 
mechanisms o f brain injury and epileptogenesis rather than a model-specific phenomenon. 
With this in mind and for the more practical reasons outlined above, we have chosen the 
pilocarpine rat model for our initial investigations into SE, brain injury and epileptogenesis.
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CHAPTER 4: MRI. STATUS EPILEPTICUS A N D  EPILEPSY
Observe due measure, for right timing is in all things the most important 
factor
Hesiod
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4.1. INTRO DUCTIO N
Magnetic resonance imaging has revolutionised the investigation of pathologies in vivo, 
especially in disorders of the central nervous system, and it is now routinely used for both 
diagnostic and research purposes. Its non-invasive nature and ability to provide 
information about anatomical, functional and metabolic processes means that MRI is 
becoming the medical imaging modality o f choice in many diagnostic areas. Furthermore, 
because of its non-invasive nature, longitudinal studies can be conducted. This means that 
the natural evolution of pathologies can be monitored in single subjects and here lies the 
main strength of MRI.
In epilepsy research, and perhaps more pertinently in epileptogenesis research, the ability to 
follow pathology subsequent to SE on to the development of spontaneous recurrent 
seizures offers an exciting alternative to traditional methods such as histology. Also a 
sequence o f events occurs from the onset of a seizure through to its termination, but how 
these events translate into the injury associated with SE remains unclear. Traditional in vivo 
techniques have been employed to measure various physiological phenomena, such as 
electrical signals during a seizure, but these methods tend to be limited by the lack of either 
spatial or temporal resolution. The spatial resolution and discrimination of soft tissue that 
MRI offers is unparalleled by any other modality and the advent of increasingly faster 
imaging MR techniques offers the possibility for investigating evolution of these 
phenomena.
Another advantage of MRI is that it can be used to investigate a variety o f changes in tissue 
state by utilising various types of contrast, with each contrast offering unique information. 
For example, T t and T2 imaging interrogates the local physical micro-environment of tissue 
water. In addition, more recent developments in MR contrasts, such as diffusion and 
perfusion imaging, provide the tools to investigate directly the underlying physiological 
nature o f changes in the tissue.
A comprehensive review of the theories that underlie MRI are beyond the scope of this 
thesis, and interested readers are directed to “NMR and its applications to living systems”,
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which explores these areas in greater detail (Gadian, 1996). This chapter will review the 
basic theory of nuclear magnetic resonance (NMR), which underpins MRI, and also the 
theory behind the associated contrasts that have been used in this thesis. Also previous 
MRI studies on epilepsy will be reviewed.
4.2. PRINCIPLES OF NUCLEAR MAGNETIC RESONANCE
Nuclear magnetic resonance exploits the magnetic moment generated by the spin of atomic 
nuclei. The most frequently investigated nucleus in MRI is the proton (1H) because of its 
abundance in organic matter, and its relatively high magnetic moment compared with other 
nuclei. When an object is placed into a magnetic field (B0), such as the field of an MRI 
scanner, the nuclear spins take up one of two directions in relation to the field: either 
parallel or anti-parallel. As one nucleus that is oriented in one direction essentially cancels 
out another that is oriented in the opposite direction, it is the net difference between the 
populations o f the two directions - known as the longitudinal magnetisation - that can be 
manipulated for detection in MRI.
The longitudinal magnetisation can only be detected if it is disturbed away from B0 (z-axis), 
which can be achieved by applying a radiofrequency (RF) pulse in the plane perpendicular 
to B0. This creates an oscillating magnetic field (Bt) that causes the nuclei to rotate away 
from the z-axis towards the x-y plane. The frequency (co0) at which the longitudinal 
magnetisation can be disturbed is called the Larmor (resonance) frequency and this is 
determined by the strength of B0, and the property o f a given atomic nucleus known as the 
gyromagnetic ratio (y). This relationship is described by the equation:
w0 =  Y®0
I f  the RF at the Larmor frequency is applied for an appropriate time, all of the net 
magnetisation for that specific nucleus will tilt into the x-y plane and as such this pulse of 
RF is called a 90° pulse (figure 4.1). Once the net magnetisation is moved away from B0, 
the signal can be detected by a receiver coil. As the nuclei precess in the x-y plane, an
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electrical current oscillating at the resonance frequency is generated in the coil and it is this 
signal that is processed to give the final MR image.
1) 2)
90°
XX
Coil 
Signal
Figure 4.1. Net magnetisation. 1) Net magnetisation shown in red that resides along the t^ -axis cannot 
he detected by the coil 2) Application of a 90° RF pulse tilts the magnetisation into the x-y plane and 
signal can now be detected
4.3. SEQUENCES: SIGNAL. RELAXATION AND MANOEUVRE
A 90° pulse causes the entire net magnetisation to be tilted into the x-y plane and this 
‘generates a signal that can be detected by a receiver coil. However, this signal, known as the 
free induction decay, disperses at a rate described by the term T2* (fig- 4.2).
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Figure 4.2. Free induction decay. The signal decay following a 90° RF pulse.
T2* relaxation consists of two independent elements and their relationship is defined by:
i / t 2* = i / t 2 + 1 /T 2’
The T2 component refers to the fundamental loss o f phase coherence in the x-y plane over 
time. Also known as the transverse or spin-spin relaxation time, T2 describes the alteration 
of the precession rates of the nuclei through interactions with neighbouring nuclei, and this 
takes place independently of energy exchange with the lattice.
The T2’ component describes the effects of magnetic field inhomogeneities that result in 
the dephasing o f spins. T2* comprises both of these elements and it is the susceptibility of 
T2* to field inhomogeneities that makes it sensitive to the blood oxygenation level 
dependent, or BOLD, effect, which is widely used in functional MRI studies.
The relaxation times that have been described so far only characterise the processes that 
occur in the x-y plane. A further relaxation time describes the recovery of net 
magnetisation along the z-axis, and this is the Tj relaxation time. Also known as the 
longitudinal or spin-lattice relaxation time, this time constant describes the rate o f energy- 
exchange between the excited hydrogen nuclei and their molecular environment, which 
may be facilitated by the presence o f macromolecules and tissue structures in the 
immediate surroundings.
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Tj and T2 describe fundamental processes in NMR, and both can be measured through 
manipulation o f the nuclei with particular sequences o f radiofrequency pulses applied at the 
resonance frequency. T 1 and T2 are commonly measured using the inversion recovery and 
the Hahn spin echo sequences respectively. Both will be described in brief below.
4.3.1. The inversion recovery sequence
The inversion recovery sequence is the most well known method for interrogating (see 
fig. 4.3). It consists of two RF pulses: a 180° pulse followed by a 90° pulse. The initial 180° 
pulse flips the net magnetisation from the +z direction to the —z direction and this then 
gradually relaxes back to the original state. A 90° pulse is then applied before the net 
magnetisation completely recovers, tilting the net magnetisation into the x-y plane and thus 
enabling the signal to be detected. A delay time (TD) then allows the magnetisation to 
return back to equilibrium.
The period between the two pulses is called the inversion time (TI). By scanning at a series 
of different TI times T t can then be determined.
180° 90°
TI TD
Figure 4.3. The inversion recovery sequence. TI, or the inversion time, is the time between the initial 
180° and the subsequent 90° RF pulse for investigating T;. The 90°RF pulse tilts the magnetisation 
along \  into the x-y plane whereby the signal can be detected. A. delay time, TD, then allows the net 
magnetisation to recover to equilibrium.
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4.3.2. The Hahn spin echo sequence
The Hahn spin echo sequence involves two RF pulses, 90° and 180°, separated by a time 
known as T E /2  (fig. 4.4). TE, or echo time, is the time between the initial 90° pulse and 
the resulting echo signal. The 90° pulse tilts the magnetisation into the x-y plane and, as 
previously mentioned, the signal decays due to the loss o f coherence as the nuclei dephase 
over time. In essence, the dephasing occurs as a result of some nuclei spinning faster or 
slower due to T2* processes.
TE/2
Echo 
signal
90° 180°
TE *►
Figure 4.4. The Hahn spin echo. TE, or echo time, is the period between the initial 90° pulse and the 
resulting echo signal. Note that the echo signal resembles a reflected image of a free induction decay signal as 
the nuclei regain and then lose coherence.
A simple analogy is a clock with an hour hand and a minute hand. If following a 90° RF 
pulse both hands point at 12 then, following a period o f time, the two hands separate as 
the minute hand moves faster in the clockwise direction, which is akin to losing coherence 
in the x-y plane. If a 180° RF pulse is applied at time T E /2 , then this causes both hands to 
move in an anti-clockwise direction. At this point, the minute hand is now behind the hour 
hand and following another period of T E /2 , the minute hand reaches back to 12 at the 
same time as the hour hand. This results in the echo signal. Thus the 180° RF pulse acts as 
a refocusing pulse. However intrinsic T2 relaxation processes leads to a loss o f signal that 
cannot be retrieved by this refocusing, and therefore the resulting signal yields information
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about T2. T2 can be determined by performing experiments using a series of different TE 
values.
4.4. T H E  BASIS OF IMAGING USING NM R
In MRI, a series of magnetic gradients are required for spatial localisation of signal from a 
sample. MR imaging manipulates two components of the signal generated following the 
application of an RF pulse: the frequency at which the spins oscillate, and the phase at which 
this oscillation occurs. This can be achieved by applying three gradients along the x, y and 2 
planes, the timings o f which are illustrated for a single-slice spin echo sequence in figure
4.5.
Figure 4.5. Rudiofrequency pulse and gradient timings for a two-dimensional Fourier-transform imaging 
sequence. G„ is the gradient for slice selection, Gy is the phase-encoding gradient, and Gx is the read 
gradient. The dashed lines on the Gy gradient indicate that n Gy values are acquired in consecutive scans. 
TR denotes repetition time and TE denotes echo time.
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The first gradient, G z, that is applied is along the z-axis and is known as the slice select 
gradient. When this field gradient is applied, the nuclei experience different fields according 
to the position along the z-axis, and thus the nuclei at each point along z have a specific 
Larmor frequency. Therefore if an RF pulse is applied that encompasses only a specific 
bandwidth o f frequencies then this would result in an excitation of the nuclei within a 
selected slice. However, this gradient causes the nuclei to dephase and thus a negative 
gradient is applied following excitation to remove these effects. Similarly to the 90° 
excitation pulse, the G z gradient is applied again during the 180° pulse to select the region 
for excitation.
The second gradient, Gy, is applied after RF excitation and is called the phase encoding 
gradient. Applied along the y-axis, the phase encoding gradient acts to alter the phase of 
the spins relative to their previous state such that the phase change can be subsequently 
detected. In order to do this, this gradient is applied after the excitation pulse and before 
signal acquisition. The amplitude of this gradient is altered in a step-wise fashion following 
signal acquisition thereby altering the phase o f the spins to differing degrees.
The third gradient, Gx, is known as the frequency encoding, or readout, gradient and this is 
applied along the x-axis during the acquisition of the echo signal. This field gradient causes 
the spins to experience different fields according to the position along this axis, and 
therefore to oscillate at correspondingly different frequencies. Similarly to the Gz gradient, 
the frequency encoding gradient also causes dephasing and therefore a compensatory 
gradient is also applied before the acquisition o f signal.
The matrix o f raw data acquired in this way has to be processed to obtain the final image 
and this is achieved by using the Fourier transform, which defines a relationship between a 
signal in the time domain and its representation in the frequency domain. The signals 
undergo a 2 dimensional Fourier transformation to extract the signal intensities as well as 
the spatial distribution of the spins in the x-y plane. By manipulating the gradients and the 
RF pulses, different types of image contrast can be generated.
4.5. DIFFUSIO N AND  PERFUSION IMAGING
Tj and T2 , which reflect the physical micro-environment o f water in tissue, form much of 
the basis of tissue contrast in MRI and can provide excellent definition o f structures in the 
brain (Gadian, 1996; van der Weerd et a l, 2004). This is because water molecules can be 
free or bound to macromolecules and their state will affect T t and T2; this can be exploited 
to give the contrast seen in MR images. However, a drawback to these methods is that the 
precise relationship between these parameters and physiological phenomena is not 
completely clear.
Diffusion and perfusion imaging are sophisticated techniques for generating tissue contrast 
and can be directly related to physiological phenomena. For these reasons, diffusion and 
perfusion imaging, along with T t and T2, were incorporated into our studies. In the 
following section the theory that underlies these techniques is reviewed.
4.5.1. Diffusion
Free diffusion describes the unrestricted random movement of molecules in space over a 
given period of time. However, diffusion is restricted in complex biological systems 
because o f the presence of natural barriers such as cell membranes, and therefore it is not 
truly free (Baird and Warach, 1998). Therefore in biological tissues, self-diffusion of water 
is referred to as apparent diffusion, and it can be described quantitatively by the apparent 
diffusion coefficient (ADC), which has units o f mm2sec'1. ADC can be influenced by a 
variety o f factors including temperature, viscosity o f the medium and the local 
microarchitecture of the tissue.
MR imaging can be made sensitive to diffusion by using a pair opposing magnetic field 
gradient pulses to spatially encode water molecules (Baird and Warach, 1998) (fig,4.6). If 
the water molecules remain in the same position following the gradient pulses, then they 
experience the full extent of the opposing pulses and thus will not generate any loss of 
signal. However, if the water molecules have moved away from their original position then
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the second pulse, or rephasing pulse, leads to a loss of signal such that the degree of signal 
change is inversely related to the degree of diffusion. This is why on diffusion-weighted 
images the areas o f high diffusion will appear hypointense and low diffusion will appear 
hyperintense, while the opposite is observed in the calculated ADC maps. Additionally, it is 
also worth noting that diffusion can occur in any direction and therefore encoding diffusion 
along only one axis is not sufficient to measure ADC. Thus a series of encoding gradients 
in different directions have to be applied for calculating ADC.
Echo
90° 180° signal
Figure 4.6. A  spin-echo sequence with the incorporation of gradients that generate diffusion weighting. 
These gradients (GJ can be applied along any axis, and generally multiple directions are required to ensure 
no directional bias. Also the amplitude of these gradients can be modulated to change the degree of diffusion- 
weighting as indicated by the arrows. By performing these steps, A D C  can be directly calculated from the 
resulting set of images.
4.5.2. Perfusion
Blood provides a constant source of essential nutrients for tissue function and survival. It is 
delivered to the tissue by the vascular system, but it is only through the capillaries that the 
exchange o f oxygen, nutrients and clearance o f waste products between tissue and blood 
occurs, and this is reflected in perfusion or cerebral blood flow (CBF). This contrasts with 
bulk flow through major vessels, such as arteries and veins, in which no exchange occurs.
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As such, perfusion is defined as the volume of blood delivered to a mass of tissue within a 
given period of time with units of ml/lOOg/min (Thomas et al,\, 2000). For the purposes of 
the present study, measuring perfusion can identify changes in the haemodynamics of 
tissue during SE and subsequent injury.
There are two main MRI approaches for measuring CBF: bolus tracking and arterial spin 
labelling (ASL). The bolus tracking methods are widely used clinically, and require the 
intravenous injection of an exogenous tracer, a gadohnium-based contrast agent. The ASL 
techniques also require a tracer, but this tracer is endogenous in the sense that the water 
protons in blood are magnetically labelled, and because of this, ASL methods allow 
multiple measurements to be performed without the limitations associated with 
administrating exogenous substances. This is the main reason that the ASL methods were 
chosen for our studies on SE.
The ASL methods for perfusion measurement are based on the fact that the magnetisation 
and relaxation characteristics of tissue water are affected by the inflow o f blood water 
(Thomas et al., 2000). MR imaging can be made sensitive to CBF if the magnetic spin state 
of blood water is different from that of the tissue. This can be achieved by magnetically 
labelling the blood water that will flow into the imaging slice. In the current study, a 
continuous ASL (CASL) method was used for labelling the blood (Detre et al., 1992).
The CASL techniques require the acquisition of two images: a CBF-sensitised image in 
which the blood has been magnetically labelled, and a control image. In this technique, a 
radio frequency pulse is continuously applied to a pre-determined set of blood vessels in 
order to invert or tag the blood entering the imaging slice. This tagging is typically applied 
to the neck in which there are four major vessels that supply blood to the brain. When the 
labelled blood perfuses the brain tissue of the imaging slice, there is an exchange of spins 
and this alters the magnetisation and relaxation characteristics of the tissue, and thus 
renders the image sensitive to CBF. A control image is also acquired in which the blood is 
not labelled. The difference between the two images is directly related to blood flow and 
therefore CBF can subsequently be calculated.
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Imaging
slice
Inversion
planeI t
Inflowing arterial blood
Figure 4.7. Representation of the continuous arterial labelling (CASL,) technique. A n  axial scan of the 
rat brain showing the position of the imaging control and labelling planes. Blood inflowing from the neck is 
magnetically labelled when passing through the inversion plane. The site of the inversion slice was chosen in 
each animal by locating the coordinates for the back of the cerebellum. The control plane was chosen by 
default to be equidistant to the imaging slice in the opposite direction.
4.6. MRI IN EXPERIMENTAL EPILEPSY
4.6.1. Tj and T2 in epilepsy
‘ T2 increases in the hippocampus have been observed following SE in humans 
(VanLandingham et al., 1998; Scott et al., 2003) and also in a variety of SE models including 
both chemically-induced and electrically-induced models (Bhagat et al., 2001; Roch et al., 
2002a; Dube et al., 2004; Nairismagi et al., 2004). In all of these MR studies, transient T2 
changes have been reported within the first 7 days after SE and they have been interpreted 
as reflecting the presence of oedema.
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Righini and colleagues performed one o f the first studies that followed the progression of 
brain injury after SE for longer than the initial few hours (Righini et al, 1994). After KA- 
induced SE, the rats were imaged from 3 hours to 9 days and the investigators noted a 
hyperintense T2-weighted signal from 24 hours to 72 hours after kainate injection. An 
initial decrease in ADC followed by an increase was also observed.
In a study that investigated the lithium-pilocarpine rat model of SE, Roch and colleagues 
observed T2-weighted hyperintensities and demonstrated a clear association between these 
hyperintense regions and areas o f neuronal swelling (Roch et al., 2002a). Therefore, they 
suggested that the T2 changes that were observed in the acute period are likely to reflect 
oedema formation and resolution, which parallel interpretations of similar changes 
observed in stroke research (Baird and Warach, 1998). They also reported an initial 
transient MRI change in the piriform and entorhinal cortices, in which there was a period 
of normalisation by 5-9 days and a subsequent hyperintense T2 signal in the chronic phase 
(3-9 weeks). The investigators noted that the latter phase appeared to coincide with the 
onset o f spontaneous seizures (Roch et al, 2002a). A similar T2 change in the limbic areas 
following electrical stimulation of the amygdala was also reported by Nairsmagi and 
colleagues (Nairismagi et al, 2004). However, neither o f these studies have been able to 
provide any evidence of a relationship between these early MR changes and subsequent 
severity o f epilepsy (Nairismagi et al, 2004). It is also worth noting that late T2 increases 
have been observed in patients and in experimental models which correlated with neuronal 
loss and the neuropathological features of MTS (Briellmann et al, 2002; Roch et al, 2002a).
In a study by Jupp and colleagues in the amygdala-kindled rat model, T2 changes were also 
reported. They reported progressive T2 increases in focal regions of the hippocampus 
without any changes in hippocampal volume, which suggests that T2 can change without 
any concomitant cell loss (Jupp et al, 2006). A similar phenomenon has also been observed 
in the experimental febrile seizure rat model (Dube et al, 2004). Dube and colleagues 
reported a transient T2 change without any histological evidence o f cell death, and they 
suggested that the T, change may indicate pathological cellular processes such as oedema 
that promote epileptogenesis.
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4.6.2. Diffusion in epilepsy
Non-invasive MR imaging of animal models of epilepsy began in the early 1990s (Lythgoe 
et a l, 2002). These early studies used ADC and T2-weighted imaging to investigate SE and 
focussed on the acute structural changes following a seizure. These studies reported 
reductions in ADC, during and shortly after SE, in a variety of seizure models without 
concomitant T 1 and T2 changes at early time points (Zhong et al\, 1993; Zhong et al, 1995; 
Prichard et al, 1995; Ebisu et a l, 1996).
Since then, ADC changes associated with SE have been described during the acute period 
with reports of both increases and decreases in ADC (Tokumitsu et al., 1997; Wall et al, 
2000; Fabene et al, 2003; Engelhorn et al, 2007). Engelhorn and colleagues investigated 
ADC changes during SE in the pilocarpine rat model, and reported that ADC values were 
decreased 90mins after SE onset in all the regions that were analysed, which included the 
hippocampus, thalamus, piriform cortex and the cortex. However, by 120mins of SE most 
regions had returned to baseline with the exceptions o f the hippocampus and the thalamus. 
An ADC decrease was also reported by Zhong and colleagues in the flurothyl rat model 
after 80mins of SE (Zhong et al, 1995). In contrast, van Eijsden and colleagues noted a 
significant hippocampal ADC increase at 3h o f SE, which returned to baseline by 5h of 
continuous seizure activity in the isoflurane-anaesthetised lithium-pilocarpine rat model 
(van Eijsden et al, 2004).
Nakasu and colleagues investigated ADC changes over a period of 7 days in the kainic acid 
rat model (Nakasu et a l, 1995). They observed an initial ADC decrease at the lh  time point, 
with a subsequent dramatic decrease in the amygdala-piriform cortex at 24h. By 3 days, this 
region had normalised. In contrast, no significant ADC changes were observed in the 
hippocampus or in the parietal cortex. On the other hand, hippocampal ADC decreases 
were observed following the induction of SE with the anti-cholinesterase inhibitor, soman, 
by Bhagat and colleagues (Bhagat et al, 2001).
In another study, Wall and colleagues monitored diffusion changes over a 24h period (Wall 
et al, 2000). They also observed striking ADC decreases in the piriform cortex. They
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imaged at 3, 6, 9, 12 and 24h after pilocarpine-induced seizures, and reported a maximal 
ADC decrease in the piriform cortex at 12h, which remained low at 24h, while cortical 
ADC was decreased at 12h but had returned to baseline by 24h. In the hippocampus, ADC 
was significantly increased by 24h. This hippocampal ADC increase was also observed 
following pilocarpine-induced SE at 12 h (Fabene et al, 2003). Fabene and colleagues also 
noted that ADC decreased in the amygdala and the cortex of these rats.
In all o f these studies, decreases in ADC have been attributed to cytotoxic oedema, 
whereas the ADC increases were considered to be due to a breakdown of the blood-brain- 
barrier leading to vasogenic oedema. ADC changes have been most frequently 
characterised in stroke, and it is in stroke studies that Moseley and colleagues established 
that ADC decreases following ischaemia were the result of the formation of cytotoxic 
oedema and a consequence o f the relocation o f water from the extracellular to the 
intracellular compartment (Moseley et al, 1990). This has been subsequently demonstrated 
in SE, and it has been suggested that this is due to excitotoxic seizure activity, which 
disrupts ion homeostasis leading to movement of water from extra- to intracellullar space 
(Baird and Warach, 1998; Roch et at, 2002a). Evidence o f cell death and neuronal swelling 
following SE has been reported at times that coincide with ADC decreases (Wall et al., 
2000; Roch et al., 2002a).
The nature o f the diffusion changes remains controversial, especially with regards to the 
hippocampus. Both ADC increases and decreases have been reported in the early period, 
but these changes may reflect the length o f SE or the mode of induction, which can 
influence outcome (Fujikawa, 1996).
4.6.3. Perfusion in epilepsy
There have only been a few studies that have used MRI to investigate the haemodynamic 
response related to SE. One of the early studies was by Fabene and colleagues (Fabene et 
al, 2003), who investigated the effects of pilocarpine-induced SE at 12h by measuring 
relative cerebral blood volume (rCBV) using an iron-based contrast agent. They observed 
regional areas of high rCBV, most notably in the hippocampus, cerebral cortex and the
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thalamus. They noted concomitant diffusion- and T2-weighted changes in these regions and 
attributed these changes to oedema formation. Furthermore, the areas with the most 
substantial increases in perfusion were areas associated with areas that displayed the 
greatest neuronal loss. Fabene and colleagues followed up this study with another in which 
they imaged rats after 4-aminopyridine-induced SE at 2h, 24h and 3 days (Fabene et al!,
2005). They reported decreases in ADC and T2-weighted hyperintensities in the 
hippocampus, medial thalamus, temporal and parietal cortices that normalised by 3 days. 
For rCBV, they observed increases that were highest at 2h post-seizure induction in the 
hippocampus (16%), the parietal cortex (32%) and the medial thalamus (44%), which all 
normalised by day 3. Their analysis with electron microscopy indicated that these early 
changes at 2h were associated with astrocytic swelling, which gradually resolved by day 3.
Engelhorn and colleagues used a semi-quantitative approach with a gadolinium-based 
contrast agent for investigating perfusion changes during pilocarpine-induced SE 
(Engelhorn et a l, 2005). They observed perfusion increases during the early phase of SE 
and a subsequent decrease as SE progressed up till 2h. They reported that areas with a 
maximal decrease in perfusion were associated with substantial neuronal loss. These studies 
indicate that perfusion-imaging is sensitive to various changes in the brain following and 
during SE. However, perfusion imaging has yet to be used to investigate these processes in 
a longitudinal fashion, and therefore this type of imaging forms part o f the studies that are 
presented in the later chapters of this thesis.
4.7. SUMMARY
This chapter has aimed to review briefly the basic theories that underlie MRI and also the 
variety of different imaging techniques that have been used in the current project. In 
addition, a review of MRI studies on seizures, epileptogenesis and epilepsy demonstrate 
that these longitudinal and multiparametric investigations can provide important 
information about the underlying disease processes.
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CHAPTER 5: M ETHODOLOGICAL DEVELOPM ENTS
If I find 10,000 w a ys something won't work, I haven't failed. I am not 
discouraged, because every wrong attem pt discarded is another step  
forward
Thomas A. Edison
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5.1. INTRO DUCTIO N
The main aim o f the work presented in this thesis was to use MRI to monitor changes in 
brain structure and function during SE and the evolution o f subsequent injury.
For animal MR imaging, anaesthesia is typically used to reduce stress and to limit motion, 
as stress can influence physiology and motion can distort the acquired images. However, 
using anaesthesia for imaging SE and subsequent injury presents a problem in that the 
effect of anaesthesia on these phenomena are not completely understood.
Although the precise mechanisms of action of anaesthetic agents are unknown, these drugs 
are known to exert their effect by acting direcdy on the CNS. This therefore suggests that 
anaesthesia could potentially influence our investigations into SE. This is supported by the 
fact that anaesthetic agents are used for the treatment of refractory SE (Shorvon, 1994), 
which suggests that SE could be modulated by these drugs. Furthermore studies have 
demonstrated anaesthetic agents can influence pathology in a number of brain insults, 
including cerebral ischaemia and traumatic brain injury (Warner et al, 1993; Statler et al.,
2006), but the neuroprotective effect has also been suggested to delay rather than prevent 
the evolution o f the injury (Kawaguchi et al., 2000). Also halothane, an inhalant anaesthetic, 
has been shown to confer a neuroprotective effect during electrically-induced SE (Walker et 
al, 1999), and thus indicates that altering SE with anaesthesia can influence post-SE 
pathology. Taken together, these data suggest that anaesthesia may have an effect on SE 
and subsequent injury. As the effects of anaesthesia have not been determined, the MRI 
investigations were divided into two distinct components:
1) MRI of brain injury following SE
2) MRI during SE
For these investigations, a series of preliminary studies were carried out in order to arrive at 
the final methodologies used in the later chapters of this thesis. In this chapter, the key 
developments in these methodologies for each of these components are presented, the first 
o f which was to set up an animal model of SE. The developments began with the
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experiments for MRI of brain injury following SE as standard techniques were used and 
the pilot studies conducted were to investigate the most appropriate time points for study. 
The developments for MRI during SE include investigations into an appropriate 
anaesthetic for seizure induction, and modifications of the MRI set up for the later 
investigations.
5.2. SETTING UP T H E  PILOCARPINE/LITHIUM -PILOCARPINE M ODEL
The lithium-pilocarpine model was used for the reasons given in section 3.6. The lithium- 
pilocarpine model and pilocarpine model have similar patterns of seizure onset and 
neuronal damage (Clifford et al, 1987). However, for the lithium-pilocarpine model there is 
an extra step, in that a pre-treatment with lithium chloride is required. As this was the first 
epilepsy model to be set up in our laboratory, the availability of expertise from the UCL 
Institute o f Neurology, London with the pilocarpine model meant that it was prudent to 
start with this particular model before moving on to the lithium-pilocarpine model.
5.2.1. The Racine scale: behavioural assessment of SE
One of the requirements of establishing an SE model is that there needed to be a method 
for assessing the progression on to SE. A convenient and standard method of assessing the 
progression o f seizure activity and SE is by using a stereotypical behaviour scale, which was 
first developed in experiments by Racine (Racine, 1972). This scale, known as the Racine 
scale, is presented below in table 5.1 together with the corresponding seizure type; the 
onset o f SE parallels seizure stage 3.
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Seizure stage Animal behaviour Seizure type
0 Immobility Partial
1 Facial automatisms Partial
2 Head nodding Partial or secondary 
generalised
3 Unilateral forelimb 
clonus/bilateral forelimb 
clonus
Secondary generalised
4 Bilateral forelimb clonus and 
rearing
Secondary generalised
5 Rearing, falling and 
generalized convulsions
Secondary generalised
Table 5.1. The Racine scale for behavioural assessment of seizure progression in the rat with the 
corresponding seizure type.
5.2.2. The rationale for a seizure of 90 minutes
It was decided that a 90 minute prolonged seizure was appropriate for the proposed 
investigations. This was because a persistent pilocarpine-induced SE lasting for 90 minutes 
has been shown to result in all animals progressing on to spontaneous recurrent seizures 
(Mello et al., 1993). Also, earlier suppression of SE has been demonstrated to lead to fewer 
animals developing spontaneous recurrent seizures (Lemos and Cavalheiro, 1995). A longer 
seizure duration was not considered because a higher mortality rate is associated with 
longer and more severe episodes of SE (Cavalheiro et al., 2006).
Two pilot studies were undertaken to assess the successful implementation of a seizure that 
lasts for 90 minutes, first in the pilocarpine model and then in the lithium-pilocarpine 
model. The outcome measures for both studies were that the animals progressed on to 
Racine stage 3 and that the seizure had to continue for 90 minutes, at which point 
diazepam was given to abolish SE. All injections were administered intraperitoneally.
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5.2.3. The pilocarpine protocol
The following protocol, courtesy of Dr. Annalisa Scimemi (Department of Clinical and 
Experimental Epilepsy, UCL-Institute of Neurology), was used to induce and abolish SE:
a) Methylscopolamine 1 mg/kg 20 minutes before pilocarpine
b) Pilocarpine hydrochloride 320mg/kg
c) Methylscopolamine lm g/kg 60 minutes after 1st dose
d) Diazepam lOmg/kg 90 minutes after onset of SE (stage 3 Racine scale)
Seven Sprague-Dawley rats underwent this protocol. One animal died 30 minutes after the 
administration of pilocarpine. Two rats did not progress onto SE but did display some 
head nodding behaviour. Four of the animals progressed onto stage 3 of the Racine scale 
by 40 minutes, and proceeded on to stage 5. All of the rats that progressed on to SE 
continued to display the stereotypic behaviour until after diazepam administration.
5.2.4. The lithiumpilocarpineprotocol
The differences between the pilocarpine model and the lithium-pilocarpine model are that 
lithium is administered typically between 18-24h before pilocarpine, and also a lower dose 
of pilocarpine is required for SE. It is notable that pre-treatment with lithium can be given 
between 2-24h before pilocarpine without affecting the number of animals that will express 
SE (Chaudhary et al!, 1999). Referring to the literature, 3mEq/kg of lithium chloride and 
30mg/kg o f pilocarpine were the standard dosages used. The following protocol was used:
a) Pre-treatment with lithium chloride, 3mEq/kg, 18-24 hours prior to SE 
induction
b) Methylscopolamine lm g/kg 20 minutes prior to pilocarpine
c) Pilocarpine hydrochloride 30mg/kg
d) Methylscopolamine lm g/kg 60 minutes after 1st dose
e) Diazepam lOmg/kg 90 minutes after the onset o f SE (stage 3 Racine scale)
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Four rats underwent the protocol. All of the animals progressed onto SE within 40 
minutes, and the seizure continued until after diazepam administration.
These pilot studies demonstrated that SE could be successfully induced using either the 
pilocarpine or the lithium-pilocarpine methods, and that the seizure will last for at least 90 
minutes.
5.3. MRI OF BRAIN INTURY FOLLOWING STATUS EPILEPTICUS
The main aim o f this study was to use MRI to characterise brain injury following SE and to 
identify any early predictors of outcome. The main benefits of using MRI are the ability to 
provide longitudinal multi-parametric information in individuals. As such, an approach was 
used that incorporated quantitative T 1} T2, ADC and CBF as well as a high resolution 
whole brain anatomical scan at a range of time points. However, the chronic MRI 
monitoring o f disease processes is a time-consuming and costly endeavour. Therefore it 
was cmcial to establish the most appropriate time points before beginning such a study.
Two pilot studies were undertaken for this purpose. The first was to evaluate whether there 
are any significant changes over the initial hours following the termination of SE, and the 
second study was used to evaluate long term changes following SE.
5.3.1. M RI
Scans were performed on a 2.35T horizontal bore magnet (Oxford Instruments, UK) 
interfaced to a SMIS console (Guilford, UK). Physiological parameters monitored include 
electrocardiography (ECG) recordings and rectal temperature, which was maintained at 
37±1°C using an air warming system.
All animals were anaesthetised with 1.5% isoflurane in a 60:40 N20 : 0 2 mix delivered via a 
nose cone and placed on a animal holder with bite and ear bars securing the head to
minimise movement artefacts. Physiological parameters monitored include 
electrocardiography (ECG) recordings and rectal temperature, which was maintained at 
37±1°C using an air warming system.
Images were acquired using a volume transmitter coil and a separate decoupled surface 
receiver coil. A central coronal imaging slice was selected that included the hippocampus 
and the piriform cortex (-3.3mm from bregma). The central slice was determined by visual 
inspection o f anatomical landmarks. All sequences were run using a 2mm-thick coronal 
slice.
T, maps were obtained using the multiple acquisition of spin and gradient echoes with an 
interleaved echo planar imaging (MASAGE-IEPI) sequence (Thomas et a l, 2002). The 
parameters used were: TR= 1,500 ms, 16 averages, with TE1=24 ms, TE2=65 ms, 
TE3=106 ms (for definitions of TE1/2/3, see Thomas et al^  2002).
Quantitative ADC maps were calculated from trace-weighted single shot spin-echo EPI 
images. The parameters were as follows: TR = 1500 ms, TE = 56 ms, 48 averages, b— 38 and 
872 s/m m 2. Duration of acquisitions: T2 = 4 mins and ADC = 9 mins.
5.3.1.1. Image processing and data analysis
ADC and T2 maps were reconstructed using in-house software written in IDL Software 
Version 5.6 (Research systems Inc., Boulder, CO, USA). The hippocampus was delineated 
on all processed images and analysed with SMIS Image Display Version 3.7.
5.3.2. M RI within the first 4 hours after SE
The progression o f pathological changes during the initial hours following SE was not 
known, and thus a brief investigation was conducted to provide an indication of whether 
there are any substantial changes following SE during this early period.
Two animals were used to investigate this initial period following SE and to see whether 
MRI can be used to detect any notable changes. SE was induced in two animals and serially
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imaged using T2 and diffusion at 30, 60, 120, 150 and 210 minutes following SE (fig. 5.1). 
The images were assessed and no changes in either ADC or X> in the brain were found 
over this period. This experiment indicated that there were no overt MR changes within 
the initial 210 minutes following SE, which was important for the purposes of imaging on 
day 0 after SE.
30mins 60mins 120mins 150mins 210mins
Figure 5.1. A D C  and T2 maps in the first 210 minutesfollowing SE.
5.3.3. M RI following SE over 77 days
The aim of this pilot study was to establish that it was possible to image animals following
SE for an extended period, and that these animals could survive SE followed by serial
anaesthesia. Four adult male Sprague-Dawley rats weighing 200-275g underwent the 
lithium-pilocarpine protocol (section 5.2.2). The animals were scanned at various time 
points after SE. Imaging was as follows:
Rat 1: 1, 5,7,14, 21, 28, 35, 42, 56, 63, 70 and 77 days 
Rat 2: 5, 7,14, 21, 28, 42, 49, 56, 63, 70 and 77 days 
Rat 3: 3, 7,14,21, 28, 35, 42, 49, 56, 63 and 70 days 
Rat 4: 1, 3, 7,14, 21, 28, 35, 49, 56, 63 and 70 days
The hippocampal T2 data are presented in figure 5.2. No overt changes in T2 or ADC were 
observed over the initial few days after SE in the hippocampus other than on day 3 for rat 
4. This change on day 3 was consistent with experimental and clinical studies in which an
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early and transient response has been reported (Nakasu et al., 1995; Scott et al!, 2002; Roch 
et al., 2002a). However, the region associated with the hippocampus at the beginning of the 
study displayed concomitant high T2 and increased ADC during the later periods following 
SE (fig. 5.3), which is consistent with the presence of CSF and an increase in ventricular 
volume. This suggests that the hippocampus continues to atrophy following the early 
period, however the hippocampus tissue did not demonstrate any further changes, which 
parallel previous MRI studies (Nairismagi et a l, 2004).
Furthermore, visual inspection of the images suggests that there was little difference 
between day 21 and day 70 (fig. 5.3). Therefore these data indicate that MRI can detect 
changes only during the acute phase following SE and that the later periods are associated 
with hippocampal atrophy and ventricular enlargement, which stabilised by day 21.
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Figure 5.2. Chronic hippocampal T2 time course following SE. Four animals were imaged over a variety 
of times. Blue arrow indicates that there was a high hippocampal T2 3 days after SE for rat 4 (R04). No 
other changes were observed
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Figure 5.3. A D C  maps and T2 maps acquired on 3, 21 and 70 days post-SE. Red arrows indicate 
areas of high A D C  and high T2, which are consistent with signal from CSF.
5.4. MRI DURING STATUS EPILEPTICUS
A series of experiments were performed to design a set up that allows SE to be investigated 
with MRI, and this section outlines some of these studies.
For both ethical reasons and the prevention of motion, anaesthesia has been used 
traditionally in MRI investigations into experimental animal models of disease (Lukasik and 
Gillies, 2003). However, if anaesthesia is used to prevent motion then behaviour cannot be 
used to assess SE. Furthermore, the problem with anaesthesia also presents another 
problem in that many anaesthetic agents have anti-convulsant properties. Therefore it was 
necessary to use an alternative method for assessing SE, and EEG was set up for this 
purpose.
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5.4.1. The electroencephalogram
The electroencephalogram (EEG) has been the primary tool for investigating epilepsy since 
its discovery in 1924. EEG measures the extracellular electrical signal that originates in the 
changes in postsynaptic potentials at neuronal cell bodies and dendrites o f pyramidal cells. 
The extracellular currents that are generated are small, but it is the summation and 
synchrony of the activity of a large population of neurons that generates a detectable signal 
for EEG  (Teplan, 2002). EEG is the only method that directly measures activity in the 
brain and offers a very high temporal resolution in the order of milliseconds. On the other 
hand, it has a disadvantage in that it cannot offer much in spatial information (Teplan,
2002). It is E E G ’s sensitivity to synchronous neuronal activity that makes it the gold 
standard tool for investigating and diagnosing epilepsy.
It is notable that MRI offers excellent spatial resolution and that the combination of EEG  
with MRI techniques has been implemented for investigating brain function (Linden, 2007; 
Mantini et al., 2007). However, the implementation o f these methods in parallel is not 
trivial. Problems exist in that the EEG  electrodes have to be compatible with MRI. Also 
the action o f the MRI gradients can lead to disruption of the EEG  signal and therefore 
sophisticated software is required to extract the EE G  information. Thus the simultaneous 
acquisition o f EEG  and MRI was not considered for this project.
5.4.2. Investigation into inducing and maintaining SE  for 90 minutes under anaesthesia
5.4.2.1. Introduction
In clinical medicine, general anaesthesia is always used as an adjunct to another procedure 
with the sole exception of the treatment o f refractory SE (Campagna et al., 2003). The 
potentiation o f the GABAa receptor and the inhibition of excitatory ion channels, such as 
the neuronal nicotinic and glutamate receptors, lead to the reduction in neuronal 
excitability and underlie the mechanisms o f action of the general anaesthetics (Rudolph and 
Antkowiak, 2004). However, the inhibitory effect of anaesthetics presents a problem in that
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one of the aims of this project was to use MRI to investigate the onset and termination of 
SE, which requires exciting the brain.
Certain anaesthetic agents have been associated with seizure activity. For example, 
lignocaine at high doses has been shown to induce seizures but on the other hand it is an 
effective anti-convulsant at lower doses (Shorvon, 1994). Nonetheless, this particular agent 
cannot be used because if a seizure is to be induced then this would lead to motion 
artefacts during MRI. As some anaesthetics may have a pro-convulsant effect, the aim of 
the present experiments was to investigate the induction and maintenance of SE under an 
anaesthetic regimen. Two were chosen: isoflurane and fentanyl/medetomidine.
5.4.2.1.1. Isoflurane
Isoflurane is a volatile gaseous agent that belongs to a class of drugs known as the inhalant 
anaesthetics, which include halothane and sevoflurane (Campagna et al., 2003). The precise 
mechanism o f action for isoflurane, like the other dmgs of its class, remains unclear; 
however it has been shown to have action on various neurotransmitter systems including 
those o f GABA, glycine, acetylcholine and glutamate.
Isoflurane is a commonly used anaesthetic in MR studies of small animals (Lukasik and 
Gillies, 2003). Its main advantage is that, as an inhalant anaesthetic, it is simple to modulate 
the depth o f anaesthesia to maintain homeostasis, and it is cleared rapidly from the body 
making it particularly suitable for MRI (Flecknell et al., 1996). However, isoflurane is also 
used for the treatment of refractory SE (Shorvon, 1994) and may therefore prevent the 
onset o f pilocarpine-induced SE. Nevertheless, van Eijsden and colleagues have 
successfully used inhalant anaesthetics for the induction and maintenance of SE using the 
lithium-pilocarpine method in rats (van Eijsden et al., 2004). Therefore, the induction and 
maintenance o f SE using pilocarpine under isoflurane anaesthesia was investigated with 
EEG.
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5.4.2.1.2. Fentanyl/ medetomidine
The combination of fentanyl and medetomidine can be used to induce surgical anaesthesia 
in small animals (Meert and De, 1994; Wolfensohn and Lloyd, 1998). However, whether 
SE can be induced under this anaesthetic regimen has not previously been investigated.
Fentanyl belongs to the family of drugs derived from morphine, and it is approximately 
one thousand times more effective as an analgesic than morphine (Lukasik and Gillies,
2003). It has a preferential action on the p-opioid receptor and has been shown to 
potentiate seizures in a dose-dependent manner (Cherng and Wong, 2005). Medetomidine 
is an a 2-adrenegic agonist and causes sedation (Wolfensohn and Lloyd, 1998). In relation to 
SE, the C^-adrenegic agonists have been shown to modulate seizure activity and have both 
pro- and anti-convulsant properties (Halonen et al., 1995). Therefore, the induction and 
maintenance o f SE using pilocarpine under fentanyl/medetomidine anaesthesia was 
investigated with EEG.
5.4.2.2. Methods
All animal care and procedures were carried out in accordance with the UK Animals 
(Scientific Procedures) 1986 Act.
5.4.2.2.1. Study Design
Thirteen adult male Sprague-Dawley rats (250-300g) were randomly divided into two 
groups: isoflurane ^= 6 ) or fentanyl/medetomidine (n=7). The animals were anaesthetised 
and intrahippocampal EEG electrodes were surgically implanted. 20 minutes of baseline 
EEG  was acquired before pilocarpine was administered and then continuously until the 
end o f the experiment. In total, 3 hours o f EEG  was recorded irrespective of whether or 
not SE was induced. The experimental design is outlined in figure 5.4.
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Continuous EEG acquisition
Anaesthesia EEG implantation Pilocarpine protocol
Figure 5.4. Study design for the investigations into inducing and maintaining SE  for 90 minutes under 
anaesthesia.
5.4.2.2.2. Surgery
The animals were anaesthetised with either isoflurane (1.5% in a 60/40 N20 : 0 2 mix) or 
fentanyl (300|ig/kg, i.p) and medetomidine (300pg/kg, i.p). Tungsten wire electrodes 
(50jlm diameter, Science Products GMBH, Germany) were implanted bilaterally at 
symmetrical points in the hippocampus for EE G  recording (AP, -4mm from bregma; ML, 
2mm, and DV, 3.2mm from the neocortex). The hippocampal electrodes were referenced 
to a ground electrode attached to the tail of the animal.
5.4.2.2.3. Assessment of anaesthesia: reflex behaviour
There is no literature that describes drug interactions with the pilocarpine protocol and 
therefore reflex behaviour was used to assess the level of anaesthesia. The paw pinch 
withdrawal reflex and the corneal reflex are considered to provide a good estimation of the 
depth o f anaesthesia suitable for surgical procedures, and these reflexes were used 
throughout this study to ensure that the animals were under suitable levels of anaesthesia 
(Green, 1982). If  the animal retained either reflex during any period of the protocol then, 
for fentanyl, an additional dose of lOOpg/kg of was given, or for isoflurane, the level of 
isoflurane was increased. The depth of anaesthesia was assessed using reflex behaviour 
every 15mins to ensure the animal remained unconscious throughout the experiment.
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5A.2.2.4. Pilocarpine protocol
Preliminary experiments (n=3, data not shown) indicated that multiple doses of pilocarpine 
were required to induce SE under anaesthesia using the lithium-pilocarpine protocol. As 
the doses required for inducing SE were similar to the levels used in the pilocarpine model 
without lithium, the pre-treatment with lithium was abandoned and the pilocarpine model 
was used for subsequent studies. The precise reasons for the loss or reduced ability of 
lithium to sensitise the CNS to pilocarpine is unclear but this result suggests that this effect 
is blocked or reduced whilst under anaesthesia. Furthermore, the standard dose of 
320mg/kg induced SE in only 8/15 animals (see section 5.2.3), and further studies 
indicated that a dose of 375mg/kg was more efficacious for inducing SE under anaesthesia.
5A.2.2.5. E E G  acquisition
EEG  was acquired and recorded continuously using a Bioamp differential amplifier 
interfaced with a Powerlab data acquisition system (AD Instruments, Australia). Signals 
were filtered between l-120Hz and also a 50Hz notch filter was used to reduce noise and a 
sampling rate of 1024 per second.
5A.2.2.6. Data Analysis
Analysis o f electrophysiological data was carried out off-line on a Pentium computer, using 
Chart software (AD Insturments, Australia).
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5.4.2.3. Results
5.4.2.3.1. A.nimal behaviour
No reflex behaviour was observed in any animals throughout the duration o f the 
experiments. The isoflurane-anaesthetised animals remained motionless throughout. The 
fentanyl/medetomidine anaesthetised animals displayed facial automatisms following 
pilocarpine administration. Also tonic extensions o f the forelimbs and hindlimbs, in which 
the entire body of the rat became outstretched, were observed. These tonic extensions 
lasted for a few seconds, occurred intermittently, and only during the period of increased 
EEG  activity.
5.4.2.3.2. Desynchronisation after pilocarpine
All animals under either anaesthetic protocol displayed a reduction in EEG  amplitude 
following pilocarpine administration (fig. 5.5b-c). The desynchronisation persisted for the 
duration o f the experiments in the isoflurane-anesthetised animals. In the 
fentanyl/medetomidine-anaesthetised animals, desynchronisation continued until the onset 
of SE.
5.4.2.3.3. Time to SE
None o f the animals under isoflurane anaesthesia progressed to SE (n = 6). In contrast, 6 
out o f 7 animals under fentanyl/medetomidine anaesthesia progressed to SE (fig. 5.5d). O f 
the animals that did progress onto SE, the mean SE onset time following pilocarpine 
administration was 22.83 ±1 .9  mins (mean ± sem).
5.4.2.3.4. Duration of SE
In the animals that did progress on to SE, seizure activity persisted until the administration 
of diazepam, at which point the amplitude of the EE G  gradually reduced (fig. 5.5e).
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Figure 5.5. Intrahippocampal EEG recording in a fentanyl/medetomidine anaesthetised rat. a) 3 h 
EEG  acquisition for duration of experiment; b) baseline EEG ; c) EEG  desynchronisation post­
pilocarpine (375mg,/ kg); d) increase in EEG  indicates the rat in SE; e) decrease in EEG  following 
diazepam (10mgjkg). Red arrow denotes pilocarpine administration, blue arrow indicates diazepam 
administration.
5.4.2A. Discussion
All animals remained under anaesthesia for the duration of the experiment. All of the 
animals in both anaesthetic protocols have a reduction in EEG activity following 
pilocarpine administration, due to the desynchronisation of neuronal activity. It is likely 
that this was a result of a sudden mass activation of the muscarinic system by pilocarpine, 
leading to a disruption of rhythmic neuronal firing, this association between EEG 
desynchronisation and cholinergic stimulation has been reported previously (Rasmusson et 
al., 1994)
99
The isoflurane-anaesthetised animals did not progress on to SE and the reduced EEG 
activity persisted for the duration of the experiment. The activation of the cholinergic 
system is crucial for the cholinergic drugs to induce SE, and it has been hypothesised that 
this system is important in the maintenance of sustained seizure activity that drives 
excitatory mechanisms responsible for neuronal damage (Cavalheiro et al, 2006). The EEG 
desynchronisation indicates that pilocarpine was efficacious in activating the cholinergic 
system in both anaesthetic regimens (Rasmusson et al, 1994) but this raises the question as 
to why isoflurane was effective at preventing the onset of SE. The mechanism of action of 
isoflurane remains unclear (Campagna et al, 2003). However, these data indicate that the 
inhalant anaesthetic does not act as a competitive antagonist at the cholinergic, or more 
specifically muscarinic, receptors. This is supported by findings that indicate an attenuation 
on calcium influx, which is downstream of the muscarinic receptor (Corrales et al., 2004) 
and this may act to prevent the secondary activation of excitatory systems such as 
glutamate.
It is also notable that van Eijsden and colleagues have reported studies using a similar 
inhalant anaesthetic to isoflurane, halothane, with fentanyl/fluanisone for anaesthesia 
induction, in which they successfully induced SE using the lithium-pilocarpine method (van 
Eijsden et al, 2004). However, our preliminary experiments with either the pilocarpine or 
lithium-pilocarpine method and halothane yielded similar results to isoflurane, and even 
with a doubling and tripling of the pilocarpine doses and reductions in the levels of 
anaesthesia, no signs of seizure activity could be detected (data not shown). This finding is 
supported by other studies in which the anti-convulsant activity of halothane has also been 
demonstrated (Murao et al., 2000; Murao et al, 2002). However, it is notable that these 
studies, as well as the current study, did not use fentanyl/ fluanisone for inducing 
anaesthesia and therefore it may be possible that this method for induction followed by 
halothane is an effective method for producing SE using the lithium-pilocarpine method, 
as reported by van Eijsden and colleagues (van Eijsden et al, 2004).
Under the fentanyl/medetomidine regimen, 6 out o f 7 animals progressed on to SE and 
this activity persisted until diazepam was administered. A number of features were 
identified during seizure activity. Facial automatisms developed and there was also 
intermittent generalisation of seizures that manifests as tonic extension o f the limbs.
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Although these animals were still unconscious, these episodes could be problematic for 
MRI during SE. Recent experiments have used fentanyl by itself and have successfully 
induced SE with pilocarpine (Engelhorn et a l, 2005); however, fentanyl is an analgesic by 
itself and does not satisfy the criteria for anaesthesia (Wolfensohn and Lloyd, 1998). 
Furthermore, although their set up had “an especially designed MR-compatible head 
holder, allowing reliable fixation to avoid seizure-related movements”, no details were 
provided and also it is not clear as to whether these tonic extensions were observed 
(Engelhorn et a l, 2005). Nevertheless, SE was successfully induced with pilocarpine under 
anaesthesia using fentanyl/medetomidine anaesthesia.
An alternative to using anaesthesia is to use neuromuscular blockade. This class of drugs 
prevents activation of the neuromuscular junction and thus skeletal muscle contraction. 
These paralysing agents are, rightly, heavily regulated due to the negation of any reflex 
action and thus it is not possible to gauge the consciousness o f an animal. These 
regulations were put in place following reports o f patients who were paralysed but 
conscious during surgical operations, and these situations are considered to be among the 
most traumatic events that can happen to humans or animals. However, there could still be 
a case o f using neuromuscular blockade in investigations such as SE if they are used in 
combination with anaesthetics. Such a combination would remove the problems associated 
with motion for MRI and it may be possible to investigate some of the fundamental 
mechanisms that underlie seizure initiation, maintenance and propagation without affecting 
the seizure itself, which may be worth pursuing in future studies.
5.4.2.5. Conclusion
In conclusion, this study demonstrates that it is possible to induce SE under 
fentanyl/medetomidine anaesthesia, but not under isoflurane. However, even though the 
animals were under anaesthesia, SE was associated with motor events that may be 
problematic for MRI.
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5.4.4. deduction of motion artefacts: changes to the MRI animal holder
The previous study demonstrates that it is possible to induce SE and maintain the seizure 
for 90mins whilst the animal is under anaesthesia. This step was critical as the welfare of 
the animal is paramount and suffering has to be kept to the minimum. However, even 
though the seizure can be induced, motion remains a problem and this leads to degradation 
of the MR image quality. As muscle relaxants cannot be used, various alterations to the 
MRI animal holder were developed to minimise physically the movement of the brain.
The initial step was to induce SE with the animal on the animal holder and to investigate 
whether it was possible that the existing set-up was sufficient for MRI of SE. The animal 
holder was designed for anaesthetised animals and the animals lay on their backs with ear 
bars and a bite bar that act to secure the head in place for imaging (see fig 5.6).
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Figure 5.6. A  photograph of the animal holder used for M RI of the rat. Note the animal lies on its 
hack. Also for this probe, ear bars and bite bars are used to hold the head of the anaesthetised animal in 
place for MRI.
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It quickly became apparent that the set-up was insufficient to prevent motion during SE 
using this animal holder design. The main problem was the intermittent tonic extension of 
the forelimbs and hindlimbs that pulled the animal out o f the ear bars.
The irregular nature of the tonic extensions meant it was not possible to predict when 
these would occur and therefore the process of adapting the animal holder was particularly 
time consuming. A typical experiment required the animal to be anaesthetised and set up 
on the animal holder, which would take between 40-60 minutes. Once set up, pilocarpine 
was administered to the animal and seizure activity began in around 30 minutes. After this 
point the tonic extensions of the limbs could occur at any point thereafter, and it was only 
after this point that an adaptation could be made to the animal holder.
Various alterations to the animal holder were made and these steps were cumulative. 
Reducing the size of the ear bars for the animal was tried to try to lock the head more 
firmly in place than with the pre-existing ear bars. An experiment with an animal on the 
animal holder seemed to indicate that this could be successful. However, further 
experiments indicated that this was not the case.
The animal holder design had an adjustable bite bar for the teeth that slid back and forth, 
and this was sufficient for traditional imaging o f anaesthetised animals. However, for SE 
imaging, as the rat came out of the ear bars the bite bar also slid out of place. Therefore a 
lock was added to secure the bite bar firmly in place. This also proved to be insufficient.
When the rat experiences the tonic extension o f the limbs, it also arches its neck backwards 
and it was thought that this was the motion predominantly responsible for the animal 
coming out of the ear bars. To prevent this from happening, the animal was wrapped 
tighdy in a plastic sheet. The plastic sheet limited the movement of the body as the seizure 
took hold and did seem to reduce the movement of the neck but was also not sufficient for 
preventing the animal from coming loose. Adaptations were also tried by raising and 
supporting the base of the head at varying degrees by attempting to limit the neck arching 
motion.
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At this point, it was thought that the main problem was the ear bars and also that the 
animal was lying on its back. Therefore an alternative animal holder was used that was 
designed and engineered by Dr. Edward Proctor (fig. 5.7). This animal holder has the 
animal lying on its front with the nose secured into a nose cone and no ear bars are used. 
In this set-up, the surface coil is placed directly onto the head of the animal and can 
provide an additional means of securing the animal. Initial experiments indicated that this 
MRI animal holder was promising as the animal would not drop out of the field of view if 
and when the tonic extensions occur; however the rats were still liable to move, although 
the nose cone did limit lateral movement. The adaptations on the first animal holder were 
added on to this new probe in a step-wise fashion. A further adaptation was to add a 
support for the surface coil. This was because it was thought that as the surface coil was 
placed on the head, then any movement may cause movement to the coil and manifest 
itself as a loss in signal.
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Figure 5.7. A  photograph of the adapted animal holder used for M RI during SE of the rat Note the 
animal lies on its front. Also for this probe, no ear bars and bite bars are used, and a nose cone, reinforced 
surface coil and a platform support were incorporated to limit motion during MRI.
The addition of the various adaptations appeared to have limited the motion and the tonic 
extensions did not move the animals to such a great degree. Nevertheless, the main 
limitation of the bench experiments was that it was not possible to evaluate whether subtle 
movement still occurred, and whether this motion would produce artefact and if so to what 
degree.
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Early experiments with perfusion MRI indicated that movement was a problem and that 
the rat can move back or forward. This was in the order o f millimetres and was apparent 
on the MR images as a different slice to the previous acquisition was observed. It was 
assumed that these movements were due to the tonic extensions as this could not be 
direcdy assessed when the rat was in the MR scanner. This seemed logical because the 
movement was only intermittendy observed between contiguously acquired images and 
also because this was seen at least 30 minutes following pilocarpine administration. 
However, it was thought that if the movement was only intermittent then it may be 
possible to scan during SE and then visually assess and remove the images that had motion 
artefacts. Therefore, a protocol was designed to limit the effect of motion.
5.4.5. M RI of status epilepticus protocol
Perfusion imaging is sensitive to acute functional changes during brain pathology (Thomas 
et al., 2000; Lythgoe et a l, 2002) and provides information about energy supply (see section 
4.5-6). Thus, perfusion imaging was used to investigate SE. However, motion remained a 
problem and an MRI protocol was designed to reduce the influence of movement.
5.4.5.1. Reducing the effect of motion on M RI
In MRI, numerous methods have been developed for suppressing the problems associated 
with motion (Gadian, 1996). For example, in cardiac imaging successive data acquisitions 
can be synchronised to a specific phase of the cardiac cycle. However, the irregularity of 
the motion associated with SE means that imaging cannot be synchronised to any specific 
physiological phenomena such as those measured with EEG. Another method is to use 
rapid imaging techniques, such as echo-planar imaging (EPI) or parallel imaging, which are 
widely used in studies that require fast imaging, for example in functional imaging. 
Although EPI has been implemented on our current system, the development of additional 
techniques was beyond the remit of this thesis and therefore this was not pursued any 
further and so an alternative approach was taken.
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For any imaging experiment, the signal-to-noise ratio needs to be sufficient to distinguish 
tissue from background noise. The simplest way to increase the signal-to-noise is by 
increasing the number of averages (n) for a given acquisition; this leads to an increase in the 
signal-to-noise ratio of Vn (Gadian, 1996). The current implementation of the perfusion 
and diffusion techniques on our MRI scanner uses multiple averaging, 88 and 32 averages 
respectively, and produces one averaged data set at the end of each scan. The problem with 
imaging SE is that any motion during the acquisition o f any one of the averages leads to 
artefacts for that given data set. However, averaging can also be performed after acquisition 
and this can be utilised for imaging SE (fig. 5.8).
The prevalent motion that was thought to affect imaging SE with our set up was the 
intermittent tonic seizures, which last for a few seconds. If  the averages for a scan were 
reduced then the images that have been affected by motion can be identified and omitted 
from a data set. Therefore a series of low average scans was acquired continuously for 
imaging SE and averaged together after the end of the experiment.
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F igure 5.8. Representation of perfusion-weighted image (PWI) acquisition for SE. The central tine 
indicates motion at a particular point in time. The normal average experiment would result in the loss of 
data due to motion artefact for that entire period However, i f  low average acquisitions were used then that 
partinlar experiment can be removed, and although some data would be lost, the rest of the acquisitions 
over that period can be used Grey boxes indicate scans that have been affected by motion artefact.
5.4.6. Conclusion: a final protocol for M RI during SE
In summary, a series of methodological developments was necessary to enable the study of 
SE with MRI, the first o f which was being able to induce SE under 
fentanyl/medetomidine. Although the animal remained unconscious under this form of 
anaesthesia for the duration of an experiment, motion was a problem. As such, a number 
l o f adaptations were made to the animal holder for additional restraint, and also an MRI 
protocol, which consisted of low average perfusion acquisitions, was designed to minimise 
the adverse effects of motion. These developments were all integrated in to the set-up for 
our MRI studies for monitoring SE.
«
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5.5. SUMMARY
This project was divided into two distinct components for our investigations into SE using 
MRI: following SE and during SE. Different methodological developments were required 
for each set of studies.
In the MRI of SE-induced brain injury, various time points following SE were investigated. 
The pilot studies that were conducted indicated that there were no detectable changes 
during the first few hours post-SE. Also, the assessment of tissue with MRI indicated that 
T2 changes may occur during the early period, but the later time points were associated 
with hippocampal atrophy. Furthermore, results indicated that hippocampal volume at 21 
days after SE was similar to that of volumes on day 70.
In the MRI during SE, the main problems were anaesthesia and motion, and a new 
anaesthetic regimen with fentanyl/medetomidine was found to be conducive to 
pilocarpine-induced SE. However, motion still presented a problem, and various methods 
were tried to reduce the impact of movement. The first method was to develop physical 
means to limit motion to allow the animal to be imaged. This was followed by changes in 
the design o f the MRI protocol that would allow the omission of degraded images.
These developments provided the basis for the design o f the experiments presented in this 
thesis.
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CHAPTER 6: M RI FOLLOW ING STATUS EPILEPTICUS
A bad beginning makes a bad ending
Euripides
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6.1. INTRODUCTION
As described in the previous chapter, MRI can be used to monitor the temporal events 
during SE. In a similar manner, MRI can also be used to investigate the period following 
SE.
SE can cause brain injury that continues to evolve over time, and it has been hypothesised 
that this injury is associated with temporal lobe epilepsy (Cavanagh and Meyer, 1956; Scott 
et al., 2006). Following the cessation of SE a host of complex physiological mechanisms are 
recruited and include cell death, inflammation, neurogenesis and mossy fibre sprouting, 
which have been implicated in post-SE pathology (Parent, 2002; Walker et al., 2002; 
Vezzani and Granata, 2005; Pitkanen et al., 2007). The roles that each of these processes 
may play in post-SE pathologies are beginning to be revealed, and studies have suggested 
that these mechanisms may contribute to varying degrees in specific aspects post-SE. For 
example, one possible consequence of SE is cognitive decline, and evidence suggests that 
cell death as a result of SE may underlie this pathology (Niessen et a l, 2005). On the other 
hand, the contribution of cell death to subsequent epilepsy is less clear as drugs that 
provide neuroprotection after SE may not influence the expression of later epilepsy 
(Brandt et a l, 2006).
The characterisation of physiological pathways after SE, such as inflammation and cell 
death, indicates that these processes may be transient or delayed (Fujikawa, 1996; 
Jankowsky and Patterson, 1999). These data suggest that aspects of post-SE injury may be 
expressed in a time-dependent manner. However, the temporal relationships between these 
processes and later outcome have not been fully defined. A number of studies have 
indicated that various MRI indices are altered during the early phase after SE, and these 
have been observed in a variety of animal models and also in humans (Roch et al., 2002a; 
Dube et al., 2004; Nairismagi et al., 2004; Jupp et al., 2006). Although the molecular bases 
for these changes remain unclear, the temporal relationships between these early changes 
and the evolution of brain injury have not been fully investigated. Therefore it was the aim 
of this study to monitor the progression of brain injury following SE with a particular
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emphasis on the early period and to investigate the relationships between early injury and 
later outcome
For the purposes of these investigations, the lithium-pilocarpine model of SE was 
monitored with multi-parametric MRI over a period of 21 days. The multi-parametric MRI 
technologies used include quantitative T1} T2, diffusion, and, for the first time in studies 
following SE, perfusion. In addition, a high resolution T2-weighted anatomical scan was 
acquired for investigating structural changes following SE.
A further aim was also incorporated into the experimental design to investigate the effect 
of anaesthesia on the pathophysiology following SE. MR imaging of animals requires the 
use of anaesthesia to prevent motion, and in this study, animals are serially imaged in order 
to characterise brain injury following SE. Therefore it is possible that anaesthesia could 
modify the pathophysiology following SE, and thus control groups were included to 
investigate the effect of anaesthesia on the pathophysiology following SE.
I l l
6.2. MATERIALS AND METHODS
6.2.1. Experimental design
All animal care and procedures were carried out in accordance with the UK Animals 
(Scientific Procedures) 1986 Act. The study design is outlined in figure 6.1 and the rationale 
for the design is provided below.
This study involved four groups: full-imaging lithium-pilocarpine (FLP), full-imaging 
lithium-saline (FLS), control-imaging lithium-pilocarpine (CLP), and control-imaging 
lithium-saline (CLS) (fig.6.1). The full-imaging groups were used to characterise the 
progression o f brain injury following SE using MR and were imaged at least 24 hours 
before lithium injection and then subsequently after SE on days 0, 1, 2, 3, 7, 14, and 21. 
The control-imaging groups were used to investigate the effect of anaesthesia on 
pathophysiology following SE and were therefore imaged before lithium injection and on 
day 21. After imaging on day 21, all animals were sacrificed for histological analysis in 
which neuronal damage was assessed with Nissl stain.
The MRI protocol consisted of a high resolution T2-weighted spin-echo sequence to 
identify regions o f pathology across the whole brain, and single slice quantitative Tls T2, 
diffusion and perfusion maps. As the quantitative measurements could only be conducted 
on a single slice, this slice was chosen to include the hippocampus and the piriform cortex, 
which are regions known to be damaged following SE (Roch et al., 2002a).
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Day 0
Day 1 
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Day 14
___________ Day 21
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Figure 6.1. Experimental design. This study involved two main groups, either full-imaging or control 
imaging. Within each of these groups, the animals were administered either lithium-pilocarpine or lithium- 
saline. The fu ll imaging groups were imaged before lithium injection (pre-SE) and subsequently after SE on 
days 0, 1, 2, 3, 7, 14 and 21. The control-imaging groups were imaged only on pre-SE and on day 21. 
After imaging on day 21, all animals were sacrificed for histology.
6.2.2. Animal Preparation
26 adult male Sprague-Dawley rats weighing 200-270g at the beginning of the experiment 
were used (supplied by Charles River, Margate, Kent, UK). The animals were housed with a 
standard light/dark cycle and with access to food and water ad libitum. The animals were 
housed in groups of three or four before SE induction and housed singly thereafter.
The animals were divided randomly into one of the four groups — FLP (n = 9), FLS (n = 
7), CLP (n = 5), CLS (n = 5). All animals were injected with lithium chloride (3 mEq/kg,
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i.p., Sigma-Aldrich, Dorset, UK) approximately 18-22 hours before seizure induction. On 
the following day, the animals were injected with methylscopolamine (1 mg/kg, i.p., Sigma- 
Aldrich) to reduce the peripheral cholinergic effects of pilocarpine and then following 15- 
20 minutes with pilocarpine hydrochloride (30 mg/kg, i.p., Sigma-Aldrich) in the lithium- 
pilocarpine groups or saline in the lithium-saline groups. Diazepam (10 mg/kg, i.p., 
Phoenix Pharma Ltd, Gloucester, UK) was administered 90 mins after the onset of SE to 
terminate the seizure. Lithium chloride, pilocarpine hydrochloride and methylscopolamine 
were freshly prepared prior to administration using 0.9% saline.
6.2.3. Behavioural assessment of seizures: the Racine scale
The Racine scale of limbic patterns of seizure was used to assess the progression to SE 
(Racine 1972). The Racine scale was described previously in section 5.2.1, and animals were 
considered to have progressed on to SE when stage 3 was observed.
6.2.4. M RI
Scans were performed on a 2.35T horizontal bore magnet (Oxford Instruments, UK) 
interfaced to a SMIS console (Guilford, UK). All animals were anaesthetised with 1.5% 
isoflurane in a 60:40 N20 : 0 2 mix delivered via a nose cone and placed on a probe with bite 
and ear bars securing the head to minimise movement artefacts. Physiological parameters 
monitored include electrocardiography (ECG) recordings and rectal temperature, which 
was maintained at 37 ± 1°C using an air warming system.
Images were acquired using a volume transmitter coil and a separate decoupled surface 
receiver coil. A central coronal imaging slice was selected that included the hippocampus 
and the piriform cortex (-3.3 mm from bregma). The central slice was determined by visual 
inspection of anatomical landmarks.
A high resolution T2-weighted spin-echo was used for volumetric analysis. The parameters 
for this sequence were 1500 ms repetition time (TR), 80 ms echo time (TE), 30 mm field-
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of-view (FOV) with a 128 x 128 matrix, a 1 mm slice thickness and 10 averages. The 
duration of acquisition was 35 mins.
All subsequent sequences were run on a 2 mm-thick coronal slice.
For non-invasive CBF measurement, we used the CASL method (Alsop and Detre, 1996), 
based on spin-echo echo-planar imaging (EPI) with interleaved adiabatic fast-passage 
inversion and control measurements. The centre of the inversion plane was situated 2 mm 
behind the back of the cerebellum in all animals (approximately 10 kHz frequency offset); 
for the control image the same offset value was used, but with the sign reversed. A post­
labelling delay time of 500 ms was used to minimise transit time effects and intravascular 
artefacts. The echo time (TE) was 36 ms, the repetition time (TR) 1000 secs, and 88 
averages were acquired. A non slice selective inversion recovery (IR) EPI sequence was 
used to obtain the tissue T t and the spin density (M0) parameters necessary for subsequent 
CBF quantification. Images were acquired with 2000 ms repetition time (TR), 18 ms echo 
time (TE), an inversion time (TI) array of 284 ms, 434 ms, 634 ms, 834 ms, 1234 ms, 1734 
ms, 2734 ms, and 3734 ms and 88 averages were used. The IR data were fitted to obtain T t, 
a0 and M0 assuming a mono-exponential recovery function. Subsequently, these values 
were used to calculate CBF from the difference between the labelled and control image 
(Alsop and Detre, 1996). Assumptions were T t of arterial blood = 1 . 5  secs, blood:brain 
partition coefficient for water (A) = 0.9, efficiency o f the spin labelling pulse = 0.71 
(previous results; data not shown), tissue transit time = 250 ms, arterial transit time = 
200 ms. Duration of acquisitions: T t = 11 mins and CASL = 1 6  mins.
Quantitative T2 and ADC maps were obtained using the methods described in section 5.3.1. 
Duration of acquisitions: T2 = 4 mins and ADC = 9 mins.
Total scan time was 75 minutes.
6.2.5. Image processing and data analysis
The high resolution T2-weighted images were reconstructed using SMIS reconstruction 
software (SMIS version 6.1). Tt, T2, ADC and CBF maps were reconstructed using in­
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house software written in IDL Software Version 5.6 (Research systems Inc., Boulder, CO, 
USA) in order to obtain quantitative maps. Four regions of interest (ROI) (see fig. 6.2) - 
cortex, piriform cortex, hippocampus, thalamus - were delineated on all processed images 
and analysed with SMIS Image Display Version 3.7.
For the high resolution T,-weighted anatomical scans, analysis was performed using ImageJ 
(version 1.38, NIH, USA).
Figure 6.2. Representative regions of interest drawn to delineate anatomical structures for quantitative 
analysis. Numbers indicate regions corresponding to: 1, cortex; 2, hippocampus; 3, thalamus; 4, piriform 
cortex.
6.2.6. Volumetric assessment of brain structures
Four contiguous high-resolution T2-weighted anatomical slices (-2.3 to -6.7 from bregma), 
which covered the hippocampus, were used for volumetric assessment. Regions of interest 
were drawn by an independent observer who was unaware of the groupings of the animals. 
The regions drawn were as follows: hippocampus, ventricle and whole brain.
Hippocampal tissue borders were defined using a standard rat brain atlas (Paxinos, 1995) 
(See fig. 6.3). Ventricular borders were defined by the hyperintense regions on the scans. 
Volumes were calculated by multiplying the areas of the given region of interest by the slice 
separation (1.1mm).
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Figure 6.3. Regions of interest for volumetric analysis. A. high-resolution scan from one animal 
Highlighted areas are hippocampal regions of interest that were drawn for calculating hippocampal volumes. 
Numbers show approximate distance from Bregma.
6.2.7. Statistical analysis
A repeated-measures (degrees of freedom-adjusted mixed-model) two-way ANOVA was 
conducted on the time courses of the CBF, Tls T2 and ADC data for each brain region. 
The main effects for these analyses were days (-1, 0, 1, 2, 3, 7, 14, 21) and treatment 
(pilocarpine, saline). Similarly, repeated measures (degrees of freedom-adjusted mixed- 
model) two-way ANOVA was used to test changes on day 0 with main effects as: days (-1. 
0) and treatment (pilocarpine, saline).
For investigating the effect of serial imaging on MR measurements of tissue status, regional 
differences between day 21 and pre-SE were calculated for the four groups - FLS, FLP, 
CLS and CLP - a Kruskal-Wallis one-way ANOVA was used.
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One-way ANOVA was used to investigate differences in whole brain volumes and 
hippocampal volumes between the four groups. For cases in which significant differences 
were found, a post-hoc Tuke.y test was used to identify group differences.
Multiple regression analysis was used to investigate the relationship between hippocampal 
volumes and ventricular volumes.
Principal component analysis and regression analysis was used to investigate the 
relationships between early injury and hippocampal volumes on day 21. This was followed 
by a principal component analysis of the early injury data.
All statistical analyses were performed in SPSS for Windows Version 14.0.
6.2.8. Histopathology
Following the final scan, the animals were deeply anaesthetised with 5% isoflurane in 100% 
N20  and were perfused transcardially, using 4% paraformaldehyde in PBS (pH 7.4). The 
brains were immediately removed and rotated at 4°C in 1% paraformaldehyde in PBS (pH 
7.4) for 2 hours. Finally, the brains were put in 30% sucrose in PBS and stored overnight at 
4°C for cryoprotection. The brains were then frozen with dry ice and stored at -80°C. 40 
pm coronal slices were taken, and sections were stained with Nissl and examined by light 
microscopy.
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6.3. RESULTS
6.3.1. Behaviour
Within 5 min after the injection of pilocarpine, rats developed diarrhoea, piloerection, and 
other signs of cholinergic stimulation. During the following 15-20 min, they exhibited head 
bobbing, scratching, masticatory automatisms, and increased exploratory behaviour. 
Progression to SE started between 25-40 min after pilocarpine administration with bilateral 
forelimb clonus and episodes of rearing and falling.
6.3.2. Pre-existing brain abnormalities
Pre-existing brain abnormalities were identified during the pre-SE time point in 3 animals 
(fig. 6.4). In all 3 of these animals, the high-resolution T2-weighted images revealed 
unilateral hyperintense regions which indicated an enlarged ventricle. These rats were 
removed from the study due to these abnormalities, and no further imaging was conducted. 
In total, 26 rats that did not have abnormalities on the scans were included in the present 
study.
Figure 6.4. Example of a hyperintense T2-weighted signal that was identified in this animal during the 
pre-SE time point (arrow). This animal was subsequently removed from this study. Scale bar equals 2mm.
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6.3.3. MRI over 21 days following SE
The MRI time course for T2, T 1} CBF and ADC measurements are presented in the 
following sections. For each of the MRI time courses, the results are given with three sets 
of data: representative MR maps acquired over the course of 21 days, which indicates the 
regional nature of the brain injury; the MR measurements for individual animals, which 
demonstrates the consistency and variability of the regional analysis; and a mean time 
course for the full imaging lithium-pilocarpine group and the full imaging lithium-saline 
group, which is presented for the ease o f the reader.
6.3.3.1. T2 changes following SE
Figure 6.5 shows the T2 maps acquired over the 21 day time course from a single animal. 
Figure 6.6 shows the measured T2 relaxation times in individual animals in the FLP and 
FLS groups, and figure 6.7 shows the mean T2 time course. Cortical T2 relaxation times 
before drug administration were 67.4 ms ± 0.25 and 67.1 ms ± 0.54 (mean ± s.e.m) for the 
FLP and FLS groups respectively. T2 in the other regions measured at this time point were: 
hippocampus (71.5 ms ± 0.9; 69.6 ms ± 0.7), piriform cortex (77.3 ms ± 0.9; 77.0 ms ± 
0.8), thalamus (62.4 ms + 0.4; 61.5 ms ± 0.5).
The following results are expressed as a percentage from baseline measurements measured 
pre-SE. Comparisons of T2 values were made between the pre- and day 0 time points and 
these indicated that T2 was increased in all of the brain regions analysed. In the cortex, an 
increase from pre-SE to 103.6% ± 0.65% (F = 22.80, p < 0.001) was measured (mean + 
s.e.m). The hippocampus increased to 105.7% ± 1.75% (F = 5.11, p = 0.042), the piriform 
cortex to 104.4% ± 1.84% (F = 5.34, p = 0.038), and the thalamus to 107.0% ± 1.80% (F 
— 13.75, p — 0.003). By day 1, T2 in the cortex and the thalamus returned to levels observed 
in pre-SE and the day 1 CLS levels. Plowever, the T2 increases continued in the 
hippocampus and the piriform cortex, and reached an observed maximum on day 2-115%  
± 2.48% and 141% ± 5.06% respectively. By day 7, T2 returned to baseline levels for both 
structures.
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Statistical analyses on the T2 time courses indicated that there were significant pilocarpine- 
induced time-dependent T2 changes in the cortex (F = 3.53, p = 0.014), hippocampus (F = 
11.53, p < 0.001), and the piriform cortex (F = 16.12, p < 0.001). However, no significant 
pilocarpine-induced time-dependent changes were observed in the thalamus (F = 2.59, p = 
0.056), but a significant pilocarpine effect was detected (F = 18.56, p < 0.001).
These data indicate an early regional and transient T2 change following SE.
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Figure 6.5. T2 maps of a single animal from the FLP group. Note the T2 increase in the piriform cortex 
on day 1, 2 and 3 (blue arrow). A.lso hippocampal T2 was increased on day 2 in this animal (white 
arrowj. Scale bar equals 2mm.
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Figure 6.6. T2 relaxation times for individual animals in the: a) cortex, b) hippocampus, c) piriform 
cortex and d) thalamus. T2 measurements were performed before lithium administration (day -1) and 
subsequently on days 0, 1, 2, 3, 7, 14 and 21. The red lines are measurements obtained from individual 
FLP animals and the blue lines from the individual FLS animals.
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Figure 6 .7. Mean regional T2 relaxation time courses before and following SE. Mean regional data were 
measured in the: a) cortex, b) hippocampus, c) piriform cortex, and d) thalamus. T2 was measured in all 
animals 1 day before lithium administration (day -1), and subsequently on days 0, 1, 2, 3, 7, 14 and 21 
after SE. Data shown as mean ± s.e.m. The red line represents the animals in the full imaging lithium- 
pilocarpine experimental rats (n — 9), and the blue line depicts the full imaging lithium-saline control 
animals (n — 7).
6.3.3.2. T, changesfollomng SE
Figure 6.8 shows the T, maps acquired from a single animal from the FLP group. Figure 
6.9 shows the T x time courses in the brain regions of individual animals, and figure 6.10 
shows the mean Tt time course for FLP and CLP groups. Mean pre-SE measurements 
in the FLP animals were: cortex, 1280 ms ± 8.1; hippocampus, 1355 ms ± 8.3; piriform 
cortex, 1387 ms ± 11.5; thalamus, 1085 ms ± 10.7 (mean ± s.e.m). In the FLS group, the
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mean T\ in each region were: cortex, 1256 ms ± 6.9; hippocampus, 1302 ms ± 20.6; 
piriform cortex, 1384 ms ± 16.7; thalamus, 1097 ms ± 3.9.
The following results are expressed as a percentage from baseline measurements measured 
pre-SE. Cortical T t increased from pre-SE levels to 105% ± 1.1% (F = 19.09, p < 0.001) 
on day 0. By day 1, a decrease was observed when compared to pre-SE (95.8% ± 0.7%). 
N o T j changes were observed in the cortex thereafter. In both the hippocampus and the 
piriform cortex, increases in were observed on day 0 to 103.4% ± 1.1% (F = 9.39, p = 
0.009) and 107.0% ± 1.4% (F = 5.48, p = 0.036) respectively. This trend continued and an 
observed mean peak was identified on day 2: FLS, 105.8% ± 1.0%; FLP, 120.6% ± 3.3%. 
In the thalamus, a change was observed only on day 105% ± 2.4% (F = 4.69, p = 0.049). 
By day 7, all regions returned to pre-SE levels.
The statistical analysis o f the T t time-courses indicated that there were significant 
pilocarpine-induced time-dependent changes in the cortex (F = 16.69, p < 0.001), 
hippocampus (F = 9.59, p < 0.001), and piriform cortex (F = 10.55, p < 0.001). No 
significant changes were found in the thalamus (F = 0.421, p = 0.528).
These data indicate an early and transient T t change following SE across all four regions 
analysed. All changes in the regions normalised by day 7.
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Figure 6.8. T1 maps of a single animal from the FLP group. Note the T1 increase in the piriform cortex 
on day 1, 2 and 3 (blue arrow). Also hippocampal T1 was increased on day 2 in this animal (white 
arrowj. Scale bar equals 2mm.
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Figure 6.9. T1 relaxation time course in the: a) cortex, b) hippocampus, c) piriform cortex and d) 
thalamus. T, measurements were performed before lithium administration (day -1) and subsequently on 
days 0, 1, 2, 3, 7, 14 and 21. The red lines are measurements obtained from individual FLP animals and 
the blue lines from the individual FLS animals.
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Figure 6.10. Mean regional T1 relaxation time courses before and following SE. Mean regional data 
were measured in the: a) cortex, b) hippocampus, c) piriform cortex, and d) thalamus. T, was measured in 
all animals 1 day before lithium administration (day -1), and subsequently on days 0, 1, 2, 3, 7, 14 and 
21 after SE. Data shown as mean + s.e.m. The red line represents the animals in the fu ll imaging lithium- 
pilocarpine experimental rats (n = 9), and the blue line depicts the fu ll imaging lithium-saline control 
animals (n — 7).
6.3.3.3. CBF changes following SE
Figure 6.11 and 6.12 shows the individual CBF time courses for the brain regions analysed, 
and figure 6.13 shows the mean CBF time course over 21 days. The mean pre-SE CBF 
measurements for the FLS and FLP animals respectively were as follows: cortex, 115.6 
ml/lOOg/min ± 8.3, 125.7 ml/lOOg/min ± 6.8; hippocampus, 87.6 ml/lOOg/min ± 5.6, 
91.4 ml/lOOg/min ± 8.6; piriform cortex, 133.2 ml/lOOg/min ± 7.9, 137.5 ml/lOOg/min 
+ 8.2 and thalamus, 129.5 ml/lOOg/min ± 7.9,130 ml/lOOg/min ± 7.9 (mean ± s.e.m.).
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On day 0, significant CBF decreases across brain regions were observed in the FLP 
animals. Expressed as percentage of the pre-SE measurements, mean cortical blood flow 
decreased to 43.0% ± 11.4% (F = 13.37, p = 0.003), in the hippocampus CBF was at 75% 
± 17.7% (F = 6.73, p = 0.02), the piriform cortex was reduced to 64.0% ± 10.5% (F = 
9.11, p = 0.009) and the thalamic blood flow was measured at 69.7% ± 12% (F = 1.98, p = 
0.181). Cortical CBF was increased to 151% ± 15.6% on day 1, but by day 2 had returned 
to pre-SE levels. In the hippocampus, CBF was at an observed maximum on day 2 at 
164.8% ± 14.8%. Similarly, the observed maximum in the piriform cortex was also 
observed on day 2 (104.5% ± 15.5%). All regional CBF measurements had returned to pre- 
SE levels by day 7.
Statistical analysis of the cortical CBF time-course demonstrated that there were significant 
pilocarpine-induced time-dependent effects (F = 8.50, p < 0.001). These effects were also 
demonstrated in the time-courses for the hippocampus (F = 8.74, p < 0.001) and the 
piriform cortex (F = 2.97, p = 0.031). However, no significant effects were observed in the 
thalamus (F = 0.137, p = 0.717).
These data indicate that there was a regional and transient CBF change following SE.
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Figure 6.11. CBF maps of a single animalfrom the FFP group. Note the decrease in blood flow across 
the entire brain on day 0 (blue arrow). A.lso hippocampal CBF increases considerably on the day 2 time 
point (white arrow). No changes in CBF were noted following day 2 in this animal. Scale bar equals 2mm.
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Figure 6.12. CBF time course in the: a) cortex, b) hippocampus, c) piriform cortex and d) thalamus. 
CBF measurements were performed before lithium administration (day -1) and subsequently on days 0, 1, 
2, 3, 7, 14 and 21. The red lines are measurements obtained from individual FLJP animals and the blue 
lines from the individual FLS animals.
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Figure 6.13. Mean regional cerebral blood flow (CBF) time courses before and following SE. Mean 
regional data were measured in the: a) cortex, b) hippocampus, c) piriform cortex, and d) thalamus. CBF 
was measured in all animals 1 day before lithium administration (day -1), and subsequently on days 0, 1, 
2, 3, 7, 14 and 21 after SE. Data shown as mean ± s.e.m. The red line represents the animals in the fu ll 
imaging lithium-pilocarpine experimental rats (n = 9), and the blue line depicts the fu ll imaging lithium- 
saline control animals (n — 7).
6.3.3.4. A D C  changes following SE
Figure 6.14, 6.15 and 6.16 shows the ADC time courses o f  the individual regions following 
SE. However, only ADC data for seven o f the nine animals were included for analysis as 
the data from the remaining two animals were corrupted. The m ean AD C measurements 
before drug administration for FLS and FLP respectively were: cortex (6.95 x 10 4m m 2sec"' 
±  0.106, 6.70 x 104mm2 se c 1 ± 0.198); hippocampus (7.16 x 1 0 4m m 2 sec 1 ±  0.114, 6.81 x 
104m m 2sec 1 ±  0.153); piriform cortex (7.82 x 10"4m m 2sec"1 ±  0.159, 6.81 x 1 0 4m m 2sec"1
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± 0.153); thalamus (7.30 x 10'4mm2sec'1 ± 0.092, 6.97 x 10"4mm2sec"1 ± 0.153) (mean ± 
s.e.m.).
The following results are expressed as a percentage from baseline measurements measured 
pre-SE. In the FLP animals, cortical ADC were reduced to 90.7% ± 1.63% (F = 31.2, p < 
0.001) of pre-SE on day 0. Significant reductions in ADC were also observed in the 
piriform cortex to 81.5% ± 3.41% (F = 5.25, p = 0.04) and the thalamus to 98.1% ± 
2.05% (F = 11.72, p = 0.005). In contrast, although a mean change from pre-SE to day 0 
of 93.9% ± 1.15% was detected in the hippocampus, this result was not statistically 
significant (F = 2.481, p = 0.141). By day 1, the ADC returned to pre-SE levels and no 
further changes in any regions with the exception o f the piriform cortex were observed. 
The ADC in the piriform cortex continued to decrease and maximal change was observed 
on day 1 at 61.6% ± 10.2% of pre-SE levels. By day 7, ADC in the piriform cortex had 
returned to pre-SE levels and no further changes were observed (fig 6.10 and 6.11).
Analysis o f the entire ADC time courses indicated that there were time-dependent 
pilocarpine effects in the piriform cortex (F = 10.41, p < 0.001). Significant pilocarpine 
effects were detected in the cortex (F = 10.22, p = 0.009) and the thalamus (F = 11.55, p = 
0.005). However, no significant effects were detected in the hippocampus (F = 2.08, p = 
0.174).
Although the quantitative hippocampal ADC data did not demonstrate any significant 
differences in the FLP animals, visual inspection of the ADC maps showed a decrease 
within a sub-region of the hippocampus on day 2 (fig 6.10). This region appeared to 
correspond with the CA1 subfield of the hippocampus. The reason why this decrease in 
ADC was not detected could be due to the averaging of the ADC across the entire 
hippocampal region, and thus subde changes are lost in this form of analysis. In total, 5 of 
the 7 animals demonstrated a regional ADC decrease in the hippocampus on day 2.
These data indicate that there is a regional and transient ADC change following SE, which 
normalised by day 7. Furthermore, an ADC increase was also observed on day 14 in the 
hippocampal region that was due to CSF and confirmed on the high resolution anatomical 
images.
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Figure 6.14. A D C  maps from the same animal acquired over 21 days following SE. Note the regional 
decrease in A D C  in the hippocampus as indicated by the yellow arrow. Also the A D C  increase — as 
indicated by the blue arrows - on days 14 and 21 suggests CSF and thus indicating hippocampal atrophy. 
Scale bar equals 2mm.
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Figure 6.15. A D C  time course in the: cortex, hippocampus, piriform cortex and thalamus. CBF 
measurements were performed before lithium administration (day -1) and subsequently on days 0, 1, 2, 3, 
7, 14 and 21. The red lines are measurements obtained from individual FLP animals and the blue lines 
from the individual FLS animals.
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Figure 6.16. Mean regional apparent diffusion coefficient (ADC) time courses before and following SE. 
Mean regional data were measured in the: a) cortex, b) hippocampus, c) piriform cortex, and d) thalamus. 
A D C  was measured in all animals 1 day before lithium administration (day -1), and subsequently on days 
0, 1, 2, 3, 7, 14 and 21 after SE. Data shown as mean L s.e.m. The red line represents the animals in 
the fu ll imaging lithiumpilocarpine experimental rats (n — 7), and the blue line depicts the full imaging 
lithium-saline control animals (n — 7).
6.3.4. Volumetries: hippocampal, ventricular and brain volumes 21 dayspost-SE
For whole brain volumes, no significant differences were detected between the FLS, FLP, 
CLS and CLP groups (F = 0.254; p = 0.857).
The relationship between ventricular volumes and hippocampal volumes were investigated 
(fig. 6.17) with a third order polynomial regression model. This analysis indicated that there 
was a strong relationship between hippocampal and ventricular volume (R2 = 0.905, F =
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60.00
71.77, p < 0.0001). Furthermore visual analyses of the MR images indicate that the animals 
with smaller hippocampi had ventricle enlargement in areas that are associated with 
hippocampal dssue in the normal brain. In addition, the two animals with the largest 
ventricle volumes also showed signal in regions associated with piriform cortex and 
amygdala (fig. 6.17a, 6.18). The high resolution scans together with T2 and ADC, and 
histology indicated that the regions o f hyperintense signal in the hippocampal regions are 
CSF and not hippocampal tissue.
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F igure 6.17. The relationship between hippocampal and ventricular volumes measured on day 21. 
Regression analysis indicated that a third order polynomial was an appropriate regression model for these 
data. (R2 =  0.905, F  = 71.77, p  < 0.0001). Representative animals (a-c) across the distribution have 
been highlighted and an anatomical M R image is presented in the right panel, a) shows hyperintense signal 
and had the lowest hippocampal volume and also revealed signal from areas associated with the piriform 
cortex; b) shows an animal from the middle of the distribution of hippocampal volumes and signal can be 
detected from regions that corresponded with the normal hippocampus; c) shows an animal with a non­
pat ho logical hippocampal volume. Scale bar in a) equals 2mm.
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Figure 6.18. Representative high resolution anatomical M R scans and corresponding histopathology 21 
days following lithium-pilocarpine-induced SE. The samples are from the following groups: (a-c) fu ll 
imaging lithium-pilocarpine animal (FLP), (e-f) full imaging lithium-saline (FLS), (g-i) control imaging 
lithium-pilocarpine (CLP), and (j-l) control imaging lithium-saline (CLS). (b, e, h and k) shows the 
Nissl-stained hippocampus, and (c, f, i and I) shows the Nissl-stained piriform cortex. The histological 
sections were taken at a magnification of x40. Red arrows denote region of hippocampal atrophy, which is 
confirmed on histology. White scale bar in a) equals 2mm; black scale bar in b) and c) equals 200jum.
Hippocampal volumes between the four groups were investigated and significant 
differences were found (F = 5.84; p = 0.004) (fig. 7.19). Post-hoc analyses indicated that 
there were no differences between the saline control groups (p = 0.999) or between FLS 
and FLP (p = 0.589). However, significant differences were observed between CLS and 
CLP (p = 0.008). In addition differences were found between the two pilocarpine groups 
(p = 0.048).
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Figure 6.19. Hippocampal volume 21 days after SE.
6.3.5. The relationship between acute hippocampal MR changes and hippocampal volumes on day 21
The relationships between hippocampal MR changes on days 1, 2 and 3 and hippocampal 
volumes on day 21 were investigated in the FLP animals (fig 6.20). Statistical analyses 
indicated that there were significant relationships between the MR measurements on 2 day 
after SE with hippocampal volume on day 21 (fig 6.20), but none were found between 
either days 1 or 3 and hippocampal volume.
A principal component analysis was performed on the day 2 data because of the significant 
relationships observed. Two components were extracted (fig. 6.21). The first component 
was highly weighted to T2, CBF and T1} whereas the second component was weighted 
predominantly with ADC. Regression analysis was conducted on these two components 
and a significant relationship was found between the first component and hippocampal
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volumes on day 21 (R2 = 0.899, F = 44.5, p = 0.001). However, no significant relationship 
was found with the second component (R2 = 0.007, F = 0.37, p = 0.854) (fig. 6.21).
These data indicate that Tl9 T2 and CBF measured 2 days after SE can be used to predict 
the severity of injury 21 days following SE.
Day 1 Day 2 Day 3
R2 = 0.008 R2= 0.552
MR parameter
CBF
R2= 0.361
R*= 0.4680.009
ADC
R2= 0.364R2 = 0.028 R 2 =  0 .1 3 1
Figure 6.20. The relationships between the MR measurements during the acute period following SE and 
hippocampal volume on day 21. Note that relationships can be observed on day 2 only.
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Figure 6.21. Principal component analysis of the T„ T2, CBF and A D C  measured on day 2 and the 
relationship with hippocampal volumes on day 21. Principal component analysis extracted two components 
(a). Regression analysis of the first component, which was weighted heavily towards T2, T 1 and CBF, with 
hippocampal volumes revealed a strong relationship (b). However, no significant relationship was found 
between the second component, which was weighted towards AD C , and hippocampal volume on day 21 (c).
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6.3.6. Effect of serial isoflurane anaesthesia on brain injury
For investigating the effects o f serial anaesthesia, two groups that were imaged before 
lithium injection and on day 21 (CLS, CLP) were compared against the imaged time course 
groups (FLS, FLP). The differences between the data acquired on day 21 were subtracted 
fro the corresponding data before lithium injection for each region to investigate these 
effects.
6.3.6.1. Effect of serial anaesthesia on T2
O n day 21 - the final imaging time point — statistical analysis indicated that there were no 
significant T2 differences between the four groups in any o f the brain regions: cortex, p = 
0.920; hippocampus, p = 0.218; pirifonn cortex, p =  0.456; thalamus, p = 0.771 (fig. 6.22)
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F igure 6.22. T2 relaxation times differences fo r individual brain regions. T2 values fo r day 21 were 
subtracted from corresponding pre-SE values. Please note the range for the piriform cortex (-20 to 80ms) is 
different to the other brain regions (-15 to 10ms).
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6.3.6.2. Effect of serial anaesthesia on T,
Figure 6.23 shows the regional data for T r  The analysis indicated no significant differences 
in the hippocampus (p = 0.086), piriform cortex (p = 0.461) or the thalamus (p =  0.730). 
However, cortical differences were observed (p = 0.016). Post-hoc analysis of cortical 
T t demonstrated that there were significant differences between the FLP and CLP groups 
(p = 0.029).
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F igure 6.23. T 1 relaxation time differences for individual brain regions. T1 values for day 21 were 
subtracted from corresponding pre-imaging data. Please note that the scale for the piriform cortex (range - 
400 to 800ms) is differentfrom that of the other brain regions (range -200 to 150ms).
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6.3.6.3. Effect of serial anaesthesia on CBF
Analysis of the four groups was performed to investigate the possible effect of repeated 
anaesthesia following SE (fig. 6.24). No statistical differences were observed in the cortex 
(p = 0.093), hippocampus (p = 0.109), piriform cortex (p = 0.447) or the thalamus (p = 
0.838).
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Figure 6.24. CBF differences for individual brain regions. CBF values for day 21 were subtracted from 
corresponding pre-SE CBF values.
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6.3.6.4. Effect of serial anaesthesia on A D C
The ADC differences from pre-SE to day 21 were analysed to investigate the effects of 
repeated imaging following SE (fig. 6.25). No significant differences were observed in the 
cortex (p = 0.351), hippocampus (p = 0.198), or the thalamus (p = 0.516). A significant 
difference was observed in the piriform cortex (p = 0.020), however a post-hoc analysis 
indicated there were no significant differences between the pilocarpine groups (p = 0.088).
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Figure 6.25. AiDC differences for individual brain regions. A D C  values for day 21 were subtracted 
from pre-SE. Please note the range for the piriform cortex (-3 to 7 x  1G4 mm2 sec1) is differentfrom that of 
the other brain regions (-3 to 2 x  10  ^mni sec1).
These data indicate that serial anaesthesia has an effect on brain injury following SE, and 
differences were observed in cortical Tt and ADC in the piriform cortex after SE.
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6.4. DISCUSSION
The assessment of brain pathology with multiparametric MRI, a novel aspect of which is 
the inclusion of perfusion imaging, has identified characteristic regional differences during 
the early phase following SE. The observed changes all normalised by day 7 and remained 
at baseline levels until the end of the study. In contrast, hippocampal atrophy continued. 
During the acute period, peak MR changes in the hippocampus and the piriform cortex 
were observed on day 2. Moreover hippocampal MR changes on day 2 were found to have 
strong relationships with hippocampal volumes on day 21, suggesting that the combination 
of T2, T 1 and CBF imaging may potentially be used as an early biomarker in the clinical and 
experimental setting. The results from this experiment support the hypothesis that SE can 
cause acute brain injury and that the neurodegeneration process continues beyond this early 
period.
As anaesthesia is a requirement for small animal MR imaging, a novel part of this study was 
the inclusion o f groups to control for the possible effects of serially using isoflurane 
anaesthesia. Our results indicate that repeated isoflurane anaesthesia may reduce the loss of 
hippocampal tissue after SE, and may have an effect on the pathology in the cortex and the 
piriform cortex.
6.4.1. T„ T2 and A D C  changes
One of the novel aspects of this study is the monitoring of brain injury following SE with 
quantitative T t imaging, which showed a similar pattern to T2 changes. Previous MRI 
studies have investigated T2 and ADC changes following SE and have also shown that 
these parameters change during the early period (Nakasu et al., 1995; Wall et al., 2000; 
Bhagat et ah, 2001; Dube et al., 2004; Nairismagi et al., 2004). Moreover, these changes 
occur predominandy in the hippocampus and the piriform cortex, which are regions that 
have been widely shown to be vulnerable to SE, and this has been reported in electrical 
stimulation as well as chemical induction SE models including the lithium-pilocarpine 
model (Roch et ah, 2002a; Dube et al., 2004; Nairismagi et al., 2004). Our data indicated that
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T2 increases and ADC decreases in these two regions during the first 7 days following SE, 
and these changes have been widely interpreted as the presence of oedema formation 
(Nakasu et al, 1995; Bhagat et al., 2001; Roch et al, 2002a; Nairismagi et al, 2004). However, 
although all these MRI studies have reported piriform cortex changes that follow a similar 
trend to the data presented in this study, the changes in the hippocampus have been 
reported to show a different pattern.
Previous studies have shown that various MRI changes occur in the hippocampus. For 
example, ADC increases during the first week and also T2-weighted hyperintensities that 
increase in the first 2 days and continue to be high for up to 9 weeks following SE have 
been reported, which are in contrast to what we have observed (Wall et al, 2000; Roch et 
al, 2002a; Fabene et al, 2003). In the current study, hippocampal decreases in ADC were 
observed, and furthermore, although T2 increases were also observed, these changes 
normalised by day 7 after SE, which are consistent to other studies that have reported 
similar results (Nakasu et al, 1995; Dube et al, 2004; Nairismagi et al, 2004). Model 
differences are unlikely to underlie these contradictory data as between these studies 
various modes of SE induction have been used. One possible explanation that may 
underlie these discrepancies may be due to differences in data processing.
The region o f interest for the hippocampus can be drawn can be o f one of two different 
ways and depends on the question that is being investigated. The first is a region of interest 
that encompasses the traditional outline of the rat hippocampus and this region is 
maintained throughout the study. However, if the hippocampus atrophies then this region 
will measure CSF as well as the characteristics from the tissue. Therefore, increases in ADC 
and T2 as a result of CSF will be measured, as signal is not solely from the hippocampus. 
This method for drawing a region of interest that includes the non-pathological borders of 
the hippocampus can provide information about the progression of hippocampal atrophy 
(Wall et al, 2000). The second method of drawing a hippocampal region of interest 
concerns solely the MR changes within the hippocampal tissue, and requires the region of 
interest to be modified according to the atrophy o f the hippocampus. This can be done by 
using the combination of T2 and ADC data to evaluate whether CSF is included into the 
region that is drawn. By using this method, the hippocampal tissue characteristics can be 
measured, which was the method used in this study. Therefore these two methods of
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processing may underlie the contradictory reports, with respect to the hippocampus, in the 
epilepsy literature.
The present study also reported acute transient T2 increases in the piriform cortex, and it is 
interesting to note that Roch and colleagues found that T2 increases in the piriform cortex 
are required for the subsequent onset of spontaneous recurrent sei2ures. Although this 
finding was reported in 21 day old rats, this may also suggest that the animals in the present 
study will progress on to epilepsy.
In general, previous studies have shown that neuronal swelling and cell death occur during 
the first week after SE with parallel changes in ADC and T2 (Nakasu et al, 1995; Fujikawa, 
1996; Roch et al., 2002a) and, therefore our data are likely to indicate that the ADC, T 1 and 
T2 changes following SE reflect the formation and resolution of oedema.
6.4.2. Perfusion
Another novel part of this study was the investigation of haemodynamic changes following 
SE. We measured regional quantitative CBF following SE and observed reductions in CBF 
at the day 0 time point for all regions. After this time, CBF was increased in the cerebral 
cortex, hippocampus and the piriform cortex. By day 2 CBF returned to baseline in the 
cerebral cortex, CBF in the hippocamus and the piriform cortex remained high. 
Subsequendy (day 7) the CBF in all regions returned to baseline, after which no further 
changes were observed.
In the present study, a significant reduction in CBF was observed in all regions at day 0. A 
similar finding was reported by Engelhorn and colleagues, although this was observed 
during the later phase of SE (Engelhorn et al., 2005). Furthermore, they reported that 
perfusion increased within a few minutes of SE and subsequendy decreased as SE 
progressed. They also observed a relationship between the early blood flow reduction and 
subsequent cell death, but an underlying mechanism for the CBF decrease was not 
explored. One possible hypothesis that may explain the observations in the present study is 
that the CBF decrease reflects a failure of cerebral autoregulation, which has been reported
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as a result o f prolonged seizure activity (Lothman, 1990). The concept suggests that as 
cerebral autoregulation fails, the CBF becomes wholly dependent on systemic blood 
pressure. In the current study, diazepam was administered to stop the seizure and this may 
explain the finding in this study. Diazepam acts primarily through the potentiation of 
inhibitory GABAa receptors leading to a reduction in seizure activity. The reduced seizure 
activity would thereby result in a concomitant decrease in systemic pressure. A 
combination of reduced central and systemic activity may in turn lead to an attenuation of 
CBF.
Following the initial decrease in CBF, blood flow increased in various regions following 
SE. Elevated levels of cerebral blood volume (CBV) have been reported 12 h after the 
onset of SE by Fabene and colleagues. They reported various hyperperfused areas that 
included the hippocampus, cerebral cortex and the thalamus. We observed similar elevated 
levels of perfusion by day 1 in the cerebral cortex and the hippocampus but did not 
observe any changes in thalamic perfusion. Moreover, cortical CBF was increased and 
reached a maximum on day 1, and hippocampal CBF was high on days 1 and 2. There also 
appeared to be a non-significant but systematic increase in CBF on day 2 in the piriform 
cortex (see fig. 6.12 and 6.13).
The discrepancy in the thalamus between the Fabene study and our studies may be due to a 
number of methodological differences between these studies. Fabene and colleagues did 
not use lithium pre-treatment and also gave the animals a 4 h seizure compared to the 90 
minutes used in this study, either of which may exacerbate injury leading to changes in 
perfusion. Also they measured relative CBV whereas absolute CBF was measured for this 
study. Nevertheless it is the measurements at different time points that are likely to underlie 
this discrepancy. It is possible that 12 h perfusion does, in fact, increase in all of these 
regions in our animals but whereas perfusion remains high in the cerebral cortex and the 
hippocampus at 24 h, thalamic perfusion may have returned to normal by this period.
Nevertheless, perfusion increases have been observed in a variety of conditions, such as 
subarachnoid haemorrhage and SE, and have been associated with cell death and 
inflammation (Rowe et al, 1998; Blamire et a l, 2000; Fabene et al., 2003; Engelhorn et al, 
2005). However, investigations into the time course for CBF changes after SE has not been
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previously reported and therefore the mechanisms that underlie these alterations in CBF 
following SE remain unclear.
Local blood flow is primarily maintained by the release of paracrine vasodilators from 
endothelial cells, which can be induced by various mechanisms including neurotransmitters, 
neuropeptides and physical vascular stimuli, such as shear stress (Scotland et a l, 2005). To 
date, endothelial-derived vasodilatation is thought to occur through three main pathways: 
nitric oxide (NO), prostacyclin (PGI^ and endothelium-derived hyperpolarizing factor 
(EDHF) (Brandes et al., 2000), but the relative contribution of these pathways to the 
observed CBF changes have not been studied in the current study.
NO is generated by the action of the nitric oxide synthase family of proteins (NOS) and 
excessive amounts of NO have been shown to cause cell injury and death (Moncada and 
Bolanos, 2006). Presently, three isoforms of NOS have been identified: endothelial derived 
NOS (eNOS), neuronal NOS (nNOS), and the inducible form, iNOS (Cuzzocrea and 
Salvemini, 2007). In CNS injury, two post-injury periods have been defined with reference 
to high levels of NO production: immediately after injury and several hours-to-days later. 
The initial period has been associated with nNOS generated by neurons, and the later 
period with iNOS produced by infiltrating inflammatory cells (Conti et al., 2007). However, 
whether this trend occurs following SE is not clear, but NOS up-regulation has been 
shown to play a role in the injury caused by SE (Montecot et a l, 1998; Chuang et a l, 2007) 
and seem to parallel the activation of inflammatory cytokines (De Simoni et a l, 2000). 
Moreover, these changes seem to correspond with the period of elevated CBF that we have 
observed in this study.
PGI2 is a prostaglandin that is produced by the activation of cyclo-oxygenase (COX) family 
of proteins. Two forms of COX have been currently identified: COX-1 and COX-2 
(Cuzzocrea and Salvemini, 2007). Whereas COX-1 is present in tissues and plays a 
cytoprotective role in normal physiological function, COX-2 is expressed during 
inflammation (Vanheel and Van, V, 2000). The increased expression of COX-2 has been 
identified following SE-induced injury and were found to be localised almost exclusively 
around the hippocampus and the piriform cortex (Turrin and Rivest, 2004). Furthermore, 
in these regions the temporal pattern o f expression of COX-2 following pilocarpine-
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induced seizures parallel the transient nature of the CBF time courses that were observed 
in this study (Turrin and Rivest, 2004). It is notable that a recent study indicated that 
celecoxib, a selective COX-2 inhibitor, administered after lithium-pilocarpine-induced SE 
has been shown to reduce the subsequent severity and frequency o f spontaneous recurrent 
seizures (Jung et al, 2006). This suggests that COX-2 may have a key role to play in the 
modulation of outcome following SE.
Vasodilatation cannot be fully accounted for by the actions of NO and PGI2, and there is 
now strong evidence for the existence of a third pathway, EDHF (Bryan, Jr. et al, 2005). 
The identity of EDHF remains elusive, but its defining characteristic is that it requires the 
involvement of potassium channels, which are often calcium-activated (Bryan, Jr. et al., 
2005). Although electrolyte imbalance has long been associated with seizures (Shorvon, 
1994; Hinterkeuser et al, 2000; Cock et al., 2002), and a persistent elevation of intracellular 
calcium has been implicated in the pathogenesis o f epilepsy (Delorenzo et al, 2005), 
whether EDHF has a role to play post-SE has not been explored.
Taken together, these data indicate that the observed CBF change may reflect an 
inflammatory process and also cell death, both of which have been identified during this 
acute period following SE. However, further studies are required to elucidate the 
underlying basis for these observed CBF changes and the relationship with later injury. It is 
possible that an acute inflammatory reaction following SE plays a key role in subsequent 
brain injury and epileptogenesis.
6.4.3. Volumetric assessment 21 days post-SE
Analysis of the volumetric data indicated that there were no significant brain volume 
differences between the four groups 21 days after SE. However, hippocampal volume 
differences were found; these results will be discussed further in section 6.4.5. In addition, 
regression analysis indicated that there was a strong association between ventricular and 
hippocampal volumes.
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MRI has been previously used to measure hippocampal volumes post-SE in animal models 
and in humans, and reductions in hippocampal volumes have been reported following the 
early period post-SE (Scott et al, 2002; Wolf et al, 2002; Niessen et al, 2005). Although 
multiple areas are known to be injured by SE, the hippocampus appears to be particularly 
vulnerable to prolonged seizure activity. It is also notable that the reduced hippocampal 
volumes measured with MRI are related to functional deficits; a relationship that has been 
widely reported using histological assessment of hippocampal volume with spatial memory 
tests (Moser et al, 1995; Nunez et al, 2000; Wu et al, 2001). These data suggest that MRI 
volumetries are a valid method for assessing of hippocampal volumes.
The finding that brain volume did not change following SE has been reported previously 
60 days after SE in the pilocarpine rat model (Niessen et al, 2005), and our results also 
replicate this finding. In addition, the data from the current study are similar to the results 
reported by Niessen and colleguaes, in which reductions in hippocampal volumes and 
enlargement of ventricular volumes were observed. Taken together, these results suggest 
that neuronal loss after SE occurs predominantly in the hippocampus.
Although the relationship between ventricular volume and hippocampal volume has also 
been reported (Niessen et al, 2005), in the present study regression analysis indicated that 
the association between increasing ventricular volumes and atrophy of the hippocampus 
was only true up to a degree after which the relationship no longer holds. This was 
observed in two of the animals that showed the most severe hippocampal atrophy and 
enlarged ventricles, in which signal from CSF could also be seen from the piriform cortex 
and the amygdala. Whether the injury was caused by a particularly severe form of SE or by 
some unknown environmental condition remains unclear. The severity of injury caused by 
SE has been shown to depend on its duration (Fujikawa, 1996), but environmental stresses 
have also been associated with hippocampal atrophy (Zhao et al, 2007). Also, 
environmental stress is associated with selective neuronal loss in the CA1 and CA3 regions 
of the hippocampus, which are also particularly vulnerable to SE-induced injury (Fujikawa, 
1996; Zhao et al, 2007). Whether environmental stress has any implications on the 
progression of cell loss seen in SE-induced injury has yet to be explored.
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6.4.4. The serial effect of isojlurane on brain injury after SE
The m a i n  purpose of investigating the effects of isoflurane was to see whether the 
pathophysiology following SE was affected when the animals were serially imaged. The 
experimental design for this study included additional control groups for investigating such 
an effect. Significant differences in hippocampal volumes between the full-imaging and 
control-imaging pilocarpine groups were observed in which the FLP group showed less 
hippocampal atrophy than the CLP group. Also, when the tissue status was assessed by 
quantitative MRI, significantly different changes were found in the cortical T 1 and ADC in 
the piriform cortex. Taken together, these data indicate that the serial use of isoflurane may 
confer a degree of neuroprotection following SE.
The neuroprotective effect of isoflurane has been demonstrated in experimental models of 
traumatic brain injury and ischaemia but its effect following SE has not previously been 
explored (Statler et al., 2006; Koerner and Brambrink, 2006). Similarly to other general 
anaesthetics, the mechanisms of action of isoflurane remain unclear but it has been shown 
to act on a host of neurotransmitter systems including those involving GABA, glycine, 
acetylcholine, serotonin as well as the three types of ionotropic glutamate receptors 
(Rudolph and Antkowiak, 2004). However, which of these mechanisms are important in 
neuroprotection is not known.
The long term neuroprotective effect of isoflurane has also been questioned in that this 
effect dissipates around 2-3 weeks after ischaemia; in contrast, this effect has been shown 
to persist following traumatic brain injury (Statler et al., 2006). In relation to the current 
study, whether the neuroprotection persists after the 21 days is not known. Furthermore, as 
multiple doses of anaesthesia were given for the imaging time course, and thus it was not 
possible to assess whether it was the cumulative effect of isoflurane or this was due to an 
early effect after SE. It has been suggested that it is the timing o f the anaesthesia that is 
critical in that this effect is exerted at or very near the time of brain injury, and it is 
therefore likely that the neuroprotection observed may be due to an early effect of 
anaesthesia (Statler et al., 2006). Although the neuroprotective effect was investigated in this 
study, its effect on epileptogenesis was not studied and the change in brain injury following 
SE may suggest an interesting avenue for further study.
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The question remains as to whether the MRI time course has been altered due to the effect 
of isoflurane. The acute transient response after SE that were observed have been detected 
following SE in previous MR studies that used other anaesthetics, such as ketamine, and 
also in humans (Nakasu et al, 1995; Scott et al., 2002; Roch et al, 2002a). Therefore these 
studies suggest that the acute and transient response that was observed does occur 
irrespective of the anaesthetic used. However, whether this response has been modulated is 
not known. Nevertheless, these results indicate that future studies should take the potential 
effects of anaesthesia into consideration.
6.4.5. The relationships between maximal hippocampal M R changes on day 2 and hippocampal volume on 
day 21
One of the main findings in this study is that maximal hippocampal MR changes measured 
2 days after SE were strongly associated with hippocampal volumes on day 21, which was 
not observed with either day 1 or day 3 measurements. Further analysis indicated that it 
was the combination of T:, T2 and CBF measurements on day 2 that was highly predictive 
of hippocampal volumes on day 21 and suggesting an early biomarker for injury.
Although all four of the parameters were found to be altered in the hippocampus over the 
first 3 days, it is unclear why it was only at 2 days after lithium-pilocarpine induced SE that 
a relationship with later injury was found and whether this is a model-specific 
phenomenon. Similarly to this study, T2 and ADC changes, as well as in T 1(? and rCBV, 
have been reported acutely post-SE pathology in experimental models and in humans 
shortly after the seizure (Nakasu et al, 1995; Wall et al, 2000; Roch et al, 2002a; Scott et al, 
2003; Nairismagi et al, 2004). However, quantitative measurements at similar intervals over 
this acute period have not been previously attempted, and thus it is unclear as to whether 
the peak changes occur specifically at 2 days in other forms of SE. Clarification of this 
phenomenon in humans may provide a diagnostic tool for identifying patients who may 
progress on to a poor outcome, and offer an opportunity for early intervention.
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During this early period, a variety of processes has been described, including cell death, 
inflammation and increased neurogenesis (see chapter 2). Each of these processes is likely 
to be contributing to differing degrees to each o f the parameters, and the physiological 
basis of each of these changes has previously been discussed. One particular physiological 
process that is consistent with both oedema (Tt and and increased CBF is 
inflammation, which is invariably present following an insult (Blamire et a l, 2000; 
Ambrosini et al,!, 2005). Inflammation is a process that has been previously implicated in 
post-SE pathology and inflammatory molecules have been identified during this early 
period (see section 2.3.2) (Jankowsky and Patterson, 2001; Vezzani and Granata, 2005). 
However, a direct relationship between early inflammation and later outcome has not, to 
our knowledge, been previously reported. Due to this relationship, we hypothesise that 
status epilepticus is associated with acute brain inflammation which modulates brain injury 
and subsequent epileptogenesis, and thus a reduction in inflammation will reduce the 
incidence and severity of later epilepsy. A recent study that investigated the post-SE effect 
of selectively inhibiting COX-2, a key inflammatory pathway, supports this hypothesis 
(Jung et al!, 2006). Clearly, the period around 2 days requires further study, and identifying 
concomitant molecular changes may elucidate novel pathways for investigating post-SE 
pathology.
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6.5. CONCLUSION
This study supports the hypothesis that SE induces progressive injury that continues to 
evolve following the acute period. Changes in T1? T2, ADC and CBF can be observed 
during this acute period and may reflect the onset and resolution o f inflammation. 
Moreover, peak changes in T2 were observed during this early period, 2 days after SE, and 
our analysis indicates that there is a striking relationship between T1} T2 and CBF changes 
and hippocampal volume measured on day 21. Taken together, these results suggest that 
we have identified an early biomarker on day 2 for outcome in the lithium-pilocarpine 
model. This may be an important period following SE-induced injury and may indicate a 
window of opportunity for early intervention. Further studies are required to elucidate the 
mechanisms that occur during this period, and this is the basis of investigations reported in 
the following chapter.
CHAPTER 7: PROTEOM E CHANGES ASSOCIATED WITH
MAXIMUM HIPPOCAMPAL M R I ABNORM ALITIES 
FOLLOWING STATUSEPILEPTICUS
Do not dwell in the p a st, do not dream o f the future, concentrate the mind 
on the present moment
Buddha
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7.1. INTRODUCTION
Chapter 6 reported on the temporal evolution of brain injury following SE, characterised 
using multi-parametric MRI. In that study, the hippocampus of the lithium-pilocarpine rat 
was found to elicit a maximum MRI response at 2 days after SE. Moreover, this response 
demonstrated a significant relationship with the evolution of injury on day 21. Therefore 
these data indicated that early hippocampal injury can predict later injury. However, the of 
the MRI changes is unknown.
Studies have demonstrated that a host of physiological processes are activated during this 
period following SE. By day 2 these include inflammatory, cell death as well as neurogenic 
mechanisms (Fujikawa, 1996; Vezzani and Granata, 2005; Parent et a l, 2006a) (see chapter 
2), as well as alterations in neurotransmitter systems and Ca2+ signalling (Raza et al., 2001; 
McNamara et al., 2006). However, one of the main difficulties of comparisons between 
studies is that different animal models or implementation o f animal models are used. For 
example, although the duration of the prolonged seizure has been shown to be crucial for 
the progression of brain injury and the development o f spontaneous recurrent seizures, 
seizures that range from 20 mins to 6 hours can be found throughout epilepsy literature 
(Mello et al., 1993; van Eijsden et al., 2004; Dube et a l, 2006). In MRI studies conflicting 
reports exist, for example, both ADC increases and decreases have been reported following 
SE (Nakasu et al, 1995; Wall et al., 2000; Fabene et al., 2003). Thus it is possible that 
alterations in the temporal profile of the underlying molecular changes may also exist 
between different studies. Therefore to identify specific molecular changes that parallel the 
MRI parameters reported in chapter 7 we performed an image guided proteomic study.
In this study, MRI was combined with proteomic analysis to elucidate the protein changes 
associated with the maximal hippocampal MRI changes 2 days post-SE.
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7.1.1. Proteomics
Proteomics encompasses a variety of techniques that are defined by the large-scale 
characterisation of proteins expressed by the genome (Hoehn and Suffredini, 2005). These 
techniques include chromatography, electrophoresis, mass spectrometry and protein arrays. 
O f these techniques, protein separation by two-dimensional gel electrophoresis (2-DE) 
combined with protein identification by mass spectrometry are currendy the most widely 
used methods for investigating proteome changes. 2-DE is the best established technique 
that can be routinely applied for parallel quantitative expression profiling of large sets of 
complex protein mixtures (Gorg et al, 2004). For this reason, 2-DE was selected as the 
technique to be used to investigate the molecular changes that parallel the MRI changes 
reported at 2 days post-SE.
A detailed review of these techniques is beyond the scope of this thesis, however an 
overview of the basic principles that underlie 2-DE and mass spectrometry will be 
presented. The interested reader is referred to some excellent reviews on these methods 
and others used in proteomics (Gorg et al, 2004; Hoehn and Suffredini, 2005).
7.1.1.1. Two-dimensional gel electrophoresis (2-DE)
The 2-DE method involves successive separation of proteins on the basis of charge and 
molecular mass and is capable of resolving more than 5,000 proteins in a mixture (Gorg et 
al, 2004). A protein sample is first separated by isoelectric focussing on a pH gradient 
immobilised on a gel strip to which high voltage is applied. Proteins migrate until they 
reach a point on the pH gradient at which that particular protein carries no net electrical 
charge, the so called isoelectric point (Greene et al, 2002). After the proteins have reached 
their isoelectric point, the gel strip is subsequently applied to the top of a sodium dodecyl 
sulfate polyacrylamide gel, for electrophoresis (SDS-PAGE) in the second dimension 
which separates proteins on the basis of molecular mass. Protein spots are then visualised 
by silver staining. The final result is essentially a 2 dimensional protein map of the sample, 
with each spot on the gel corresponding to a single protein. Imaging software can then be 
used to analyse the gels, to search for spots that differ in abundance between experimental
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samples. Spots of interest can be cut out of the gel for identification using mass 
spectrometry.
7.1.1.2. Uquid chromatography coupled to tandem electrospray mass spectrometry
Mass spectrometry measures the mass to charge ratio (m/z) of ionised peptides or protein 
ions based on the flight of the charged particles through an electric or magnetic field 
(Hoehn and Suffredini, 2005). There are a variety of configurations for a mass 
spectrometer and their main components are the ionisation source, the mass analyser and 
the detector. The configuration used in this study was liquid chromatography coupled to 
tandem electrospray mass spectrometry, or LC-MS/MS. As with any configuration of mass 
spectrometry, the same fundamental principles apply. In brief, the sample is ionised and 
then accelerated from the ion source into an analyser, which separates the molecules 
according to their m /z ratios. The advantage of the LC-MS/MS configuration is that it can 
provide sequence information which enhances protein identification (Hoehn and 
Suffredini, 2005).
Following excision of proteins spots from the gel they are digested with the pro tease, 
trypsin, to generate peptides which are amenable to LC-MS/MS analysis. Peptides are 
separated by liquid chromatography which is coupled to the mass spectrometer. Peptides 
are ionised by electrospray ionisation and the ions enter the tandem mass spectrometer, 
which incorporates two distinct analysers separated by a collision cell. Peptides are 
separated and their mass determined in the first analyser. Peptides of selected mass/charge 
ratio enter the collision cell and are dissociated into fragments of varying lengths owing to 
collision-induced fragmentation. The fragments of the peptide then pass into the second 
mass analyser where the masses of these ‘product’ ions are determined. Analysis of the 
difference in mass between fragments allows the amino acid sequence of the peptide to be 
determined. Peptide sequence can then be used to interrogate protein databases to reveal 
protein identity.
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7.2. MATERIALS AND METHODS
The MRI experiments, which were a separate set from those in chapter 6 as the animals 
had to be sacrificed for tissue sample extraction, and the sample extraction was conducted 
by me, whereas the protein separation and western blot component was conducted by Dr. 
Nick Greene, Abiodun Bamidele, Sandra de Castro and the protein identification with mass 
spectrometry by Drs Robin Wait, Kit-Yi Leung and Shajna Begum.
7.2.1. Experimental Design
All animal care and procedures were carried out in accordance with the UK Animals 
(Scientific Procedures) 1986 Act. The experimental design for this study is outlined in 
figure 7.2.1.1.
10 adult male Sprague Dawley rats (200-220 g) were divided into one of two groups: 
lithium-pilocarpine (n = 6), lithium-saline (n = 4). CBF and T2 imaging were performed 
these animals before lithium injection to obtain a baseline measurement and also to verify 
that the brains of these rats were anatomically normal before inclusion into this study. 
Following injection of either saline or pilocarpine, the animals underwent further CBF and 
T2 imaging on days 0, 1 and 2 days after treatment. After the final imaging time point, the 
animals were sacrificed and their hippocampi were excised for proteome analysis.
For the purposes of this study, ROI MRI analysis was performed on the hippocampus and 
also the piriform cortex. Analysis was performed on the piriform cortex because previous 
studies have indicated that acute T2 changes in this region are required for the subsequent 
development of spontaneous recurrent seizures (Roch et al., 2002b).
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Figure 7.1. Experimental design. The animals were imaged before and after the induction of SE. 
Following imaging on day 2, the animals were sacrificed and the hippocampi were removed for proteome 
analysis.
7.2.2. Eithium-pilocarpine model
The drug protocol for the lithium-pilocarpine model was identical to the one described in 
section 6.2.2. In brief, lithium-chloride chloride (3 m Eq/kg, i.p., Sigma-Aldrich, Dorset, 
UK) was injected 18-20 h before pilocarpine treatment. Methylscopolamine (1 mg/kg, i.p., 
Sigma-Aldrich) was administered 15 mins prior to pilocarpine treatment, and pilocarpine 
hydrochloride (30 mg/kg, i.p., Sigma-Aldrich) was then injected to induce status epilepticus 
(n=6 rats). Dia2epam (10 mg/kg, i.p., Phoenix Pharma Ltd, Gloucester, UK) was 
administered 90 mins after the onset of SE to terminate the sei2ure. Control rats (n=4) 
received all treatments with the exception of saline instead o f pilocarpine.
7.2.3. Magnetic resonance imaging
Animals were anestheti2ed with 3% isoflurane and maintained on 1.5% isoflurane with 
60/40% N 20 / 0 2 delivered via a nose cone. Rats were placed on a probe with bite and ear 
bars securing the head to minimi2e motion artifacts. Physiological monitoring included
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electrocardiography (ECG) recordings and rectal temperature recordings. Temperature was 
maintained at 37 ± 1 °C using an air warming system.
Imaging was performed 1 day prior to any injections and on day 0, 1 and 2 days after SE. 
Images were acquired using a volume transmitter coil and a separate decoupled surface 
receiver coil, using a 2.35 Tesla horizontal bore magnet (Oxford Instruments, Oxford, UK) 
interfaced to a SMIS console (Guildford, UK). Coronal images were obtained 
approximately 3.3 mm from bregma.
T2 and CBF data were acquired using a MASAGE-IEPI sequence (Thomas et a l, 2002) and 
a continuous arterial spin labeling sequence respectively. The sequence parameters were 
identical to the ones described in section 6.2.4.
All images were reconstructed with IDL Software Version 5.2 (Research Systems Inc., 
Boulder, CO) in order to obtain quantitative T2 and CBF maps. CBF and T2 values were 
calculated for the hippocampus and piriform cortex. Repeated-measures (degrees of 
freedom-adjusted mixed-model) two-way ANOVA was performed on the T2 and CBF data 
(mean ± sem). The main effects were: treatment (saline, pilocarpine) and individual time- 
points (pre-SE, day 0, day 1 and day 2).
7.2.4. Sample preparation
Rats (6 pilocarpine-treated and 4 controls) were sacrificed at 2 days after SE following MRI 
and the hippocampus and forebrain were removed by dissection, immediately frozen on 
dry ice and stored at -70 °C. Tissue samples were minced using a needle and homogenised 
by sonication (15 seconds at 15 pm amplitude) in 1 ml lysis buffer containing 9.5 M urea, 
2% CHAPS, 0.8% Pharmalyte pH3-10, 1% DTT, with lx  protease inhibitor cocktail 
(Complete, Roche) and 1 x phosphatase inhibitor cocktail I and II (Sigma, St. Louis, MO, 
USA). Aliquots of 200 pi were stored at -70 °C prior to 2-DE and protein concentrations 
were determined using Protein Assay Reagent (Bio-Rad, Richmond, CA).
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7.2.5. 2-DE
Protein loadings of 300 Jig were used for all gels, samples being diluted to 225 pi with lysis 
buffer, added to 225 pi rehydration buffer (8 M urea, 2% CHAPS, 0.8% Pharmalyte pH3- 
10, 0.2% DTT) and loaded by in-gel rehydration onto pH4-7, 18 cm linear IPG strips (GE 
Healthcare, Amersham, UK). 2-DE was performed as described previously with minor 
modifications (Leung et a l, 2001; Greene et al., 2002). Briefly, strips were focused for 65 
kVh using a Multiphorll (GE Healthcare). Prior to the second dimension strips were 
equilibrated for 15 minutes in equilibration buffer (6 M urea, 30% glycerol, 2% SDS, 0.05 
M Tris/HCl pH8.8) containing 1% DTT and 25 minutes in equilibration buffer containing 
2.5% iodoacetamide. The second dimension separation was carried out on 12% SDS- 
PAGE gels, with modification of the running buffer to contain 1.5% SDS. Gels were fixed 
and silver-stained using PlusOne stain (GE Healthcare).
7.2.6. Gel image analysis
Gels were scanned using a GS800 calibrated densitometer (Bio-Rad,) and analysed using 
PDQUEST (Version 7.0, Bio-Rad) and Progenesis PG220 with TT900S2S (Non-Linear 
Dynamics, Newcasde-Upon-Tyne, UK) software. A set o f 32 gels comprising 15 control 
and 17 pilocarpine-treated samples (2 or 3 gels from each animal) were selected for 
analysis. Quantitative comparisons were made between these replicate groups. Spots on 
the edge of gels that were not detected in all the gels for an individual sample were 
excluded from further analysis. Quantitation was based on the normalised volume of spots 
and statistical comparison was by student’s t-test, with p<0.05 considered significant.
7.2.7. Mass spectrometry
Protein spots were excised manually from a minimum of three different gels and subjected 
to in gel digestion with trypsin as described previously (Leung et al.y 2001). Samples were 
analysed by liquid chromatography coupled to tandem electrospray mass spectrometry (LC- 
ESI-MS/MS). Spectra were recorded using a Q-Tof spectrometer (Micromass,
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Manchester, UK) interfaced to a Micromass CapLC capillary chromatograph. Samples were 
dissolved in 0.1% formic acid and aliquots were injected onto a 300 Jim x 5 mm Pepmap 
C l8 column (LC Packings, Amsterdam, NL) and eluted with an acetonitrile/0.1% formic 
acid gradient. The capillary voltage was set to 3,500 V. A survey scan over the m/  % range 
400-1300 was used to identify protonated peptides with charge states of 2, 3 or 4, which 
were automatically selected for data-dependent MS/MS analysis, and fragmented by 
collision with argon. The resulting product ion spectra were transformed onto a singly 
charged m/ ^  axis using a maximum entropy method (MaxEnt3, Waters) and proteins were 
identified by correlation of uninterpreted spectra to entries in SwissProt/TrEMBL, using 
ProteinLynx Global Server (Version 1.1, Waters) (Wait et al., 2005). The database was 
created by merging the FASTA format files of SwissProt, TrEMBL and their associated 
splice variants (1,768,175 entries at the time of writing). No taxonomic or protein mass and 
p i constraints were applied. One missed cleavage per peptide was allowed, and the initial 
mass tolerance window was set to 100 ppm. In parallel the spectra were also searched 
against the NCBI non-redundant database (3,879,234 sequences as of August 2006) using 
the Mascot search algorithm (www.matrixscience.com). For an identification to be 
considered valid we required that two or more peptides independently matched the same 
protein sequence, that the peptide score was significant (typically greater than 55; P < 0.05), 
and that manual interpretation confirmed agreement between spectra and peptide 
sequence. In addition Mascot searches of all spectra were performed against a randomised 
version of the NCBI database using the same parameters as in the main search. In no case 
did this search retrieve more than a single peptide, and in all instances the peptide score 
was below the 0.05 significance level.
7.2.8. Western blot
Protein samples containing 1 pg total protein (in lysis buffer as above) were diluted in 
Laemmli sample buffer (Bio-Rad), resolved on 10% Nu-PAGE gels (Invitrogen, Paisley, 
UK) and transferred to Immobilon-P (Millipore, Watford, UK). Equal loading of lanes 
(based on assay of total protein) was confirmed by silver staining of parallel lanes, 
supported by equal intensity of bands on the (3-tubulin blots. Blots were incubated with 
antibodies to Hsp27 (1:1000, StressGen/Nventa, San Diego, CA), CRMP-2/DRP-2
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(1:4000, CovalAb, Cambridge, UK), Ct-tubulin or (3-tubulin (both 1:10,000, Santa Cruz 
Biotechnology, Inc.). Proteins were detected using horseradish peroxidise-conjugated 
secondary antibodies (DAKO, Ely, UK), with development using ECL+ Western blotting 
Detection System (GE Healthcare). Experiments were performed in triplicate, in each case 
using three saline-treated and three pilocarpine-treated samples. Quantity One software 
(Bio-Rad) was used for quantification of protein bands.
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7.3. RESULTS
7.3.1. Animal behaviour
For each pilocarpine-treated animal, clinical signs o f seizure activity were noted. All rats 
exhibited a well-defined pattern of behaviour following the injection of the convulsant. 
Around 5 mins after pilocarpine, the animals developed piloerection, diarrhoea and other 
signs of cholinergic stimulation. In the following 15-20 mins, head-bobbing, chewing and 
increased exploratory behaviour were observed. The rats then progressed to SE with 
episodes of head and bilateral forelimb clonus and rearing and falling around 25-35 mins 
after injection of pilocarpine.
7.3.2. T2
MRI revealed a marked T2 increase in the piriform cortex of pilocarpine-treated animals, 
which was evident at days 1 and 2 (Fig. 7.2) and a significant time-dependent difference 
was found between the pilocarpine and saline groups (F=13.28, p=0.0017). On day 2, the 
mean T2 values were 110 ± 7.2 ms (mean ± sem) for pilocarpine-treated animals and 75 ± 
1.9 ms for the saline-treated controls.
In the hippocampus, a time-dependent difference was also found (F=13.364, p=0.006). As 
expected, this was to a lesser degree (T2 (mean ± sem): pilocarpine group 88 ± 5 ms; saline 
group 72 ± 0.3 ms) at day 2, than for the piriform cortex.
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Figure 7.2. T2 relaxation times for individual animals in the: a) hippocampus, b) piriform cortex. T2 
measurements were performed before lithium administration (day -1) and subsequently on days 0, 1 and 2. 
The red lines are measurements obtained from individual lithiumpilocarpine treated animals and the blue 
lines from the individual saline treated animals.
7.3.3. CBF
CASL measurements demonstrated significant time-dependent differences in hippocampal 
CBF of the pilocarpine-injected animals when compared to the saline-injected rats (F = 
6.18, p = 0.014). Over the period of imaging, the greatest degree of hippocampal CBF 
change was observed on day 2 (fig. 7.3), with mean hippocampal CBF for the pilocarpine- 
injected group at 185.7 ± 33.6 ml/lOOg/min, and for the saline-injected animals, 72 ± 0.3 
ml/lOOg/min (mean ± sem). In contrast, no significant CBF differences were observed in 
the piriform cortex (F = 1.03, p = 0.344). On day 2, the mean CBF values in the piriform 
cortex were 127.5 ± 38.0 ml/lOOg/min and 73.0 ± 1.04 ml/lOOg/min for the pilocarpine 
and saline groups respectively.
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Figure 7.3. CBF time course in the: a) hippocampus, and b) piriform cortex. CBF measurements were 
performed before lithium administration (day -1) and subsequently on days 0, 1 and 2. The red lines are 
measurements obtained from individual lithiumpilocarpine treated animals and the blue lines from the 
individual saline treated animals.
7.3.4. 2-DE of hippocampus protein samples
In line with the experiments reported in chapter 6, MRI of the pilocarpine-treated rat brain 
confirmed that there were pathological changes in the hippocampus by 2 days, which is a 
region known to be associated with the subsequent epilepsy. Therefore this region, based 
on the spatial and temporal MRI T2 and CBF changes, was isolated for further 2-DE 
analysis. Among detectable protein species, approximately 800 spots were matched on 
pH4-7 gels generated using hippocampal protein samples. A representative gel is shown in 
figure 7.4. A set of 32 gels comprising 15 pilocarpine-treated (SE) samples (2 or 3 gels 
from each of 6 animals) and 17 control samples (from 8 animals) was selected for analysis. 
Protein spots were excised from gels and subjected to tryptic digestion followed by LC- 
MS/MS for identification (fig 7.4, Table 1). Proteins that were present with equal 
abundance in SE and control samples included a-enolase (fig 7.4; spot 2), ubiquitin 
carboxyl-terminal hydrolase (spot 3) and peroxiredoxin 6 (spot 1; confirmed by MS analysis 
of spots from 4 separate gels).
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Figure 7.4. Typical 2D protein profile for adult rat hippocampus 2 days following SE from a) Uthium- 
saline injected rat; b) Uthiumpilocarpine-injected rat. Proteins were separated on the basis of p i (pH4-7 
on the x-axis) and M r (molecular mass kDa is indicated on y-axis). Numbered spots were identified by 
LC-M S/M S (see Table 1).
I
169
Spot
no.
Protein Accession
no.
Theoretical
M r/pi
No. Matched 
peptides
1 Peroxiredoxin 6 035244 24.67/5.8 6
2 Alpha enolase P04764 46.98/6.5 8
3 Ubiquitin carboxyl-terminal 
hydrolase isozyme LI
Q00981 24.82/5.1 6
4 Tubulin beta chain P04691
P69897
49.93/4.79 14
5 Tubulin beta chain P04691 49.93/4.79 5
6 ATP synthase beta chain, 
mitochondrial precursor
P10719 56.33/5.3 2
7 Chaperonin containing T- 
complex protein 1, epsilon 
subunit
Q68FQ0 59.59/5.72 6
8 Gamma-enolase P07323 46.98/5.03 18
9 Stress-70 protein (GRP75) P48721 73.80/5.97 4
10 Vacuolar ATP synthase 
subunit B, brain isoform
P62815 56.52/5.57 6
Spots that are up-regulated in pilocarpine-treated hippocampus (p<0.01)
11 Dihydropyrimidinase related 
protein-2
P47942 62.24/5.9 11
12 Heat-shock protein beta-1 P42930 22.87/6.5 7
(HspBl) Heat 27kDa Protein 
________ (HSP 27)_________
13 Tubulin alpha chain P68370 50.10/4.94 3
14 Ezrin (p81, Cytovillin) P31977 69.22/5.83 18
15 Dihydropteridine reductase PI 1348 25.54/7.67 2
Spots that are down-regulated in pilocarpine-treated hippocampus (p<0.01)
16 Histone-lysine N- 
methyltransferase (mouse)
XP_00105 40.48/4.53 
6302
1
Table 7.1. Protein identities determined by LC-M S/M S analysis of gel spots.
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Figure 7.5. Examples of differentially expressed spots in enlarged regions of representative 2D gels from 
control (Con; A , C, E, G) and lithium pilocarpine-treated (Pilo; B, D, F, H) samples. Gels show 
increased abundance ofHSP27 (A-B; Spot 12), DRP-2 (C-D; Spot 11), Dihydropteridine reductase (E- 
F; Spot 15) and Eyrin (G-H; Spot 14) in hippocampus samples from lithium pilocarpine-treated rats 
compared to controls. Western blots (I) show increased total abundance of HSP27 and a-tubulin and 
reduced abundance of DRP-2 in lithium pilocarpine-treated rats, whereas f  tubulin shows no apparent 
difference. Molecular weight is indicated.
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7.3.5. Differential expression of heat shock 27 kDa protein
Computer-assisted image analysis was used to detect protein spots that differed in 
abundance on gels generated from hippocampus o f control and pilocarpine-treated (SE) 
rats. This analysis did not reveal any spots in control samples that were absent from all 
treated samples. In contrast, we were able to identify a protein species that was present at 
relatively high abundance (Spot 12; figs. 7.4 and 7.5) in all SE samples, but was virtually 
undetectable by silver staining on the control gels (more then 9-fold difference (p<0.001)). 
This protein was isolated from five separate gels and in each case was identified by LC- 
MS/MS as heat-shock protein beta-1 (HspBl), commonly known as heat shock 27 kDa 
protein (HSP27). Increased expression of Hsp27 in SE samples was confirmed by western 
blot (fig 7.5).
In order to determine whether up-regulation of HSP27 is specific to the hippocampus, we 
generated additional 2D gels using forebrain samples from the SE and control rats (n = 2 
for each). As for hippocampal samples the spot corresponding to HSP27 was also 
detectable at high abundance in forebrain samples from SE rats, suggesting that up- 
regulation of HSP27 may be a global response throughout the brain.
7.3.6. Quantitative changes in abundance of proteins in SE  hippocampus
Among statistically significant differences between gels, visual verification confirmed that 
in addition to HSP27, 5 other spots were present at greater abundance in SE samples, 
whereas 4 spots were decreased in abundance. Using LC-MS/MS identities were obtained 
for 5 of the varying spots, whereas the remainder were present at very low abundance and 
have not been identified to date.
A spot identified as dihydropyrimidinase related protein-2 (DRP-2; spot 11, fig 7.4 and 7.5) 
showed approximately four-fold up-regulation in SE samples (p<0.01). As DRP-2 has 
previously been reported to show multiple isoforms on 2D gels, western blotting of the 
same samples as used for 2-DE was carried out, to determine if total abundance also varies. 
Western blotting for DRP-2 revealed a major band at 65 kDa with a minor band of slightly
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higher molecular weight, as expected (fig 7.51). In contrast to the increased abundance of 
the DRP-2 spot on 2-DE, the bands on western blots were consistendy of lower intensity 
for hippocampus of pilocarpine-treated rats compared to controls. Thus, while one species 
is up-regulated following SE, the overall protein abundance of DRP-2 decreases.
Spots 13, 14 and 15 (fig 7.4) were also found to be present at significandy greater 
abundance on gels generated using SE samples compared to controls (two-fold up- 
regulation, p<0.005, fig 7.5). These spots were identified as a-tubulin, ezrin and 
dihydropteridine reductase (Table 1). Spot 13, which corresponds to a-tubulin, migrates as 
a species of approximately 18 kDa, a much lower mass than predicted. The peptides that 
were identified from this spot by LC-MS/MS (table 7.1) all lie within the N-terminal third 
of the protein and it appears likely that this spot corresponds to a fragment of the protein. 
However, western blot analysis also showed an approximate two-fold up-regulation of the 
50 kDa band, corresponding to the full length a-tubulin (fig 7.51).
Among spots that were apparently down-regulated in hippocampus after SE, spot 16 (fig
7.4, Table 1) showed a two-fold reduction in abundance (p<0.005), and was identified as 
corresponding to the predicted rat homologue o f histone-lysine N-methyltransferase (H3 
lysine-4 specific SET7).
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7.4. DISCUSSION
7.4.1. MRI changes following SE parallel our previous MRI observations
MRI demonstrated that significant time-dependent T2 changes occurred in the 
hippocampus and the piriform cortex following pilocarpine-induced SE. In addition, this 
effect was also observed in hippocampal CBF, but no significant CBF effect was observed 
in the piriform cortex. For the pilocarpine-treated animals, the T2 and CBF measurements 
at 2 days after SE from the current study with the corresponding 2 day measurements from 
chapter 6 are presented in table 7.2.
Cerebral blood flow 
(ml/ lOOg/min)
t 2
(ms)
Hippocampus Piriform
Cortex
Flippocampus Piriform 
Cortex
Results from present 
study
185 ± 33.6 127 ± 38.0 88 ± 5 .0  110 ±7 .2
Results from previous 
study presented in 
chapter 6
149 ± 11.1 135 ± 14.2 76 ±0.91 110 ±5.5
Table 7.2. A  comparison between the CBF and T2 measurements at 2 days following lithium 
pilocarpine-induced SE in the current study and the study presented in chapter 6. Data shown as mean ± 
s.e.m. These data indicate that there are consistent increases in CBF and T2 in the hippocampus and the 
piriform cortex in this study and that of chapter 6.
These data indicate that the hippocampal T2 and CBF changes have been observed here are 
consistent with the changes that were observed at day 2 in the study presented in chapter 6. 
This is important because it is at this point in time that a significant T2 relationship was 
found between early and late injury and it is this period during hippocampal injury that we 
aimed to investigate. Also, T2 changes were observed in the piriform cortex. These changes 
have been suggested to be critical for the subsequent development of spontaneous
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recurrent seizures in young lithium-pilocarpine rats (Roch et al., 2002b) and, although it is 
unclear as to whether this necessarily implies that this is true for adult rats, this may 
nevertheless indicate that these animals will eventually progress onto epilepsy.
7.4.2. Peroxiredoxin 6
Comparison between the pilocarpine and saline hippocampal samples yielded relatively few 
proteins that were significandy altered in expression at 2 days following SE. This may be 
due to the fact that only a subset of proteins, only the most abundant species in the 
samples, is detected on 2D gels. One protein that was identified was peroxiredoxin 6 
(antioxidant protein 2). Although in this study no changes were found, this protein has 
been reported to be up-regulated in the kainic acid-induced rat model of SE (Krapfenbauer 
et al., 2001)
Peroxiredoxin 6 functions as an antioxidant and has been proposed to be up-regulated as a 
response to oxidative stress. However, in our study no detectable change in abundance of 
this protein was observed and this could reflect a difference between the pilocarpine and 
kainic acid models. Alternatively, this discrepancy may be due to differences in 
methodology. In the kainic acid model study, whole brain was analysed compared to just 
the hippocampus in the present study. Also, their sample was collected at one week after 
SE whereas our samples were extracted at 2 days. Therefore, it is possible that 
peroxiredoxin 6 levels may change as a later response to tissue damage and oxidative stress.
7.4.3. Heat shock protein-27
The most striking difference between the pilocarpine-treated and control samples was the 
dramatic up-regulation of heat shock protein-27 (HSP27), which was observed in both 
hippocampus and forebrain.
HSP27 is a member of the heat-shock family o f proteins that function as cellular 
chaperones that help in the folding of nascent polypeptides or proteins that have been
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denatured by environmental stress (Hirsch et al., 2006). These proteins have been shown to 
be induced in response to a variety of stresses including seizures, heat injury and hypoxia 
and because of this are considered to be markers of cellular stress (Hirsch et al., 2006). 
Although up-regulation of the members of the heat-shock protein family - HSP70 and 
HSP72 - has previously been described following pilocarpine-induced SE, this is the first 
time that induction of HSP27 has been reported in this model (Lian et al., 2005; Tetich et 
al., 2005).
High levels of HSP27 have previously been identified in brain resected from patients with 
pharmacoresistant temporal lobe epilepsy (Bidmon et al., 2004), and other CNS disorders 
such as Alzheimer’s disease and stroke (Franklin et al., 2005). Moreover, HSP27 was 
previously found to be up-regulated in other experimental models of status epilepticus, 
such as the kainic acid model (Akbar et al., 2001; Krapfenbauer et al., 2001).
The finding in this study of increased HSP27 levels within 2 days after pilocarpine-induced 
SE, support the hypothesis that this protein is an early marker of seizure-induced cellular 
stress. The functional effect of HSP27 up-regulation following SE is unclear, but it may 
represent a neuroprotective response. Direct evidence for an in vivo neuroprotective role 
has been provided by expression of HSP27 using viral vectors in experimental models of 
stroke, associated with reduced lesion size (Badin et al., 2006). It is also interesting to note 
that HSP27 has been suggested to play a role in reducing seizure severity, which was 
observed in the HSP27 over-expressing transgenic mouse following administration of 
seizure-inducing levels of kainic acid (Akbar et al., 2003).
In the present study, the fact that HSP27 was detected at high abundance in both the 
hippocampus, which exhibited T2 and CBF changes, as well as other regions of the brain, 
suggests that the selective vulnerability experienced by the hippocampus may not be 
accounted for by a local deficiency in HSP27. Nevertheless this does not exclude the 
possibility that overexpression of HSP27 would provide some protective role in this animal 
model (Akbar et al., 2003). In addition, whether HSP27 has a role to play in epileptogenesis 
has yet to be explored.
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7.4.4. Dihydropyrimidinase related protein-2
After HSP27, the protein species that was most significantly up-regulated in hippocampus 
after SE was dihydropyrimidinase related protein-2 (DRP-2), also known as collapsin 
response mediating protein-2 (CRMP-2) or turned on after division, 64 kDa protein 
(TOAD-64). However, the overall abundance of DRP-2, as revealed by western blot, was 
lower in pilocarpine-treated samples. Multiple spots corresponding to DRP-2, and assumed 
to be post-translational variants (eg, differentially phosphorylated forms), have been 
detected in a 2D gel study of human hippocampus (Yang et al., 2004).
As multiple forms are also likely to be present in the rat hippocampus this may suggest that 
while the overall abundance of protein is reduced following pilocarpine treatment, one 
particular post-translational variant accumulates. In support of this idea, three of the 
multiple spots detected in human hippocampus were present at lower intensity in samples 
from patients with epilepsy, whereas one spot was increased in intensity (Yang et at\, 2004). 
Presumably, certain DRP-2 species must also decrease in abundance in the present study, 
but these may not be represented on our gels, or each individually do not exhibit sufficient 
reduction in levels to be detected as significandy different.
DRP-2 is not expressed in neuronal progenitors but is one o f the first markers of newborn 
neurons (Minturn et al\, 1995). Widespread expression can be found in the developing 
nervous system but it is down-regulated post-natally with the notable exception of the 
hippocampus (Uchida et al, 2005). This correlates with its presence on 2D gels of control 
hippocampus in this study. DRP-2 is enriched in neuronal axons and is thought to function 
in axonal growth and pathfinding during development of the nervous system (Arimura et 
a l, 2004). For example, overexpression of DRP-2 can induce the formation of 
supernumerary axons (Inagaki et a l 2001). Also this protein appears to play a key role in 
the mediation of signals from extracellular stimuli including guidance molecules such as 
Semaphorin 3A (Arimura et al., 2004). It is also notable that expression of truncated DRP-2 
mutants suppressed the formation of primary axons (Inagaki et al., 2001).
Given that an increase in hippocampal neurogenesis has been widely reported following SE 
in a variety of animal models (Parent et al., 1997; Bengzon et al., 1997; Gray and Sundstrom,
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1998; Parent et al, 1998) and, more pertinent to this study, within 2 days following lithium- 
pilocarpine induced SE (Ekdahl et al., 2001), it would seem unlikely that the reduction in 
overall DRP-2 reflects a reduction in hippocampal neurogenesis. This finding may in fact 
indicate that neurogenic mechanisms are altered following SE and may have implications 
for the pathogenic mechanisms of epilepsy such as mossy fibre sprouting. Although 
controversial, mossy fibre sprouting has been suggested to play a key role in the initiation 
of epilepsy (see section 2.3.4.). Whether alterations in the various DRP-2 isoforms 
contributes to mossy fibre sprouting remains to be seen, and further studies will be 
required to determine the functional effects of changes in the levels of individual variants.
7.4.5. a-tubulin
Another protein, a-tubulin, which is required for axon outgrowth, was also found to be up- 
regulated after SE. Heterodimers of a- and (3-tubulin make up the principal component of 
micro tubules, which have multiple cellular functions (Fukata et al., 2002). Synthesis of 
microtubule proteins is known to occur during growth of axons and dendrites and, like 
DRP-2, tubulin function is required for formation and guidance of axon growth cones 
(Baas, 1997; Arimura et al., 2004). In fact a possible functional link between DRP-2 and 
tubulin is suggested by the fact that DRP-2 can bind to tubulin heterodimers and promote 
microtubule assembly (Fukata et al., 2002). Thus, altered levels of DRP-2 and a-tubulin may 
be associated with axonal outgrowth, perhaps o f newborn neurons. However, increased 
abundance of a-tubulin could also relate to one o f the many other functions of 
microtubules.
Elevated levels of a-tubulin mRNA have been reported in the kainic acid model of SE and 
in a rat kindling model of epilepsy (Krapfenbauer et al., 2001; Sato and Abe, 2001; 
Hendriksen et al., 2001). Increased abundance o f a specific a-tubulin protein spot in the 
mitochondrial fraction was also noted in the kainic acid model (Hendriksen et al., 2001). In 
contrast, 2-DE analysis of hippocampi from patients with mesial temporal lobe epilepsy 
revealed reduced levels of both a and ^-tubulin compared to controls (Yang et al., 2004).
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In the present study (at 2 days post-SE), increased levels of a low molecular weight form of 
a-tubulin that may correspond to a breakdown product were detected, which could be 
suggestive of increased degradation, as in patients. However, similarly to the kainic acid 
model, our western blot analysis showed that the main full length form of a-tubulin is also 
present at increased levels following pilocarpine-induced SE (while (3-tubulin is unaffected). 
We did not detect a 50 kDa a-tubulin spot with altered abundance by 2DE, but as this 
protein is present as multiple spots on 2D gels (Greene et al1, 2002; Yang et al., 2004), it is 
likely that the variation in individual spots was insufficient to be detected in this study or 
that additional altered species (eg, post-translational variants) are present but with pi values 
outside the range used in our gels.
Although differences exist between human patients and the rat models (see section 3.1 and 
3.2), the more likely explanation for the discrepancy between our findings and in human 
patients is that this comparison relates to different stages of the disease process (Yang et al., 
2004). The human study was performed using samples resected from patients with 
epilepsy, whereas our study is performed on rats before the occurrence of spontaneous 
recurrent seizures.
Overall, alterations in abundance o f tubulin and DRP-2 suggest that there may be 
considerable synthesis and/or remodelling of the microtubule-based cytoskeleton early in 
the pathogenic process and that, at late stages of disease, cytoskeletal proteins may be 
degraded as hippocampal damage progresses.
7.4.6. E^rin
Another cytoskeleton-associated protein found to be up-regulated following SE was ezrin, 
a member of the ezrin-radixin-moesin (ERM) family o f proteins. These proteins act as 
linkers between integral membrane proteins and the actin cytoskeleton and as signal 
transduction molecules in RhoGTPase signalling to the cytoskeleton (Tsukita and 
Yonemura, 1997; Ivetic and Ridley, 2004). They are thought to be involved in regulation of 
cytoskeletal dynamics required for maintenance o f cellular morphology, cell-cell adhesion 
and formation of membrane structures such as ruffles and microvilli (Ivetic and Ridley,
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2004). Interestingly, ezrin was previously found at increased abundance in 2DE analysis of 
mesial temporal lobe epilepsy (Yang et al., 2004).
The observation of increased levels of ezrin both in human patients (Yang et al., 2004) and 
in the rat only 2 days after SE (this study), suggests that this may be a relatively early and 
long-lasting change. Although, like tubulins, ezrin is present in multiple post-translationally 
modified forms (Tsukita and Yonemura, 1997; Yang et al., 2004), increased levels of ezrin 
have been found in epilepsy patients, in contrast to tubulin. Therefore the time-course and 
functional consequences of changes in the levels of specific forms of cytoskeletal 
components may be an interesting avenue for future studies on the pathogenesis of 
epilepsy.
7.4.7. Dihjdropteridine reductase
Dihydropteridine reductase (DHPR) catalyses the production of 5,6,7,8- 
tetrahydrobiopterin (BH4) from quinonoid-dihydrobiopterin. This is a key metabolic 
reaction as BH4 has numerous cellular functions including acting as co-factor in 
degradation of phenylalanine, tyrosine and tryptophan by aromatic amino acid 
hydroxylases, and as an essential co-factor for nitric oxide synthase (NOS) (Ponzone et al., 
2004).
Deficiency of DHPR results in BH4 deficiency whose major pathogenic features are 
hyperphenylalaninemia and reduced synthesis of dopamine and serotonin (Ponzone et al., 
2004). In contrast we observe increased abundance o f DHPR in the pilocarpine-treated 
hippocampus that would suggest that this would lead to an elevation in BH4 levels. 
Moreover, as BH4 is a co-factor for NOS, which produces nitric oxide, it may be 
hypothesised that this increase in BH4 may relate to the concomitant increase in 
hippocampal CBF that was observed with MRI.
The relationships between DHPR, BH4 and NOS may also suggest a role in SE-induced 
hippocampal injury. Firstly, increased levels of BH4 have been proposed to contribute to 
neuronal cell death, via its role in NOS production, after forebrain ischemia in the rat (Cho
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et a l, 1999). In addition, NOS has been shown to be up-regulated within this early period 
following SE and directly contributes to neuronal death (Chuang et al., 2007). On the other 
hand, BH4 has also been suggested to possess a capacity for protection against NO toxicity 
(Koshimura et al., 2000). It is also notable that BH4 may contribute to neuronal death 
directly as this protein can increase Ca2+ channel currents (Koshimura et a l , 2000). 
Nevertheless the relationships between these proteins require further study in SE-induced 
pathology.
It is interesting to note that new pharmacological approaches that directly modulate the 
levels of BH4 have been proved to be effective for certain clinical conditions such as 
hypertension (Forstermann, 2006) and also new agents that act on the BH4 binding site on 
NOS have been proposed as a novel approach for conditions such as inflammation, sepsis 
and stroke (Matter and Kotsonis, 2004). Whether these agents can be used to modulate 
hippocampal injury after SE and epileptogenesis remains to be seen, but the association 
with inflammation and cell death mechanisms, which have been implicated in SE-induced 
pathology, means that these agents are an attractive avenue for research and therapy 
development.
7.4.8. Down-regulation ofprotein species
Among very few spots that were significantly down-regulated following SE, we identified a 
histone-lysine N-methyltransferase (H3 lysine-4 specific SET7), which methylates lysine 4 
of histone H3. Assembly of methylated histones at gene promoters influences regulation of 
transcription through interaction with different effector proteins (Sims, III and Reinberg, 
2006). In general, methylation at lysine 4 is associated with active transcription at a locus, 
although some interacting proteins may also be repressive (Sims, III and Reinberg, 2006). 
Thus, if pilocarpine treatment leads to reduced levels and activity o f the histone-lysine N- 
methyltransferase that is specific for lysine-4, a downstream consequence could be altered 
transcription of specific genes, which could contribute to the subsequent pathogenesis.
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7.5. CONCLUSION
In summary, during the period in which a maximum MRI-detected response in the 
hippocampus is observed following SE, there are concomitant changes in the levels of 
various proteins. Although the precise functions of these proteins, in the context of SE, are 
not completely understood, these proteins have been associated with pathogenic, 
neuroprotective and neurogenic responses and may therefore have an important role to 
play in the progression of brain injury and the development of epilepsy.
As only a subset of proteins were investigated in this study, further studies are required to 
address the later time-course of proteome changes and to examine more acidic and basic 
subsets of proteins than examined here. The identification of relevant proteins in the 
pathogenic process may allow the development of strategies for manipulation of protein 
expression that will reduce hippocampal injury and subsequent epileptogenesis.
This study demonstrates that MRI and proteomics can be used as complementary 
technologies to identify and examine regions vulnerable to pathological change, and that 
this can lead to potentially important testable hypotheses. This approach should be pursued 
in future studies.
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CHAPTER 8: M RI DURING STATUS EPILEPTICUS
From a little spark may burst a flam e
Dante Alighieri
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8.1. INTRODUCTION
The nature of the onset and progression of seizures have been associated with various 
physiological phenomena in which alterations in blood flow, pH and glucose utilisation 
have been reported (Lothman, 1990). These alterations in physiology in response to 
seizures have been hypothesised to fall into two distinct periods: compensation and 
decompensation, which have been described in section 2.1.3 (Lothman, 1990; Shorvon, 
1994). In brief, the compensation phase describes the early period of SE in which various 
physiological processes are recruited to meet the extra demands from continuous seizure 
activity, whereas the decompensation phase occurs around 30 minutes of continuous 
activity and parallels the failure of these physiological processes and the appearance of 
neuronal injury. One process that fails during the decompensation period is cerebral 
autoregulation, defined as the capacity of the cerebral circulation to maintain blood flow at 
a relatively constant level, and at this point blood flow becomes wholly dependent on 
systemic flow, which consequently may exacerbate injury (Meldrum and Nilsson, 1976).
It is widely accepted that the increase in global CBF more than compensates for the 
increase in 0 2 demand during the early compensation period (Meldrum and Nilsson, 1976; 
Kreisman et al., 1991; Shorvon, 1994) and that the magnitude of the increase in CBF 
becomes progressively smaller as the seizure continues, while the cerebral metabolic rate of 
oxygen (CMRO^ remains elevated (Meldrum and Nilsson, 1976). As a consequence of this 
gradual reduction, CBF would eventually approach a critical level for supplying adequate 
0 2 to the brain (Meldrum and Nilsson, 1976). Thus a mismatch between the supply of 
nutrients from the blood and the enhanced energy demand from the seizing neurons may 
contribute to injury in the vulnerable regions of the brain.
The hippocampus is an area that displays a selective vulnerability to SE and it is has been 
hypothesised that the resulting injury caused by SE predisposes to epilepsy. The selective 
vulnerability to SE is supported by the studies described in chapter 6 and 7 as well as 
reports that neuronal injury occurs almost exclusively in the hippocampus with seizures of 
shorter duration, and also that this region shows a progressive and pronounced atrophy 
following SE (Fujikawa, 1996; Roch et al., 2002a; Nairismagi et al., 2004). Furthermore, the
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specific hippocampal subfields injured by SE resemble the characteristic selective cell loss 
seen in patients with MTS-TLE, which suggests a causative relationship between SE- 
induced hippocampal injury and subsequent epilepsy (Shorvon, 1994). However, the 
precise mechanisms that underlie this selectivity to injury remain unclear.
A hypoxic/ischaemic mechanism was initially proposed as the main mechanism for SE- 
induced injury due to the histological similarities observed between the hippocampal injury 
induced by SE and by global ischaemia (Siesjo and Wieloch, 1986; Shorvon, 1994). 
However, it is now widely considered that excitotoxicity, as a result of excessive neuronal 
activation, is the primary mechanism for seizure-induced injury (Meldrum and Brierley, 
1973; Olney et a l, 1974; Lothman, 1990). This emerged from studies demonstrating teat 
the hippocampus can sustain injury in the absence of hypoxia (Pinard et al., 1987; Shorvon, 
1994). Nevertheless it has also been hypothesised that a localised failure in the vascular 
system may act to exacerbate injury, and as yet the regional contribution of this 
phenomenon has yet to be fully determined (Meldrum and Nilsson, 1976; Kreisman et a l, 
1991).
The regional CBF response to SE in animal models has been reported to be dependent on 
the specific actions of the particular agent used for seizure induction. Bicuculline, a 
selective GABAa antagonist, induces a similar CBF response in the neocortex and the 
hippocampus. In contrast, kainic acid produces CBF changes in which the hippocampal 
CBF is much greater than neocortical blood flow (Pinard et al., 1984). However, 
contradictory reports exist in that a relative ischaemia in the hippocampus has also been 
reported following kainic acid-induced SE (Tanaka et al., 1990). The regional CBF changes 
during pilocarpine-induced SE have not been widely investigated.
MRI can be used to investigate the processes that occur during SE and can provide 
information about the regional nature of SE (King et al., 1991; Zhong et al., 1993; Prichard 
et al., 1995; Engelhorn et al., 2005). Perfusion MRI has been widely used to investigate 
cerebral ischaemia, and the arterial spin labelling technique can be used for the non- 
invasive in-vivo measurement of cerebral blood flow (CBF), which is unparalleled within 
medical imaging (Alsop and Detre, 1996; Thomas et al., 2000; Lythgoe et al., 2002). This 
technique also offers good spatial and temporal resolution, and therefore makes it an
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increasingly popular technique for investigating the delivery of blood water to tissue. 
However, only one previous study has investigated perfusion changes during SE with MRI, 
from which the authors suggested that there is a regional relationship between the 
maximum decrease in perfusion and subsequent neuronal loss, although this study only 
investigated relative CBF (Engelhorn et al, 2005). The study reported in this chapter aimed 
to use MRI to investigate quantitative regional perfusion changes during the course of 
pilocarpine-induced SE. In order to do this, a number of methodological developments 
were first required, as outline in section 5.3.
186
8.2. M E T H O D S
8.2.1. 'Experimental design
All animal care and procedures were carried out in accordance with the UK Animals 
(Scientific Procedures) 1986 Act.
16 adult male Sprague-Dawley rats (300-400g, Charles Rivers) were divided into two 
groups: pilocarpine (n = 13) or saline (n = 3). Once the animals had been prepared for 
imaging, the animals were given scopolamine (lmg/kg). T t images were acquired at the 
beginning of the experiment for the purposes of CASL calculations. Thereafter perfusion 
imaging was performed for the duration of the experiment.
The experimental design is outlined in figure 8.1. The first 30 minutes of MRI were 
acquired for baseline measurements after which the animals were administered either 
pilocarpine (375mg/kg) or saline. Bench experiments (see section 5.3) indicated that SE 
began approximately 30 minutes following pilocarpine administration; therefore the 
animals were imaged for 150 minutes before diazepam (lOmg/kg) was given. After 
diazepam the rats were imaged for up to a further 1 hour. The animals were visually 
assessed for seizure activity following each set of diffusion and perfusion acquisitions.
Baseline Pilocarpine Early SE Late SE Diazepam
f  A f  /s *\ r A N r A \ r  A "\
I__________I_________ I__________I__________I__________I__________I
0 30 60 150 180
U mins t
Pilocarpine Diazepam
Figure 8.1. Experimental design for M RI during SE. The key events that occur over the course of M R  
imaging: pilocarpine at 30mins, SE starts at 60mins and diazepam was given at 150mins.
187
8.2.2. MRI
Animals were anesthetized with intraperitoneal injections of fentanyl citrate (300pg/kg) 
and medetomidine (300pg/kg). 1 h following the initial dose of fentanyl, a bolus of 
fentanyl (100|ig/kg) was given every 30mins to maintain anaesthesia. 0 2 was delivered 
continuously via a nose cone. Rats were placed on a probe with a nose cone and secured 
using the various adaptations outlined in section 5.3.4 to minimize motion artifacts. 
Physiological monitoring included electrocardiography (ECG) recordings and rectal 
temperature recordings. Temperature was maintained at 37 ± 2 °C using an air warming 
system.
Images were acquired using a volume transmitter coil and a separate decoupled surface 
receiver coil. A central coronal imaging slice was selected that included the hippocampus 
(fig 8.2) (-4.8mm from bregma). The central slice was determined by visual inspection of 
anatomical landmarks.
Figure 8.2. Location of imaging slice (-4.8mm from bregma) in relation to the whole rat brain (adapted 
from Paxinos et aL).
\
All sequences were run on a 2 mm-thick coronal slice. A low average perfusion acquisition 
was used in this study, the reasons for which have been outlined in section 5.3.5.
Tj images were acquired with parameters as previously described (section 6.2.4), which 
were required for the calculation of CBF, and these scans were acquired at the beginning of 
each study. Following the acquisition of T, images, perfusion experiments were conducted 
contiguously. For perfusion-weighted imaging, the CASL method was used and all
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parameters remained the same as previously described (section 6.2.4) with the exception of 
the number of averages that were reduced from 88 averages to 22 averages for this study.
Duration of acquisitions: Tj = 11 mins and CASL = 4 mins. Each animal was scanned for a 
total time of 3h.
8.2.3. Data processing
8.2.3.1. Regionalpeifusion-weighted signal intensity ratios and CBF quantitation
Tj maps, the base images acquired for the CASL acquisition and perfusion-weighted images 
were reconstructed using in-house software written in Matlab version 6.5 (MathWorks, 
Massachusetts, USA) in order to obtain quantitative T\ and perfusion-weighted signal 
intensities for CBF quantitation.
Motion during image acquisition can cause variation in signal intensity of the image that 
can result in error in the calculation of CBF. This error leads to a modulation of signal 
across the entire image and thus across all regions. Therefore to minimise the effects of 
motion, ratios were calculated to determine regional changes during SE.
8.2.3.2. Criteria for inclusion of data for analysis
The following criteria were used to identify and exclude images with motion artefacts, and 
therefore to determine which images could be included for analysis. The criteria were first 
applied to the control images (i.e. prior to subtraction) to identify motion affected images, 
and then for perfusion-weighted images to account for systematic errors introduced by the 
instrumentation:
1) All base images from a single experiment were visually assessed using MRIcro 
software (version 1.40). The software provides a facility to view the experiments 
along the time domain (fig. 8.3a), and therefore images that have been corrupted by
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m otion, which would result in a change in signal intensity, can be identified and 
thus excluded from the analysis (fig. 8.3).
2) M otion can also lead to a shift in the position o f  the imaging slice, and averaging 
images from different positions can cause error in the analysis. Therefore for every 
animal, each image was compared visually to the previous acquisition to determine 
which images could be averaged together for analysis. I f  the animal moved, the 
regions o f interest were redrawn to ensure that they corresponded to the correct
i
anatomical regions. Finally, if  the hippocam pus could no t be identified in the 
imaging slice, the complete data set was excluded from the analysis.
Figure 8.3. M R data set in an anaesthetised pilocarpine-injected animal. Visual assessment using 
MRIcro software displayed the data for the duration of the entire experiment, a) denotes view along the \  
andy-axis; h) along the  ^and x-axis; and c) along they and x-axis. Blue lines correspond to the syaxis 
(time domain), yellow for x  (read), and redfory (phase-encoding). The white arrow indicates an acquisition 
in which there was a reduction in signal and therefore was removed from the analysis.
8.2.3.3. Post-process averaging
The images that m et the inclusion criteria (section 8.2.3.2) were averaged across 5 distinct 
periods, which were determined by the E E G  experiments described in section 5.4 and the 
previous studies reviewed by Lothman (Lothman, 1990). These were:
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1) Baseline
2) Within the first 30mins following pilocarpine administration. This is the period 
before SE occurs.
3) 30-60mins after pilocarpine. From our previous experiments, this period 
coincides with the first 30mins of SE and has been associated with the 
compensation phase of SE.
4) 60-150mins after pilocarpine. This period is associated with the latter stages of 
SE and this is considered to be the decompensation phase.
5) After approximately 150mins, diazepam was administered to the animal, and 
this period should reflect the gradual cessation of epileptic activity.
8.2.3.4. Regions of interest
Three regions of interest - cortex, hippocampus, thalamus - were delineated on all 
processed images and analysed with in-house Matlab software and ImageJ version 1.38x 
(National Institutes if Health, USA).
8.2.3.5. Statistical Analysis
For CBF measurements, a repeated measures (degrees of freedom-adjusted mixed-model) 
ANOVA with contrasts to the baseline scans and the hippocampus was conducted. The 
main effects were as follows: group (pilocarpine, saline); time (pre, pilocarpine, SE, SE late, 
diazepam); anatomy (cortex, hippocampus, thalamus).
Similarly, for perfusion-weighted ratios relative to the hippocampus, a repeated measures 
(degrees of freedom-adjusted mixed-model) ANOVA with contrasts to the baseline scans 
and the hippocampus were conducted. The main effects were as follows: group 
(pilocarpine, saline); time (pre, pilocarpine, SE, SE late, diazepam); anatomy ratios 
(cortex:hippocampus, thalamus:hippocampus).
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8.3. RESULTS
8.3.1. CBF measurements
In total, 7 animals were included for analysis from the pilocarpine group. Figure 8.4 and 
table 8.1 show the CBF measurements in the cortex, hippocampus and the thalamus over 
the course of the experiment. For comparison, the saline-injected animals showed no 
systematic effects (see fig. 8.4 a) prior to administration of diazepam.
Pilocarpine CBF (ml/100g/min)
Cortex Hippocampus Thalamus
Baseline 122 ±11.0 96 ±13.9 109 ±15.0
Pilocarpine 234 ±32.1 118 ±21.0 155 ±24.4
Early Se 121 ±24.4 65 ±18.7 108 ±12.2
LateSe 132 ±31.6 105 ±14.6 153 ±30.2
Diazepam 165 ±24.2 90 ±27.2 150 ±28.4
Table 8.1. Mean regional CBF measurements before, during, and after SE. Regions include the cortex, 
hippocampus and the thalamus. CBF expressed as mean + s.e.m.
Statistical analyses indicated a regional pilocarpine effect on CBF (F = 5.06, p = 0.031) (see 
fig. 8.4b). No significant difference was found between the CBF in the hippocampus and in 
the thalamus (F = 0.766. p = 0.407). In contrast, significant differences were found 
between the hippocampus and the cortex (F = 14.73, p = 0.005). Analyses indicated that 
the CBF in the hippocampus and the cortex changed significantly with time. Comparisons 
between the magnitude of CBF change from baseline of the pilocarpine-injected animals 
and the saline-injected controls indicated that there were significant differences between 
the hippocampus and the cortex following pilocarpine injection (F = 9.45, p = 0.014) and 
during early SE (F = 6.87, p = 0.031), but no significant differences were observed for the 
late SE period (F = 1.76, p = 0.221) or following diazepam injection (F = 0.162, p = 
0.698).
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a) Saline b) Pilocarpine
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Diazepam
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60-150 150-180 
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Early SE Late SE Diazepam
Cortex Hippocampus Q  Thalamus
Figure 8.4. CBF measurements over the course of SE  in the cortex, hippocampus, and the thalamus, a) 
Saline treated rats (n — 3), b) Pilocarpine treated rats (n = 7). Data expressed as mean ± s.e.m.
8.3.2. Regionalperfusion-weighted signal intensities and CBF measurements relative to the hippocampus
Figure 8.5 and table 8.2 shows the changes in perfusion-weighted signal intensity and CBF 
in the cortex and the thalamus relative to the hippocam pus for the pilocarpine-injected 
animals. These data dem onstrated that regional changes occur following either saline or 
pilocarpine administration that were independent o f  uniform  signal change due to motion. 
Figure 8.6 shows representative perfusion-weighted images after injection o f  either saline 
or pilocarpine in which the perfusion changes in the hippocam pus relative to the cortex 
can be observed.
Pilocarpine perfu sio n -w eig h ted  s ig n a l in ten sity  ratio
Cortex:Hippocampus Thalamus:Hippocampus
Baseline 
Pilocarpine 
Early Se 
Late Se 
Diazepam
1.44 ±0.17 
2.07 ±0.26 
2.88 ± 0.48 
2.27 ± 0.35 
2.16 ±0.46
0.73 ± 0.06 
0.87 ±0.1 
1.55 ±0.47 
0.96 ±0.15 
1.09 ±0.14
Table 8.2. Mean regional perfusion-weighted signal intensity ratios relative to the hippocampus before, 
during, and after SE. Regional ratios include cortex, and thalamus. CBF ratios expressed as mean ± 
s.e.m.
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Similarly to the CBF changes observed, a repeated measures A N O V A  analysis, which 
included the cortexihippocampus and thalamusihippocampus ratios for all animals, 
indicated that pilocarpine had a highly significant regional tim e-dependent effect on 
perfusion (F =  28.8, p = 0.001). Analysis with contrast to baseline measurements provided 
weak evidence o f  an effect by pilocarpine after administration (F =  4.32, p = 0.07), and 
also demonstrated a significant effect in the early phase o f SE (F = 6.87, p = 0.03). 
However, these regional differences were not observed subsequently: late phase o f  SE (F = 
1.48, p = 0.26); and after dia2 epam administration (F = 1.63, p = 0.24).
a) Saline, cortexihippocampus
Baseline Pilocarpine Early SE Late SE Diazepam
c) Saline, thalam usihippocam pus
Baseline Pilocarpine Early SE Late SE Diazepam
□  CBF ratio
b) Pilocarpine, cortexihippocam pus
4
3 
2 
1 
0
d) Pilocarpine, thalam usihippocam pus
4 
3 
2 
1 
0
■  Perfusion-weighted ratio
Baseline Pilocarpine Early SE Late SE Diazepam
Baseline Pilocarpine Early SE Late SE Diazepam
Figure 8.5. Mean regional changes relative to the hippocampus for CBF measurements and for the 
perfusion-weighted signal intensities, a) saline-injected, cortexihippocampus; b) pilocarpine-injected, 
cortexihippocampus; c) saline-injected, thalamusihippocampus; d) pilocarpine-injected, 
thalamusihippocampus. Data expressed as mean ± s.e.m.
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HIPPO
a) Post-saline b) Post-pilocarpine
Figure 8.6. Pe fusion-weighted images post-injection from a) a saline-injected animal and b) a 
pilocarpine-injected animal These images were the average of all perfusion data following injection from 
single animals. The regions are: CTX, cortex; HIPPO, hippocampus; and TH AT, thalamus. Note the 
limited perfusion change in the hippocampus compared to the cortex. Scale bar in a) equals 2mm.
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8.4. DISCUSSION
These results demonstrate that MRI can be used to investigate SE and provides 
information about regional CBF changes during the course of a prolonged sei2ure. The 
experiments required methodological developments that were described in chapter 5. 
Results indicate that, over the course of SE, cortical perfusion changes occur to a greater 
degree than hippocampal perfusion. After diazepam administration there was an observed 
return to baseline across all regions, which may reflect the suppression of seizure activity by 
diazepam.
8.4.1. Absolute CBF, regional CBF ratios, and regionalperfusion-weighted signal intensity ratios
CBF measurements can be influenced by motion that may result in variation, which may 
lead to errors in the calculation of CBF. For this reason, the analysis and interpretation of 
the data was based not just on absolute CBF, but also on CBF ratios between different 
regions. Together, these data indicate that cortical perfusion changes to a greater degree 
than hippocampal perfusion following pilocarpine injection.
8.4.2. Perfusion changes during SE
Seizure-associated increases in CBF have been demonstrated in animal models (Meldrum 
and Nilsson, 1976; Tanaka et al., 1990; Kreisman et al., 1991; Shih and Scremin, 1992; 
Andre et al., 2002; Nersesyan et al., 2004); however, the regional profile of seizure associated 
CBF changes remain unclear.
In the experiments reported here, regional CBF changes were observed over the course of 
SE indicating that there was a greater increase in the cortex than in the hippocampus after 
pilocarpine administration and during early SE. A similar pattern was also observed in the 
thalamus relative to the hippocampus. Flowever, the degree o f perfusion change in the 
cortex tended to be greater than the thalamus, which suggests that the regions respond in a
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different manner following pilocarpine injection. Furthermore, the ratios of perfusion 
changes relative to the hippocampus indicate that both the cortex and the thalamus have 
consistently higher flows than the hippocampus following pilocarpine administration.
The increases in cortical and thalamic CBF are consistent with previous studies of CBF 
changes during seizures, and accompanying increases in glucose utilisation and increased 
CM R02 have also been reported (Pinard et a l, 1984; Tanaka et al, 1990; Kreisman et al, 
1991; Shih and Scremin, 1992; Andre et a l, 2002). These data suggests that increases in 
CBF act to compensate for the increase in nutrient demand that the seizing neurons require 
in the early phase of seizures. However, during the late SE period, the perfusion data 
indicate a decline in the magnitude of signal change that may reflect the hypothesised 
failure of cerebral autoregulation. This decline of the cerebral vascular system due to 
persistent and prolonged seizure activity may eventually lead to a mismatch in energy 
supply and demand (Meldrum and Nilsson, 1976; Kreisman et al, 1991).
In summary, the results from the current study indicate that CBF in the hippocampus does 
not increase to the same degree as the cortex. The differences between cortical and 
hippocampal CBF responses has been previously noted by Pinard and colleagues (Pinard et 
a l, 1987). In contrast to the present study, they reported a substantial increase in 
hippocampal CBF compared to the cortex following kainic acid induced SE. However, 
they also noted that there were no apparent differences in cortical and hippocampal CBF 
when the bicuculline method of SE induction was used (Pinard et a l, 1987). Therefore, 
these data suggest that the CBF response depends on the induction method. It is also 
noteworthy that intra-amygdala seizure induction with kainic acid has also been shown to 
demonstrate a limited CBF response that could not account for the concomitant glucose 
requirement in the hippocampus (Tanaka et al, 1990).
The study detailed in section 5.4.2 demonstrated that pilocarpine can be used to induce 
prolonged seizure activity under fentanyl/medetomidine anaesthesia, and previous studies 
have also demonstrated a concomitant increase in glucose utilisation in the hippocampus 
using the pilocarpine method of seizure induction (Handforth and Treiman, 1995). These 
data therefore suggest that there is an increase in energy demand in the seizing 
hippocampus. However, the relatively limited CBF change in the hippocampus may
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therefore suggest that in the current set up there may be a regional mismatch between 
nutrient demand and supply that may contribute to pilocarpine-induced injury.
Pilocarpine acts preferentially on the muscarinic component of the cholinergic system, 
whereas soman is a cholinesterase inhibitor that, in effect, acts on both the muscarinic and 
nicotinic systems (Shih and Scremin, 1992; Cavalheiro, 1995). This is in contrast with kainic 
acid model, which acts on the glutamatergic system, and bicuculline, which acts on the 
GABAa network (Meldrum and Nilsson, 1976; Pinard et a l, 1987; Tanaka et al.y 1990). 
Therefore the physiological changes associated with SE induction with pilocarpine and 
soman can be compared as both agents act on the cholinergic neurotransmitter system. 
CBF with glucose utilisation was investigated in soman-induced SE by Shih and colleagues 
who observed a lower proportional increase of CBF relative to glucose utilisation in the 
hippocampus (Shih and Scremin, 1992). Taken together with the results from the present 
study, these data support the hypothesis that a relative ischaemia occurs in the 
hippocampus during cholinergic induction of SE through an uncoupling of CBF and 
metabolism.
There is only one previous paper that has investigated perfusion changes during SE with 
MRI (Engelhorn et al, 2005). However, significant methodological differences exist 
between this study and that of Engelhorn and colleagues, including perfusion imaging 
technique, as well as SE assessment, and regional assessment of perfusion changes. 
Therefore it is not possible to compare between the two studies.
As previously noted, excitotoxicity is widely accepted as the main mechanism of seizure- 
induced injury (Lothman, 1990; Shorvon, 1994; Chen and Wasterlain, 2006). Studies that 
have demonstrated seizure-induced cell death in the absence of a hypoxic/ischaemic 
mechanism support this hypothesis (Pinard et al., 1984; Shih and Scremin, 1992). Further 
evidence includes observations of neocortical damage occurring despite CBF matching 
glucose demand, which was not found in the hippocampus (Shih and Scremin, 1992). 
However, the regional selectivity of SE-induced injury may indicate that specific regions, 
such as the hippocampus, have additional factors that underlie their vulnerability. Low 
levels of calcium-binding proteins as well as the relative abundance of NMDA receptors 
and KA receptors found in this region have been proposed to underlie this vulnerability
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(Cendes, 2004). Also the contribution of hyperpyrexia, as well as a decrease in pH, increase 
in intracellular calcium, and excessive activity of excitatory neurotransmitters may play key 
roles. The current study supports the view that a relative ischaemia may contribute to 
hippocampal injury resulting from pilocarpine-induced SE.
8.4.3. Selective population of animals
The main limitation in this study was that the periods associated with motion were omitted 
from the current analysis due to the resulting degradation of the images, therefore only a 
selective population of animals were included in the study. The study described in section 
5.4.2 reported that the tonic limb extensions were likely to cause motion problems because 
of the movement of the head, but this could not be confirmed direcdy as it is not possible 
to observe the animals during image acquisition. It was therefore by inference that the 
images omitted included these periods o f tonic motion. These movements are associated 
with generalised tonic-clonic seizures (Mares and Kubova, 2006) and reflect the tonic 
component of the seizure. However, tonic seizures have been associated with activation of 
the brainstem network, whereas the clonic stage is associated with forebrain networks, 
which include the hippocampus (Andre et al., 2002). Although it is unclear whether these 
periods play a role in hippocampal injury, the omission of the tonic seizures should be 
considered in the interpretation of these results in that further perfusion changes may be 
expected during these seizures. Therefore, one of the limitations of the current study was 
that a possible contributory mechanism to SE-induced brain injury could not be 
investigated with the current set-up.
Future studies should consider the use of neuromuscular blocking agents that would allow 
the inclusion of all aspects of seizure-associated CBF changes. Furthermore, particularly 
motion sensitive techniques, such as diffusion imaging, may be investigated in parallel with 
perfusion changes. Diffusion imaging is thought to provide an indication of cytotoxic 
oedema as a result of energy failure (Gass et al!, 2001): as the energy-requiring pumps, such 
as the Na+/K + ATPase, that maintain the electrochemical gradient across the cell 
membrane fail, which leads to cell swelling. Therefore diffusion interleaved with perfusion
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acquisitions may indicate the point at which energy failure begins with respect to CBF 
changes in pilocarpine-induced SE.
8.5. CONCLUSION
In conclusion, this study indicates that regional CBF changes occur in vivo during 
pilocarpine-induced SE under fentanyl/medetomidine anaesthesia. Cortical perfusion 
increased significantly more than hippocampal perfusion and these data support a 
hypothesis that a relative ischaemia may play a role in the selective vulnerability of the 
hippocampus to SE.
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CHAPTER 9: DISCUSSION
A journey of a thousand miles begins with a single step
Lao-Tzu
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The overall aim of the work presented in this thesis was to investigate the hypothesis that 
status epilepticus, acute hippocampal injury, mesial temporal sclerosis and temporal lobe 
epilepsy are causally related. Clinical studies have indicated that these events occur in 
humans, and provide the basis for the hypothesis that SE may cause brain injury which 
may progress on to MTS associated with epilepsy and cognitive dysfunction. Furthermore 
as MTS associated epilepsy is particularly difficult to treat with conventional medical 
therapies, it is the most common type of epilepsy that requires surgical intervention. 
Therefore, there is a real clinical need to understand the sequence of events from the onset 
of SE to hippocampal oedema, through to hippocampal sclerosis and associated epilepsy as 
this may facilitate the development of neuroprotective and anti-epileptogenic strategies. 
However, as ethical and practical considerations preclude a comprehensive characterisation 
of these events in patients, an alternative can be to use animal models to investigate these 
processes. Thus, the pilocarpine rat model was chosen in which SE, brain injury, and mesial 
temporal sclerosis with epilepsy occur that are hypothesised to be key characteristics that 
mimic SE associated pathologies in humans.
For this work, MRI was used to investigate these processes as this technology offers a non- 
invasive multi-parametric quantitative monitoring of brain events, and therefore provided a 
means to investigate the temporal characteristics of SE associated phenomena. Moreover 
as MRI is routinely used in the clinical setting due to its non-invasive nature, this provides a 
possibility of research directly translatable from bench to clinic.
The work in this thesis followed two distinct themes due to divergent methodological 
needs: MRI for monitoring the evolution of brain injury following SE, and MRI during SE. 
Chapter 5 describes some of the methodological developments that were required for both 
themes. For the MRI after SE, preliminary studies were performed to establish the 
feasibility of imaging the pilocarpine-treated animals over a prolonged period and to 
provide an indication of appropriate time points for the final study. For MRI during SE, a 
new method for inducing SE under fentanyl/medetomidine anaesthesia was developed for 
these purposes, but this set-up presented problems with movement that affected the MRI 
scanning. Thus, changes were made to the design of the MRI animal holder, and a low
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average perfusion acquisition was developed to minimise the problems associated with 
motion.
Chapter 6 deals with the evolution of brain injury following a 90 minute seizure. The novel 
aspects of this study were the inclusion of in vivo CBF and T t measurements in combination 
with quantitative T2 and ADC, with a focus on the early changes following SE. In addition, 
this was the first study that included control groups for investigating the possible effects of 
a long term exposure to isoflurane anaesthesia.
The monitoring with multi-parametric MRI demonstrated that a transient event occurs 
following SE, which normalises within 7 days; however hippocampal atrophy continues 
after this period. These findings are consistent with previous studies that have reported 
similar changes in humans and also in experimental models (Roch et a i 2002a; Scott et al., 
2003; Nairismagi et al, 2004). In addition, peak hippocampal changes in T l3 T2 and CBF 
were observed 2 days following SE during this transient period and were found to be 
predictive of hippocampal volumes measured on day 21, which therefore suggests that a 
biomarker for injury has been identified. Previous MRI studies following SE have not 
identified such a biomarker. The present experimental design differed from previous 
studies due to the emphasis on the characterisation of early injury and continued 
monitoring into the medium term. Also, quantitative multi-parametric MR measurements 
were used which included CBF and Tr  It is these elements in the experimental design that 
provided the basis for identifying the MRI biomarker at the day 2 time point. This study 
demonstrated that, for the first time, early non-invasive imaging can be used to reveal the 
evolution of hippocampal injury following SE.
In chapter 3 the role of animal models in medical research was commented on. It was 
emphasised that it is not ethical or practical to image patients for the characterisation of 
brain injury in such a sustained manner as this experiment, and this underlies the need for 
animal models. One of the possible consequences of this study in an animal model is that 
these findings may be directly translated back in to the clinical domain. Previous clinical 
studies have identified T2 increases during this early period in the hippocampus, suggesting 
that similar processes may occur in humans and animals (Scott et al., 2003). Whether this 
type of multi-parametric imaging 2 days after SE could be used to identify humans that
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may progress on to a poor outcome remains unclear. However, Tt, T2 and perfusion 
imaging are clinically approved MRI techniques that are already widely used for diagnostic 
purposes, and with the identification of a critical predictive period on day 2, it should now 
be possible to conduct such a study in humans. This may then help to identify patients 
whose hippocampi will atrophy following SE and thus offer an opportunity for 
interventional strategies.
In the context of the physiological mechanisms that underlie the MR changes detected on 
day 2, as with much of the MR literature, the precise processes remain unclear. Previous 
studies have reported that Tj and T2 increases are related to oedema (Nakasu et a l, 1995; 
Roch et al., 2002a; Nairismagi et al., 2004), and blood flow related increases have been 
identified in regions vulnerable to SE (Fabene et al!, 2003), and our findings are in 
agreement with this work. In addition, histologically- and molecular- based studies have 
provided evidence for modulation of various processes during the early period in the 
hippocampus. As described in chapter 2, these processes include cell death, neurogenesis 
and inflammation. It is possible that all of these processes, as well as perhaps others that 
have yet been identified, all contribute to the MR changes on day 2. However, these MR 
changes seem to display key characteristics that are consistent with an inflammatory 
response.
Among the four “cardinal signs” of inflammation that were first described by Celsus in the 
1st century AD are rubor (redness), tumor (swelling) and calor (heat); dolor (pain) being the 
fourth. Swelling is consistent with oedema, and both heat and redness can be generated by 
increases in blood flow to injured regions. Inflammatory markers, such as COX-2 and 
iNOS, have been identified in the hippocampus during the early period following SE and 
the temporal profile of these markers are also consistent with the transient nature of the 
MR changes (Jankowsky and Patterson, 1999; Voutsinos-Porche et a l, 2004; Turrin and 
Rivest, 2004). Thus, this supports the hypothesis that inflammation underlies the MR 
changes on day 2. If inflammation does indeed underlie these changes on day 2 then there 
may be implications for reducing the progression of SE-induced injury in that these early 
changes can be modulated with pharmaceuticals.
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While the current findings do not provide direct evidence for inflammation as the main 
contributor to the MR changes, it is possible to investigate such an effect in vivo by using 
pharmacological tools: anti-inflammatory drugs are widely used clinically and
experimentally. By using these drugs, it may prove possible to elucidate the nature of the 
biomarker. Furthermore, the relationship with early inflammation and post-SE outcome 
has not been previously investigated and such an experiment can assess the possibility of 
anti-inflammatory drugs in relation to post-SE injury. Consistent with the work presented 
in this thesis, it can be hypothesised that SE induces injury in the hippocampus and that 
the tissue responds with an inflammatory reaction. The degree of inflammation may reflect 
the severity of the initial injury, and that, as a consequence, the extent of inflammation 
measured following SE is in turn predictive of subsequent hippocampal atrophy.
Investigations were also conducted on the role of serial isoflurane anaesthesia, by 
comparing rats that were only imaged before SE and on day 21 with those imaged 
throughout the time course. Analysis of hippocampal volumes on day 21 revealed that 
there was significantly less atrophy than in the group that had serial isoflurane, suggesting 
that the serial use of isoflurane confers a degree of neuroprotection, which has not been 
previously reported following SE. Although this neuroprotective effect was found, it 
remains unclear as to whether it was the repeated nature of the anaesthesia that produced 
this effect or whether this effect was a result o f anaesthesia during the early period 
following SE. While it may also be possible that isoflurane was more efficacious at 
stopping SE than diazepam alone and therefore the imaged animals underwent a shorter 
seizure. Furthermore, as it was not possible to assess the anaesthetic in relation to the 
severity of epilepsy, the effect of isoflurane on epileptogenesis needs clarification and 
future studies should be designed to investigate this phenomenon as isoflurane may have 
therapeutic implications for post-SE pathology. Also, these data suggest that future studies 
that require the serial use of anaesthesia, such as MR studies, should consider the possible 
effect of these drugs on outcome.
Chapter 7 describes novel combined MRI and proteomic studies of the hippocampal 
changes 2 days after SE aimed at to investigating the physiological basis of these changes. 
MRI was used to monitor these early changes until day 2, at which time point the 2-DE
205
and mass spectrometry methods were used to identify the concomitant protein changes. 
The MRI results indicate hippocampal changes similar to those of the study in chapter 6, 
and a number of proteins were found to be up-regulated in the hippocampus.
HSP27, which is considered to be a marker of cellular stress, showed the highest level of 
change. Up-regulation of this protein has been shown to confer a degree of protection in 
SE (Kalwy et al, 2003). A post-translational variant of DRP-2 was also identified but the 
overall amount of DRP-2 was reduced. This protein has been implicated in neurogenesis 
and axonal guidance, and therefore modulation o f this protein may have a role to play in 
the eventual development of the epileptic circuitry. Ezrin and a-tubulin, which are both 
cytoskeletal proteins, were also found to be increased, and this may indicate the widespread 
neuronal death or remodelling that has been widely reported following SE (Fujikawa, 1996; 
Krapfenbauer et al, 2001; Nairismagi et al, 2004). DHPR was also found to be up-regulated 
in the hippocampus on day 2, and this may have a direct relationship with the increased 
hippocampal CBF. The main action of DHPR is catalysing the formation of BH4, which is 
an essential co-factor in the production of NOS (Sims, III and Reinberg, 2006). The role of 
NO in SE-induced injury remains unclear but it has been suggested to play a role in 
neuronal injury and may facilitate inflammation (Montecot et al1, 1998; Conti et al1, 2007). 
Another protein, histone-lysine N-methyltransferase, was found to be reduced and, 
although its role is unclear, a possible downstream consequence could be altered 
transcription of specific genes.
It should be noted that the proteomic approach that has been undertaken remains an initial 
early step and represents only a small proportion o f the entire population o f proteins in the 
hippocampus, and future studies may consider examining more basic or acidic proteins. In 
addition, the entire hippocampus was used for the work presented in this thesis and future 
studies may consider a more refined regional approach and isolate regions such as the CA1 
and CA3 subfields of the hippocampus that are particularly susceptible to SE-induced 
injury. Nevertheless, this study demonstrated that a combined MRI and proteomics 
method provided the means for targeting an interesting period for study. This approach 
has led to the identification of proteins that offer alternative avenues for investigations into 
hippocampal injury and, perhaps, epileptogenesis.
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Chapter 8 details the experiments in which perfusion imaging was used to investigate SE. 
Regional perfusion changes were identified, and these results indicated that, unlike the 
cortex, the hippocampus may not be receiving a sustained and increased perfusion to 
match the increase in neuronal activity, which is contrary to some studies in the literature 
(Meldrum and Horton, 1973; Shorvon, 1994). These data support the hypothesis that a 
relative ischaemia in the hippocampus may contribute to its selective vulnerability to SE.
Future studies should consider a pharmacological approach addressing the problem of 
motion associated with SE. The use o f neuromuscular blockers with 
fentanyl/medetomidine would serve to completely remove the motion problem and also, 
as ventilation would be necessary, the role o f excessive seizure activity could be 
investigated without possible confounding factors from systemic effects (Meldrum and 
Brierley, 1973). The development of such a model to investigate SE could allow new ways 
to investigate fundamental processes that occur during seizure initiation, propagation and 
termination, which are the three components of seizure evolution.
In this thesis, MRI was the main tool that was used. Its non-invasive nature and the spatial 
information that it offers made it an ideal instrument to monitor the progression of SE and 
the associated injury over time, although it is limited by the lack of specificity in that the 
processes that underlie T t, T2 and ADC are not completely understood. Nonetheless, the 
multi-parametric quantitative approach used has provided a biomarker that may be 
translatable to clinical practice, as presently a conventional clinical scanner (1.5T) has a 
similar field strength to the one used for the work presented in this thesis (2.35T). 
Advances in MRI technology have moved progressively towards MRI scanners at higher 
fields, the principal advantage of which is an increase in signal to noise ratio, which can be 
used to improve anatomic detail and reduce scan time while maintaining image quality. 
Furthermore, the development of MRI contrast agents can offer the molecular specificity 
that the methods used in the current work lack. Therefore future studies into SE should 
consider using of high field MRI scanners and also selective contrast agents.
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9.1. FUTURE DIRECTIONS
From the outset o f these experiments, it was stated that an understanding of the processes 
from SE onset through to the development of epilepsy may provide a clue to the 
development of novel preventative therapies. In light o f the identification of the early MRI 
hippocampal biomarker that can be used to predict the severity of hippocampal injury 
following SE, and the interpretation that this biomarker relates to a time point in 
inflammation, a hypothesis was generated that reducing SE-induced inflammation would 
attenuate brain injury and subsequent epileptogenesis. We have recently received funding 
for investigating this hypothesis from the Epilepsy Research UK (ERUK), who also funded 
the work presented in this thesis.
The role of inflammation following SE has been receiving increasing attention in the 
epilepsy literature, and it has been suggested to play a critical role in the development of 
epilepsy. For example, a recent study has indicated that a selective COX-2 inhibitor, which 
is a key inflammatory pathway, can reduce the severity and frequency of subsequent 
seizures. However, previous studies have not been able to monitor inflammation in vivo. 
Therefore, the methodologies developed in this project will be used to assess the acute 
efficacy of anti-inflammatory agents during this early period, and their relationship with 
later epilepsy. One of the limitations of the work presented in this thesis was that epilepsy 
was not evaluated in the animals. However, for the next study a combination of non- 
invasive imaging, video-EEG monitoring and histology will be used to assess the efficacy 
of anti-inflammatory dmgs on the development of epilepsy, the relationship between 
reduction of inflammation, as assessed by MRI, and the severity o f epilepsy, and we shall 
evaluate the use of early MRI as a biomarker for the evaluation of the development of 
epilepsy and subsequent drug therapy.
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9.2. CONCLUSION
This study has attempted to advance the understanding of status epilepticus and its 
pathological sequelae. MRI was the primary tool used in these investigations and the results 
indicate the suitability and potential of using MRI for studies into status epilepticus. For the 
first time, quantitative perfusion imaging was used to investigate the pathological sequelae 
of status epilepticus, together with traditional imaging methods, and a period during early 
injury was identified that was predictive of later injury. This suggests that MRI might be 
used to identify patients who may progress on to a poor outcome, and may be used to 
investigate neuroprotective strategies. As an animal model was used in this study, a 
combined approach with MRI and proteomics could be taken to investigate the tissue 
injury during this early period, and results indicate that during this early period a series of 
proteins are altered in the hippocampus. These proteins have a multitude of functions and 
may provide clues for alternative strategies for investigating brain injury and 
epileptogenesis.
In addition, this work in an animal model allowed the processes that occur during SE to be 
investigated with MRI. The pilot data suggest that an ischaemic mechanism may contribute 
to the vulnerability of the hippocampus to prolonged seizure activity.
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